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Abstract  
 
This study explored gender differences in quality of life and depressive symptoms over 
time among people with coronary heart disease (CHD) and compared them with a 
healthy population. Using three waves of the English Longitudinal Study of Ageing 
(2002-03, 2004-05 and 2006-07) methodological problems such as missing data and 
sources of error and uncertainty which may arise from reliance on a self-reported 
measure of CHD were addressed. 
 
A simulation study was set up to compare three techniques for dealing with missing 
data: full information maximum likelihood, multivariate normal imputation and a two-
fold fully conditional specification. Results supported the use of the latter technique 
which outperformed the other two techniques in recovering the targeted parameters, 
especially with a binary outcome.  
 
Results based on imputed data showed that compared to people from the healthy 
population, men and women with CHD had on average lower levels of quality of life. 
Men with CHD were also at higher risk of having depressive symptoms than men from 
the healthy population. Women with CHD were as likely as women from the healthy 
population to have depressive symptoms. Trajectories over time of quality of life had a 
different shape from trajectories of depressive symptoms after the onset of CHD. Men’s 
quality of life declined over time and no changes in depressive symptoms were found. 
Women’s quality of life declined only between baseline and four year follow-up, while 
in the same period their risk of having depressive symptoms reduced.  
 
A sensitivity analysis based on an external validation study and a deterministic 
sensitivity analysis helped understand the impact that misclassification of the self-
reported CHD measure could have on the results of this thesis. It was found that the 
reliability of the results presented could be affected by false positive and false negative 
cases of CHD. 
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Introduction to the thesis 
 
The present thesis focuses on gender differences in quality of life and depression 
(depressive symptoms) among older people with coronary heart disease (CHD). 
Initially, the idea of this topic came from my supervisor Dr Elizabeth Breeze who, at the 
time I started my PhD (2006), was the UCL manager of the English Longitudinal Study 
of Ageing (ELSA). She found that gender differences in quality of life and depression 
while living with angina or a history of myocardial infarction had not been researched 
systematically. We believed that ELSA could provide a unique opportunity to assess 
gender differences in quality of life and depression among people with CHD in a large 
national sample of non-institutionalized older people living in England. Using the 
ELSA data to explore gender differences in quality of life and depression could 
contribute to the existing literature, since current findings mainly come from studies that 
have focussed on patients which tend to have follow-up periods of a year or less. 
 
ELSA was designed to collect longitudinal data on health, disability, economics, social 
participation and social networks. The advantages of using these data are many, 
including the large sample size, as opposed to patient studies which usually have small 
samples; the long follow-up period (four years at the time this thesis started); the wide 
range of information collected on people’s lives allowing inclusion of several important 
covariates in the analyses; and importantly, the opportunity to use a measure of quality 
of life specifically developed for older ages, the CASP-19, as opposed to disease-
specific or health-related measures of quality of life. The term depressive symptoms 
will be used throughout the thesis to refer to people who were depressed because 
experiencing three or more depressive symptoms in the week prior to the interview. 
 
A large population study most certainly offers methodological limitations and 
challenges. As a statistician, I have an interest in addressing methodological problems 
of epidemiological studies such as sources of error and uncertainty. Two of the potential 
sources of error that I am faced with in using ELSA data may arise from missing data 
and self-reported CHD.  
 
In longitudinal studies, missing data often occur because subjects do not respond to 
certain questions (item non-response) or do not respond to a particular wave or drop-out 
15 
 
of the study (unit non-response or attrition). Both attrition and unit non-response 
contribute to lower the sample size and pose serious problems for researchers because 
missingness can affect properties of estimators and inferences. A large volume of 
methodological research is now devoted to the application of statistical techniques to 
handle missing data that arise in several settings and under different assumptions. 
Amongst the “state of the art” of missing data methods, the most widely used and 
recommended are maximum likelihood (ML) and multiple imputation methods (MI). I 
compare the performance of a ML method (full information maximum likelihood) 
against two MI methods (two-fold fully conditional specification and multivariate 
normal imputation) to deal with missing data in both continuous and binary outcomes as 
well as covariates. For doing this, I use a simulation study and the technique that is 
found to perform best is then applied to the original data. The thesis will then bring 
together substantive and methodological results.  
 
The other common source of error related to self-reported data is misclassification bias. 
In ELSA, information on diseases is collected using self-reports. It was not possible to 
have access to medical records of participants or a linkage with the Hospital Episode 
Statistics. Therefore the self-reported CHD measure available in the ELSA study could 
not be validated. For this reason, I decided to undertake a sensitivity analysis in order to 
quantify the misclassification bias and its impact on the results. 
 
Chapter 1 reviews the literature on gender differences in quality of life and depression 
amongst people with CHD, on missing data and self-reported CHD, in order to identify 
current gaps in the knowledge which then form the objectives and hypotheses of this 
thesis. Chapter 2 describes in detail the English Longitudinal Study of Ageing, the 
sample design, data collection and baseline sample characteristics. In Chapter 3 a 
comparison study of three techniques to handle missing data is conducted using a 
simulation study. First a literature review on missing data is presented, followed by a 
detailed description of the simulation study, results and discussion. In Chapter 4 the 
issue of gender differences in quality of life and depressive symptoms among people 
with CHD are explored longitudinally and missing data are imputed. First gender 
differences in quality of life and depressive symptoms are explored comparing people 
with CHD with those from a healthy group; second, men and women are compared with 
respect to four-year trajectories of quality of life and depressive symptoms. The chapter 
ends with conclusions drawn from the results. In Chapter 5 the sources of error due to 
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self-reported CHD are addressed. A sensitivity analysis based on an external validation 
study and a deterministic sensitivity analysis are conducted in order to quantify the 
misclassification bias and its impact on the results reported in Chapter 4. Chapter 6 
discusses the results, draws the conclusions, highlights the implications of the results 
found and raises questions for future research. 
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Chapter 1 Literature Review 
 
This chapter will explore the literature that is relevant to this study in order to identify 
current gaps in the knowledge which then form the objectives and hypotheses of the 
thesis. The first two sections of the chapter will review the literature on the existing 
evidence on gender differences in i) quality of life and ii) depression among people with 
coronary heart disease. The third section of the chapter reviews the literature on missing 
data and the robustness of self-reports of disease state in order to address 
methodological gaps to challenge the validity of quantitative evidence. 
1.1 Introduction  
 
Coronary heart disease (CHD) includes myocardial infarction (or heart attack) and 
angina pectoris. Myocardial infarction is caused by a blood clot that blocks one of the 
coronary arteries. The coronary arteries bring blood and oxygen to the heart, if the blood 
flow is blocked the heart muscle is damaged and might die. Angina pectoris is chest 
pain or discomfort that occurs if an area of the heart muscle does not get enough 
oxygen-rich blood. Although angina symptoms and those of a myocardial infarction are 
very similar, the amount of damage caused to the heart differs considerably. Angina is 
not a disease but a symptom of coronary heart disease which occurs on exertion and is 
relieved by rest. Therefore an angina episode does not cause any heart muscle damage 
because the blood flow is only temporarily blocked, while a myocardial infarction can 
permanently damage the heart muscle (Jevon, 2012). 
 
Traditionally coronary heart disease was considered as a predominantly male disease 
and women were often excluded from studies. In the past 15 years this belief has been 
abandoned and some research on heart disease has taken an interest in gender-based 
differences. Myocardial infarction (also known as acute myocardial infarction or heart 
attack) is common in middle aged men, while angina is the predominant presentation of 
CHD among women (Lerner and Kannel, 1986; Wenger, 2002). Later cardiovascular 
complications of myocardial infarction, which can happen months or years after the first 
event has occurred, include angina pectoris, aneurysm, congestive heart failure and the 
risk of another myocardial infarction, while cardiovascular complications of angina are 
unstable angina and myocardial infarction. The quality of life and mental health of 
people living with angina or myocardial infarction are also affected; therefore an 
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improvement in both is considered an important outcome in the life of those people with 
CHD. While there are established findings of gender differences in the manifestations, 
incidence and risk factors for CHD (Charney, 1999; Wenger, 2002; Polk and Naqvi 
2005; Stramba et al., 2006), the literature on gender difference in quality of life and 
depression in patients living with angina or myocardial infarction is not consistent.  
 
Both quality of life and depression are important outcomes in the lives of older people. 
Over the past twenty years, many studies have shown that in later life, worsening in 
mental health, as measured by both clinical and symptomatic depression, is very 
common (Baldwin et al., 2003; Beekman et al., 1995; Beekman et al., 1999; Beekman 
et al., 2002; Copeland et al., 2004; Penninx et al., 1999) with considerable impact on 
well-being and disability (Beekman et al., 2002) and increased risk of dying (Penninx et 
al., 1999, Schoevers et al., 2000). However, depression has been found to be more 
common among women than men. The evidence of higher prevalence of depression 
(minor and major) in women than in men is one of the most widely documented 
findings, in both population-based and clinical studies (Dennerstein, 1993; Kessler, 
2003). Gender differences in depression have been found to emerge during puberty 
(Angold et al., 1998) and to persist across the life course and during later life (Beekman 
et al., 1999; Cole and Dendukuri, 2003).  
 
In recent years, there has been an increasing interest in quality of life assessment among 
older people in sociological, medical and health research. In the 1970s and 1980s 
structured dependence theory dominated social gerontology in Europe. Older age was 
considered a time of potential poverty, dependency, and declining physical and mental 
health. As a consequence, ageing was perceived to decrease quality of life (William, 
1977). More recently, the concept of structured dependency has been abandoned and we 
have witnessed a shift of emphasis in social gerontology towards a positive view of 
older age as a period of life in which one is free from structured social roles (e.g. 
employment, parent of dependent children) and free to explore personal fulfilment 
(Grundy and Bowling, 1999).  Laslett (1996) in ‘A fresh map of life’ recognizes a more 
positive dimension of ageing. He sees the ‘Third Age’ as the period during which 
people are freed from work and family constraints and have time to pursue personal 
interests and a good quality of life. As the population ages and survival from coronary 
events continues to improve, assessment of quality of life has also become an important 
and useful outcome measure for evaluating the impact of disease and benefits of 
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medical interventions. As a consequence, an increasing number of studies have focussed 
on the quality of life of older people with CHD (Brown et al., 1999; van Jaarsveld et el., 
2001; Barbareschi et al., 2009).  
 
1.2 Coronary heart disease, quality of life and depression 
1.2.1 Coronary heart diseases and quality of life 
 
Improvements in treatments for coronary heart disease (CHD) have resulted in 
decreased mortality and morbidity. These treatments serve two primary goals: first, to 
prevent further progression of the disease or mortality, and, second, to relieve symptoms 
and improve function and quality of life. It is believed that following non-fatal coronary 
events patients can go back to a near normal life, which also includes going back to 
work, suggesting therefore that quality of life after a coronary event should not 
deteriorate over the long term. However, it has been demonstrated that return to near 
normal life depends on many factors and may vary by gender.  
There is the belief that an improvement in quality of life can be important as a primary 
outcome and in the determination of therapeutic benefit (Thompson and Yu, 2003). As a 
consequence, there has been increasing recognition of the importance of measuring 
quality of life among individuals following a cardiac event. Several classes of 
instruments have been designed to measure quality of life according to certain 
dimensions such as health (Turner-Bowker et al., 2002) (for which the term “health-
related quality of life” (HRQOL) is used), subjective (Hyde et al., 2003; Power et al., 
2005) and objective quality of life defined in terms of objective living conditions and 
material resources (e.g. standard of living) (Erikson, 1993). Most of the studies that 
explored quality of life among people with CHD used a health-related quality of life 
instrument, amongst which the Short Form-36 Health Survey Questionnaire (SF-36) 
(Turner-Bowker et al., 2002) is the most commonly used. The SF-36 contains 36 items 
which assess eight dimensions: physical functioning, role limitation due to physical 
problems, role limitation due to emotional problems, social functioning, depression, 
energy/vitality, pain, and general health perception. There are also two summary scores, 
one for mental health and one for physical health. Previous studies have reported 
negative effects on HRQOL following angina (Lyons et al., 1994) and myocardial 
infarction (Daly, 2000; Mendes de Leon et al., 1998) and more generally following a 
coronary event (Norris et al., 2004). However, findings from prospective studies are 
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mixed. While some found that specific domains of HRQOL improved in the long term 
(Wiklund et al., 1989; Brown et al., 1999), others showed that there was no 
improvement in HRQOL (Van Jaarsveld et al., 2001) or that the decline in HRQOL was 
limited to the immediate post-myocardial infarction period (Mendes de Leon et al., 
1998).   
 
Gender differences in quality of life among people with coronary heart disease 
 
The majority of studies on quality of life in patients with CHD suggested that women do 
not cope as well as men, as concluded by a large review by Brezinka and Kittel (1996). 
However, the existing literature on the gender differences in quality of life of people 
with CHD is sparse and somewhat contradictory.  Seven studies were found (Table 1.1) 
which have specifically addressed gender differences in quality of life of people with 
myocardial infarction (Westin et al., 1999; Bogg et al., 2000; Mendes de Leon et al., 
2001; Kristofferzon et al., 2005a and 2005b; Brink et al., 2005; Norris et al., 2007) and 
only two addressed CHD (angina and/or myocardial infarction) (Norris et al.; 2004, 
Ford et al., 2008). Some of these studies did not find any significant gender differences 
in HRQOL among patients with myocardial infarction (Mendes de Leon et al., 2001; 
Kristofferzon et al., 2005b). Several studies measured HRQOL one month after 
myocardial infarction in men and women and found that women scored significantly 
lower than men in the following domains of HRQOL: mental health (Westin et al., 
1999; Kristofferzon et al., 2005a), emotional health (Bogg et al., 2000), general health 
(Westin et al., 1999), physical health and functioning (Kristofferzon et al., 2005a), self-
esteem and family interactions (Westin et al., 1999).  
 
One year post-myocardial infarction (post-MI) women scored significantly lower than 
men on physical function (Brink et al., 2005; Norris et al., 2007), bodily pain, social 
function (Brink et al., 2005), mental health (Westin et al., 1999; Norris et al., 2007), 
general health (Westin et al., 1999) and emotional health  (Bogg et al., 2000) domains 
of HRQOL. One year post-MI the gender differences found at one month post-MI in 
self-esteem and family interaction domains of HRQOL no longer persisted (Westin et 
al., 1999). Results from one study showed that gender differences in the mental health 
dimension of HRQOL at one year post-MI did not persist once the model was adjusted 
for demographic, clinical, co-morbid and psychosocial covariates (Norris et al., 2007). 
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Results from other studies reported an improvement in HRQOL after one year post-MI 
as compared to five months in both men and women (Brink et al., 2005) and between 
four months and one year post-MI (Kristofferzon et al., 2005b). 
 
Results on gender differences in quality of life found in the literature are not consistent, 
and several limitations of the studies must be acknowledged. First, results cannot be 
generalised because all studies, except one (Ford et al., 2008) have used samples from 
selected community hospitals. The second limitation is related to the power of these 
studies. The study by Mendes de Leon et al., (2001) had a small sample size (41 women 
and 47 men). Therefore, the non-significant gender differences may be due to low 
power. Similarly, the studies of Kristofferzon et al., (2005a), Westin et al., (1999) and 
Brink et al., (2005), although prospective, had small sample sizes (74 women and 97 
men in Kristofferzon et al., 2005a;  316 men and 97 women in Westin et al., 1999; 77 
men and 37 women in Brink et al., 2005) which further decreased in the follow-up 
period (60 women and 88 men in Kristofferzon et al., 2005a;  288 men and 88 women 
in Westin et al., 1999; 65 men and 33 women in Brink et al., 2005). The study by Bogg 
and colleagues (2000) had a slightly higher sample size (220 participants); however it 
was limited to participants aged between 37 and 64. The study by Ford et al. (2008) 
used a large population-based sample; however, the results are limited by the cross-
sectional nature of the data. Only the study by Westin et al., (1999) and the study by 
Ford et al., (2008) compared the results of the CHD sample with those found in a 
control group (i.e. free from CHD); while the study by Brink et al., (2005) compared the 
HRQOL scores of the sample with myocardial infarction with Swedish normative 
scores. Another potential limitation of these studies is related to the measure of quality 
of life used. All studies have used a specific measure of quality of life which is either 
disease specific or focuses on the health-related aspects of quality of life. Of the seven 
studies, four measured health-related quality of life using the SF-36 questionnaire 
(Mendes de Leon et al., 2001; Kristofferzon et al., 2005a; Brink et al., 2005; Norris et 
al., 2007).  
 
Ford et al., (2008) used the Centre for Disease Control Prevention (CDC HRQOL-4) 
measure which had four questions assessing the number of physically and mentally 
unhealthy days over the month prior to the interview. Westin et al. (1999) constructed a 
multifaceted questionnaire to measure quality of life, which had six dimensions 
measuring general physical health, heart-related physical health, depression, experience 
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of social life and self-esteem. The extent to which this is a well-validated instrument is 
unknown. As well as the SF-36, Kristofferzon and colleagues (2005a) used Quality of 
Life Index-Cardiac (QLIC) version, which was a modified version of the Ferrans and 
Powers Quality of Life Index (Ferrans and Powers, 1985; 1992). The questionnaire was 
a self-administered disease specific measure and as such it focused on the complaints 
that were attributable to the specific characteristics of the disease (Smith et al., 2000). 
The findings of the SF-36 questionnaire in Kristofferzon’s study were not supported by 
the QLIC version. This was most likely due to the low sensitivity of the QLIC to 
changes over time and to the low Cronbach’s alpha coefficient of this instrument 
(Kristofferzon et al., 2005a). Bogg and colleagues (2000) used a modified version of the 
Quality-of-Life after Myocardial Infarction (QLMI) questionnaire; a disease-specific 
measure of health-related quality of life which was developed to evaluate a 
comprehensive cardiac rehabilitation programme for patients after myocardial infarction 
(Hillers et al., 1994).  
 
The problem related to disease-specific measures, such as QLMI and QLIC, and the 
more generic measure of health-related quality of life (like the SF-36), is that when they 
are applied to a cardiac population, they usually lack sensitivity – the ability of a 
measure to detect important changes. This limitation of the measure has been confirmed 
by Smith and colleagues (2000) where they compared the sensitivity of the above 
mentioned three measures. The SF-36 aims to measure subjective health-status; it is 
often referred as a health-related quality of life instrument although it does not have any 
underlying theoretical conceptualisation for quality of life (Carr and Higginson, 2001). 
This measure is clearly focussed on the impact of poor health on the eight dimensions 
measuring the various aspect of people’s life (Higginson and Carr, 2001). Health-related 
quality of life measures are based on proxies (such as health) “which draw on a set of 
normative assumptions about what a particular condition implies for a person’s quality 
of life without necessarily taking close account of a person’s current life experience” 
(Wiggins et al., 2008:4). Health is only one dimension of wider quality of life (Bowling, 
2005) and cannot be considered as a proxy for a holistic concept of quality of life. In 
addition, the domains used to measure health-related quality of life, such as body pain, 
physical functioning, health perception, depression, are all dimensions that influence the 
quality of life of individuals and they are often on the pathway between health and 
quality of life. The result is that the measure of health-related quality of life is not 
distinct from what influences it. 
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Table 1.1 Studies on gender differences in quality of life of people with CHD 
First author Design Number 
and age 
range of 
subjects 
Main 
outcome 
CHD 
variables 
Measures Results Comparison 
with disease-
free 
population 
Term effect  Length 
of 
follow-
up 
Westin L et al. 
(1999) 
P 413 aged 
under 70 
HRQOL AMI,  
PCI, 
CABG 
They have 
constructed 
a new 
measure 
One month post AMI women 
compared to men had decreased 
HRQOL in the domains of GH, FI, 
MH, SE. One year post AMI women 
had poorer HRQOL in the GE and 
MH domains only. 
 
Yes Decline in 
both short and 
long term 
1 month 
and 1 
year 
Bogg J  et al. 
(2000) 
P 220 aged 
37-64  
QoL  MI A Women had poorer EM of QoL 
compared with men in the short and 
long term. 
No Both short and 
long term 
decline 
3-4 
days, 
1,3 and 
6 
months 
Mendes de 
Leon  et al. 
(2001) 
 
CS 88 aged 
35-89 
HRQOL AMI B No gender differences in HRQOL. No - - 
Kristofferzon 
ML et al. 
(2005a) 
 
CS 171 aged 
30-80 
HRQOL,  
QoL 
MI B,  C Women reported lower HRQOL 
(MH, PF) than men one month post 
MI and lower levels of QoL in 
particular health and function 
dimensions. 
No - -  
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Table 1.1Continued 
Kristofferzon 
ML  et al. 
(2005b) 
P 171 aged 
30-80 
HRQOL,  
QoL 
MI B,  C Increased HRQOL in PF, ER, V, SF 
over time in both men and women. 
The QoL did not increase over time  
No gender differences in HRQOL 
and QoL. 
 
No Improvement  
in HRQOL at 
1 year follow-
up and but 
decline in QLI 
1, 4 and 
12 
months 
Norris C  et al. 
(2004) 
P 3,392 
aged ≥18  
HRQOL CHD D Women had poorer HRQOL 
(PF,RP,BP,SF) compared to men. 
No Decline in the 
long term 
1 year 
Brink E et al. 
(2005) 
P 98  HRQOL AMI B Women had poorer HRQOL (MH, 
PF) compared to men. An 
improvement in HRQOL was 
observed for both genders 1 year 
post-AMI: women had lower scores 
than men (PF, BP, SF). 
No Decline in 
HRQOL in the 
first 5 months 
and then 
improvement 
1 week, 
5 
months 
and 1 
year 
Norris C  et al. 
(2007) 
P 486 
Mean age 
59 
men,66 
women 
HRQOL  AMI B Women had poorer HRQOL (MH, 
PF) compared with men in unadjusted 
models and no gender differences 
after adjustment in MH dimension of 
HRQOL. 
No Decline in 
HRQOL 
overtime 
1 year 
Ford ES  et al. 
(2008) 
CS 50,573 
aged ≥18 
HRQOL Self-report 
CHD 
E Women had poorer HRQOL 
compared to men. 
Yes - - 
Abbreviations: CS: Cross-sectional P: Prospective R: Review HRQOL: Health-Related Quality of Life. QoL: Quality of Life.  MI: myocardial infarction. AMI: acute myocardial 
infarction. PF: physical functioning SF: social functioning MH: mental health BP: bodily pain V: vitality EM: emotional reaction GH: General health FI: Family interaction SE: 
self-esteem. A: Quality of life after Myocardial Infarction Questionnaire B: Short-Form Health Survey 36 (SF-36) C: Ferrans & Powers Quality of life Index-Cardiac version D: 
Seattle Angina Questionnaire (SAQ). E: Centers for Disease and Control Prevention HRQOL-4  
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1.2.2 Coronary heart disease and depression  
 
Over the past 30 years there has been growing evidence of the relationship between 
CHD and depression. Depression even at low levels of severity has been found to 
increase the risk of developing heart diseases (Strike and Steptoe, 2002, Hemingway et 
al., 2003; Marzari et al., 2005). Reviews of the literature on depression and CHD risk 
supported the view that psychological problems before and after coronary events not 
only increase the risk of a cardiac event but also all-cause mortality (Hemingway and 
Marmot, 1999; Rozanski et al., 1999). Established evidence has demonstrated that 
depression is common following episodes of myocardial infarction or angina and is 
associated with increased mortality (Lesperance et al., 1996, 2000; Ziegelstein et al., 
2000; Bogg et al., 2000; Ferketich et al., 2000; Bush et al., 2001; Carney et al., 2003, 
Lane et al., 2005; Parashar et al., 2006), with poor adherence to recommended 
behaviours and lifestyle changes after the cardiac event (Ziegelstein et al.,  2000, 2001) 
and with an increased risk of readmission because of cardiac complications (Lauzon et 
al., 2003). Moreover, patients with symptoms of depression after myocardial infarction 
were less likely to return to work (Stern et al., 1977; Schleifer et al., 1989). Amongst the 
possible explanations for the mortality risk associated with depression following 
myocardial infarction, some suggested that depressed patients are less likely to adhere 
to treatment and lifestyle changes than non-depressed patients (Stansfeld et al., 2002). 
Another possible explanation was that depression leads to decreased heart rate 
variability, with a greater risk of fatal arrhythmias (Stansfeld et al., 2002).   
 
Gender differences in depression among people with coronary heart disease 
 
Several studies (Table 1.2) have assessed depression in men and women after 
myocardial infarction (Forrester et al., 1992; Wiklund et al., 1993; Frasure-Smith et al., 
1999; Bjerkeset et al., 2005; Naqvi et al., 2005; Brink et al., 2005; Mallik et al., 2006; 
Norris et al., 2007). Some studies did not find any gender differences in depression 
among patients with myocardial infarction (Wiklund et al., 1993; Brink et al., 2005; 
Norris et al., 2007). Others found that women were more likely to be depressed than 
men following myocardial infarction (Forrester et al., 1992; Frasure-Smith et al., 1999; 
Naqvi et al., 2005; Mallik et al., 2006; Bjerkeset et al., 2005).  
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Longitudinal studies exploring gender differences in depression among people with 
myocardial infarction, did not report any difference between men and women in their 
prevalence of depression at five months (Brink et al., 2005) or at one year (Wiklund et 
al., 1993; Brink et al., 2005) post-MI. However, women had improved in that they 
reported less depression at one year post-MI than they had at five months post-MI 
(Brink et al., 2005). Others found that one year post-MI women were more likely than 
men to be depressed (Norris et al., 2007). 
 
Bjerkeset et al., (2005) specifically addressed gender differences in depression during 
the five years after myocardial infarction. Women had a high initial risk for depression, 
with a significant decrease after two years, while in men the risk for depression was 
only increased in the two to five years post-MI (Bjerkeset et al., 2005).  
 
Most of the studies on depression and myocardial infarction had a focus on depression 
as a risk factor for the development of myocardial infarction or cardiac mortality 
(Lesperance et al., 1996, 2000; Frasure-Smith et al., 1999; Ferketich et al., 2000; Bush 
et al., 2001; Carney et al., 2003, Lane et al., 2005; Marzari et al., 2005; Parashar et al., 
2006) or have focussed on the prevalence of depression following heart disease 
(Wiklund et al., 1993; Brink et al., 2005; Parashar et al., 2006; Mallik et al., 2006; 
Norris et al., 2007). All of these studies have used samples from selected community 
hospitals. The search of the literature failed to find any study that has addressed gender 
differences in depression following angina. Only one study specifically addressed 
gender differences in depression five years after myocardial infarction using a large 
population-based study of adults aged from 35 to 79 and used a comparison group of 
people free from myocardial infarction (Bjerkeset et al., 2005). However, this study had 
several limitations: first, there was an 11 year gap between the first and the second 
interview; second, depression post myocardial infarction was only measured once (at 
follow-up) and, as a consequence, they could not assess the course of depression over 
time. Moreover, to assess whether depression was present at baseline they used an index 
of anxiety and depression (available at baseline only), which however was not 
internationally validated.  
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Table 1.2 Studies on depression in men and women with CHD 
First 
author 
Design Number 
and age 
range of 
subjects 
Main 
outcome 
CHD 
variables 
Measures Results Comparison 
with disease-
free 
population 
Term effect  Length 
of 
follow-
up 
Forrester 
et al. 
(1992) 
CS 129  Major 
Depression 
AMI - Female gender was a significant predictor of 
depression in people with AMI. 
No - - 
Wiklund  
et al. 
(1993) 
P 595 aged 
56-83  
Depression  MI Self-
reported 
depression 
No gender differences in the prevalence of 
depression. 
No  1 year 
Freasure-
Smith  et 
al. (1999) 
 
CS 896 
Mean 
age 58 
men, 63 
women  
Symptoms 
of 
depression 
MI F Women more likely than men to report 
symptoms of depression in hospital after MI. 
No - - 
Bjerkeset 
et al. 
(2005) 
 
P 23,693 
aged 35-
79 
Anxiety 
and 
depression 
MI G Women were more likely than men to have 
depression in the first 2 years post MI, while 
men were more likely than women to have 
depression in the 2 to 5 years post MI. 
Yes - 2 and 5 
years 
Naqvi  et 
al. (2005) 
R - Depression AMI - Depression was more prevalent in women 
post-AMI than in men, and depressive 
symptoms persisted longer. 
- - - 
Brink E et 
al. 
(2005) 
P 98 Mean 
age 71 
men, 65 
women 
Anxiety 
and 
depression 
AMI G No gender differences were found in 
depression after 5 months and 1 year post-
AMI. 
No Women 
reported less 
depression at 1 
year compared 
to 5 months  
5 months 
and 1 
year 
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Table 1.2 Continued 
Mallik  et 
al. 
(2006) 
CS 2,498 Depression AMI H Women were more likely to have depression 
than men. 
Yes - - 
Norris C 
et al. 
(2007) 
P 486 
Mean 
age 59 
men,66 
women 
Depression  AMI F Women were more likely than men to be 
depressed at 1 year post-AMI , no gender 
differences were found at baseline. 
No Women 
reported 
worsening 
depression at 1 
year post-AMI 
1 year 
Abbreviations: CS: Cross-sectional P: Prospective R: Review HRQOL: Health-Related Quality of Life. QoL: Quality of Life.  MI: myocardial infarction. AMI: acute myocardial 
infarction. PF: physical functioning SF: social functioning MH: mental health BP: bodily pain V: vitality EM: emotional reaction GH: General health FI: Family interaction SE: self-
esteem. F: Back Depression Inventory (BDI). G: Hospital Anxiety and Depression Scale (HADS) H: Primary Care Evaluation of Mental Disorders Brief Patient Health 
Questionnaire 
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1.2.3 Summary and conclusions 
 
Although the statistics show that CHD is common among women, its recognition in 
women is still hampered by misconceptions about it being a man’s disease. Studies in 
the 1990s have indicated that morbidity and mortality of women with CHD exceeds that 
of men (Greenland et al., 1991; Brezinka and Kittel, 1996) and researchers have 
increasingly focussed on gender differences in CHD. There are established findings of 
gender differences in the manifestations, incidence and risk factors of myocardial 
infarction and angina (Sharp, 1994; Charney, 1999; Wenger, 2002; Polk and Naqvi, 
2005; Stramba et al., 2006). For example, among people aged over 50 years, myocardial 
infarction is the most frequent presenting feature of CHD for men (Lerner, 1986) 
whereas angina is for women (Charney, 1999).  
 
Following a non-fatal myocardial infarction event or angina symptoms most patients 
can return to a near normal life. For many people this is not the case. Moreover, there 
may be clear gender differences in adaptation to the disease. Following episodes of 
myocardial infarction or angina, patients are at risk of reporting symptoms of depression 
(Forrester et al., 1992; Frasure-Smith et al., 1999; Bjerkeset et al., 2005; Naqvi et al., 
2005; Mallik et al., 2006), pain and physical functioning (Mendes de Leon et al., 1998; 
Brown et al., 1999; Van Jaarsveld et al., 2001), and women are particularly at higher 
risk than men. Although it is evident that angina or myocardial infarction can have 
considerable impact on well-being, and that the consequences may vary between men 
and women in older age, gender differences in depression and quality of life while 
living with angina or a history of myocardial infarction at older age have not been 
researched systematically.  
 
The review of the literature on gender differences in quality of life and depression 
among people living with CHD identified some limitations and gaps in current 
knowledge. To summarise, there are no studies that have addressed gender differences 
in depression following angina. This issue is important because angina is the 
predominant presentation of CHD among women (Lerner and Kannel, 1986; Wenger, 
2002), while myocardial infarction is more common in men. To overcome this 
limitation this thesis will explore angina as well as myocardial infarction. 
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Among the few studies that have addressed the issue of gender difference in quality of 
life and depression among people with myocardial infarction, all have used a specific 
measure of quality of life, the health-related quality of life. For this reason, in this thesis 
I will adopt a measure of quality of life specifically developed for old age called CASP 
comprising four domains ('control', 'autonomy', 'pleasure' and 'self-realization'). CASP 
has been based on theories of need satisfaction (Doyal and Gough, 1991), which assume 
that quality of life at older ages is conceptualized as the degree to which human needs 
are satisfied in the above mentioned four domains (Hyde et al., 2003). This measure 
differs from health-related measures by focusing on positive aspects of quality of life 
and by being independent of health and other factors that might influence it (Hyde et al., 
2003; Wiggins et al., 2008). 
 
Only four studies (Westin et al., 1999; Bjerkeset et al., 2005; Brink et al., 2005; Ford et 
al., 2008) compared some characteristics of people with CHD with those from a control 
group or a community sample of people free from disease. However, none of the studies 
specifically explored whether gender differences in depression and quality of life were 
found in the control group. Using a healthy population as a comparison group might 
help to understand whether similar results are found in the two groups and provide 
highlights into gender differences in quality of life and depressive symptoms among 
people with CHD. For this reason, in this thesis I will be comparing results with a 
reference group of healthy individuals free from CHD, chronic diseases and any 
limiting longstanding illness. 
 
Only one study was conducted in England (Bogg et al., 2005), therefore the extent to 
which results can be generalised to the population in England is not known. All studies 
except two (Bjerkeset et al., 2005; Ford et al., 2008), used small samples from selected 
community hospitals which might affect generalisation of results and none has 
specifically focussed on an older population.  This latter issue is important because most 
CHD events occur in people aged 50 and over, where declines in quality of life and 
depression may be perceived as a “normal” consequence of ageing. Moreover, 
considering that a relatively high proportion of people aged 50 years can now expect to 
live for further 30 years or more and could potentially enjoy an active and healthy 
lifestyle, it is important to understand the impact that a non-fatal coronary event can 
have in later life. To overcome these limitations this thesis will use a large national 
sample of people aged 50 and over. 
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Lastly only some of the studies have adjusted their analyses for covariates other than 
age and gender (Norris et al., 2004, 2007; Bjerkeset et al., 2005; Brink et al., 2005; Ford 
et al., 2008). The covariates that this thesis will consider for adjustment in the analyses 
are age, cohabiting status, retirement status, education, wealth, smoking status, physical 
activity, alcohol consumption, pain, physical functioning, social support and social 
networks. These variables are fully explained in section 2.2.3 of Chapter 2. 
 
1.3 Common sources of error and uncertainty in epidemiological 
studies  
 
1.3.1 Missing data 
 
The previous section of this chapter reviewed the literature on gender differences in 
quality of life and depression among people with CHD. Most of the studies found in the 
literature used samples from selected community hospitals and only two studies (Ford et 
al., 2008; Bjerkeset et al., 2005) used population-based samples. Samples from 
community hospitals are relatively small and non-response and attrition introduce bias 
and contribute to lower the sample size. Population-based samples on the other hand 
have higher sample sizes but, they are also affected by non-response and attrition. None 
of the studies reviewed have dealt with or acknowledged the problem of missing data in 
their results.  
 
Researchers in epidemiology and other disciplines are often faced with the problem of 
incomplete data sets, particularly when the study aims at collecting a large number of 
characteristics for each individual. In longitudinal studies, missing data often occur 
because subjects do not respond to certain questions. This situation is often referred in 
the literature as item non-response. Other situations common in longitudinal studies are 
those in which subjects do not respond to a particular wave or drop-out of the study 
(because of moving out or death). This situation is known as unit non-response (in 
contrast to initial unit non-response it is prerequisite that the respondent has participated 
in at least one wave). The terms attrition, drop-out, loss to follow-up and withdrawal are 
used interchangeably in the literature to refer to this latter form of missingness. 
Therefore, in longitudinal studies the problem could be severe since we face several 
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types of missing data, such as item non-response, unit non-response and drop-out 
(Clarke and Hardy, 2007).  
 
Missing data can pose serious problems for researchers because missingness can affect 
properties of estimators and inferences. Ignoring missing data also affects the accuracy 
and precision of parameter estimation. The seriousness of the problem depends in part 
on how much data are missing. There is no clear rule regarding how much is too much 
missing data. This is because potential bias is inherent whenever observations are 
missing (Kline, 1998). Also the number or proportion of missing observations alone is 
not sufficient to indicate whether missing data are an issue or not. Rather the impact of 
missingness is determined by the research question, the information in the observed 
data, and the reason for the missing data.  
 
The implication of missingness for the analysis depends on the missingness mechanism, 
which is usually unknown. In handling missing data it is important to differentiate 
among three missing data mechanisms (Little & Rubin, 2002; Rubin, 1976): missing 
completely at random (MCAR), missing at random (MAR), missing not at random 
(MNAR)’ (Rubin, 1976, Kline, 1998, Schumacker & Lomax, 1996). MCAR refers to 
data where the missingness mechanism does not depend on the variable of interest or 
any other variable (does not depend on observed and unobserved data) (Scheffer, 2002).  
With MCAR the missing data are a simple random sample of all data values, therefore 
MCAR reflects the highest degree of randomness of the missing data mechanism and 
shows no underlying reasons for missing observations that can potentially bias research 
findings. In practice this means that, under MCAR, the analysis of only those units with 
complete data gives valid inferences (Musil et al., 2002). For example, MCAR data can 
occur when respondents accidentally skip a question on a questionnaire or if the 
participant accidentally discarded the questionnaire. In these situations there is no 
underlying pattern to the missing observations that would contribute to biased data. 
With MAR the missingness depends only on the components of a variable that are 
observed and not on those that are missing (Little and Rubin, 2002). MAR data show 
some randomness to the pattern of data omission: “For example, in a study of dietary 
intake, if participants with depression are less likely than those without depression to 
record their daily intake, then depression is a variable that predicts missing 
observations” (Musil et al., 2002:816). MAR has a very special and important role in 
longitudinal studies where, essentially, it implies that future drop-out is conditionally 
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independent of future values, given all observed past values. Another way of expressing 
MAR in the longitudinal/drop-out setting is to say that the future statistical behaviour of 
those who share the same history of measurements is the same whether they drop-out or 
not. MNAR or non-ignorable missing data occurs when missingness is related to the 
values that would have been observed. This is the most difficult condition to model. 
Non-ignorable missing data have systematic non-random factors underlying the 
occurrence of the missing values that are not apparent or otherwise measured. Non-
ignorable missing data affect generalisability of research findings and may bias 
parameter estimates, also the direction of bias is unpredictable (Musil et al., 2002). 
 
The ELSA study is subject to missing data due to item non-response and attrition. Using 
a simulation study I will compare three techniques for dealing with missing data in 
order to find the best method to be applied to the ELSA data. 
 
The reader is referred to Chapter 3 for a literature review on missing data and for a 
study of three techniques for handling missing data. 
1.3.2 Self-reported measure of disease 
 
The findings reviewed in section 1.2 of the chapter mainly come from community 
hospitals samples, which use a clinical diagnosis of CHD.  Only two studies have used 
population-based samples from which data on CHD diagnosis were self-reported (Ford 
et al., 2008; Bjerkeset et al., 2005) and was not validated with medical records or a 
clinical diagnosis. Most epidemiological studies and health surveys assess the presence 
of chronic diseases from self-report, as opposed to clinical assessments mainly because 
the collection of self-reported conditions involves lower costs (Kriegsman et al., 1996). 
However, to use self-reported data to assess CHD with confidence, it is important to 
know the validity of these measures. Clearly, inaccurate reporting of CHD by surveyed 
populations may result in people not being identified early for chronic disease-related 
illnesses or not being offered interventions, such as changes in health behaviours. In 
terms of findings, results from studies using self-report measures might be subject to 
misclassification bias.  
 
Misclassification bias is defined as the systematic error due to erroneous classification. 
When assessing misclassification bias of a test or measure sensitivity and specificity 
must be considered. The terms sensitivity and specificity are used to measure the 
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effectiveness of a test procedure in relation to a certain disease. Sensitivity is the 
proportion of those with the disease that are identified as positive by the test, therefore 
sensitivity measures how well the test detects a disease. Specificity is the proportion of 
those without the disease that are identified by the test as not having the disease. It 
follows that specificity refers to how well the test detects absence of disease (Armitage, 
Berry and Matthews, 2002). The ideal value of both sensitivity and specificity is 100% 
indicating no misclassification. However, the relationship between these two measures 
tend to be inverse that is, the more sensitive a test procedure, the less specific it is likely 
to be, and vice versa. 
 
Previous studies have reported high values of specificity and sensitivity of self-reported 
CHD (Haapanen et al., 1997; Baumeister et al., 2010). Although a number of validation 
studies have suggested that self-reported CHD is reasonably accurate when compared 
with medical records (Bush et al., 1989; Okura et al., 2004; Merkin et al., 2007; 
Yamagishi et al., 2009; Barr et al., 2009; Lampe et al., 1999; Baumeister et al., 2010), 
the extent to which self-reported measures introduced bias in the findings of 
epidemiological studies is an issue rarely addressed quantitatively (Jurek et al., 2006). 
Since it is not possible to validate self-reported CHD cases in ELSA using medical 
records, through a sensitivity analysis I will investigate the extent to which the self-
reported measure of CHD used in this thesis may lead to biased estimates and/or 
different conclusions in the results.  
 
The reader is referred to Chapter 5 for a literature review on validation studies on self-
reported CHD and for a sensitivity analysis investigating bias due to misclassification of 
self-reported CHD. 
 
1.4 Objectives and Hypotheses  
 
In the previous sections of this chapter a review of the literature on gender differences 
in quality of life and depression among older people living with CHD was presented 
and common sources of error and uncertainty occurring in epidemiological studies were 
reviewed. To summarise, the search of the literature identified that previous studies 
have not examined gender differences in depressive symptoms or quality of life in a 
national sample of older adults suffering from both myocardial infarction and angina, 
35 
 
while adjusting the analysis for a set of important covariates and making comparisons 
with a healthy reference population. Additionally, none of the studies reviewed in the 
literature have dealt with the issues of missing data. Many epidemiological studies 
involve large numbers of individuals and large numbers of variables (especially with 
repeated measurements over time), and complete data are rarely available, therefore 
addressing the problem of missing data has been recommended in order to improve the 
validity of epidemiological research results and to reduce estimation bias caused by 
missing data (Sterne et al., 2009).  
 
All studies reviewed in the literature, with the exception of two (Ford et al., 2008; 
Bjerkeset et al., 2005), used objective measure of disease. However, large 
epidemiological studies and health surveys assess the presence of chronic diseases from 
self-report. It is likely that the validity of self-reported diagnosis may vary depending on 
the severity of the disease and it is possible that misclassification introduces bias in the 
estimates. Despite these common problems, the studies that have used self-reported 
CHD have only acknowledged the issue as a limitation (Ford et al., 2008; Bjerkeset et 
al., 2005). 
 
These gaps identified in current knowledge form the key objectives for investigation. 
 
The specific objectives are: 
1. To explore gender differences in quality of life and depressive symptoms among 
men and women with CHD (angina and/or myocardial infarction) and compare 
them with healthy people of similar age (who do not have CHD or any limiting 
long-standing illness or chronic disease), in order to understand whether results 
are similar to the group of people with CHD. 
2. To compare men and women with respect to trajectories over time of quality of 
life and depressive symptoms over four years once they have experienced CHD.  
3. To compare different methods for dealing with missing data in longitudinal 
studies using the full information maximum likelihood, the multivariate normal 
imputation and two-fold fully conditional specification techniques as examples, 
in order to find the best method that yields unbiased results when applied to the 
data.  
4. To assess the sensitivity of the models to different assumptions about the 
reliability of self-reported CHD measure. 
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This PhD thesis sets out to test the following hypotheses: 
1. People aged over fifty years who have experienced CHD are at higher risk of 
experiencing depressive symptoms and poor quality of life than those who have 
not. Among people with CHD there are also significant gender differences in 
quality of life and depressive symptoms, with women being at higher risk than 
men of reporting depressive symptoms and lower quality of life. 
2. The shapes of trajectories over time of quality of life and depressive symptoms 
are different in men and women following the CHD event. Women tend towards 
a time-limited reaction (in terms of depressive symptoms and poor quality of 
life) to the actual CHD event, while men seem less able to adapt to the long-term 
consequences of the event. 
3. Ignoring missing data will give biased results. 
4. Self-reported CHD is a robust and reliable measure. 
 
The hypotheses will be tested on a large national sample of older people living in 
England, participants of the English Longitudinal Study of Ageing (ELSA). ELSA is 
the only longitudinal study in England to cover men and women from age 50 onwards 
with rich data on many different aspects of people’s lives. In addition, the Whitehall II 
study is used for the sensitivity analysis (refer to Chapter 5 for a detailed description of 
the study).  
 
The next chapter describes in detail the data set used in this thesis which comprises 
three waves of the English Longitudinal Study of Ageing.  
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Chapter 2:  The English Longitudinal Study of Ageing  
 
The first chapter reviewed the literature on gender differences in quality of life and 
depressive symptoms among older people living with CHD. From the gaps in the 
literature hypotheses and objectives were defined. This chapter describes the data sets 
and measures used in this study to test the hypotheses. 
 
2.1 Data source: The English Longitudinal Study of Ageing  
 
The data sets come from the first three waves of the English Longitudinal Study of 
Ageing (ELSA), collected between 2002-03 and 2006-07 (Marmot et al., 2003; Banks et 
al., 2006; Banks et al., 2008). ELSA is a panel study where individuals aged 50 and 
over are followed and re-interviewed every two years.  The aim of ELSA is to explore 
the unfolding dynamic relationships between health, functioning, social networks and 
economic position. It is in effect a study of people's quality of life as they age beyond 
50 and of the factors associated with it. 
 
Each survey involves a face-to-face interview and every four years there is a subsequent 
visit by a nurse in which biomedical data are taken such as blood pressure and 
anthropometric measurements as well as blood and saliva samples. 
 
The ELSA sample was designed to represent people aged 50 and over, living in private 
households in England and was selected from households that had previously responded 
to the Health Surveys for England (HSE) in 1998, 1999 or 2001 and had a household 
member born before March 1952. The HSE is an annual cross-sectional household 
survey that collects a wide range of health data and biometric measures. Each of the 
main HSE adopted a multi-stage stratified probability sampling design in which 
postcode sectors have been the primary sampling units within which addresses were 
selected with a probability proportional to their size (number of addresses). Within each 
sector, addresses were then selected systematically. Full details of the sample design 
and response rates for the Health Surveys for England have been published elsewhere 
(Erens and Primatesta 1999; Erens, Primatesta, and Prior 2001; Bakejal et al., 2003). 
Taking the three HSE years used for the ELSA sample together, a total of 31,051 
households were sampled. Of these, 23,382 households responded to HSE. The ELSA 
sample was only selected from households that responded to HSE. Furthermore, 
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households were only issued to field if they included at least one age–eligible individual 
who was living in the household at time of the HSE interview, born on or before 29 
February 1952 and who, according to administrative records, remained alive and gave 
permission to be re-contacted in the future.  
 
ELSA wave 1 (2002-03) achieved 11,391 productive interviews with eligible sample 
members. The survey achieved a household response rate of 70%; approximately 96% 
of individuals responded within households. This equates to an overall individual 
response rate of 67%. The survey also completed 636 productive interview with 
partners aged under 50 and 72 interviews with new partners (whose presence in the 
household only became known after the sample was issued). For the purpose of this 
thesis, younger partners and new partners were excluded from the analyses. Eligible 
sample members who responded at this stage were renamed ‘core members’ to 
distinguish them as the core element of the continuing ELSA sample. Core members 
were eligible for the main interview in wave 2 unless they had since died, had explicitly 
asked at the end of the first ELSA not to be re-contacted, or had moved out of England. 
A total of 8,781 core members (response rate 81.5%) participated in wave 2 (2004-05) 
and at wave 3 (2006-05) there were 7,114 respondents (response rate 73%). The 
response rate is defined as “total individual respondents to a given wave divided by total 
individuals eligible for that wave”; participants that moved into institutions or from 
England to another country at a particular wave were no longer eligible. Inclusion in 
either numerator or denominator was not conditional upon response in any previous 
wave. For the purpose of this study, wave 1 will be referred to as “baseline”, wave 2 as 
the two-year follow-up and wave 3 as the four-year follow-up, since the data are 
collected at two-yearly intervals. 
 
 
2.2 Measures 
2.2.1 Outcomes: depressive symptoms and quality of life  
 
The eight-item version of the Centre for Epidemiologic Study Depression scale (CESD-
8) administered during the face-to-face interview was used to measure depressive 
symptoms (Radloff, 1977). The questions asked the degree to which the respondent had 
experienced (or not) depressive symptoms, such as restless sleep, being unhappy and so 
on, over the past week (Table 2.1). The total score ranges from 0 to 8 (items 4 and 6 
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were reverse coded for scoring), which was recoded as: 0 ‘0-2 symptoms’ of depression 
and 1 ‘3+ symptoms’ of depression, this cut-off has been used by the Health and 
Retirement Study to classify respondents as being depressed (Steffick, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quality of life was measured using the CASP-19 questionnaire available in the self-
completion booklet. CASP-19 contains 19 items (Table 2.2) covering four conceptual 
domains of individual needs that are particularly relevant in later life: Control, 
Autonomy, Self-realization and Pleasure. The instrument has four items for the control 
domain and five for each of the others. Each item is assessed on a four-point Likertscale 
(rated ‘this applies to me: often, sometimes, not often, never’) numerically coded so that 
the most positive response was scored as 3 and the most negative response as 0. Items 3, 
5, 7, and 10 to 19 were reversed coded for the calculation of the total score so that all 
item responses were in the same direction. The resulting scale scores are summed to 
form an index with higher scores indicating better quality of life (Cronbach’s 
alpha=0.67) as recommended by Wiggins et al., (2008).   
 
The psychometric properties of CASP-19 are fully described by Hyde et al., (2003), 
while Wiggins et al., (2008) evaluated the properties of CASP-19 using data from the 
English Longitudinal Study of Ageing (ELSA). The total score (theoretically ranging 
from 0 to 57, but in ELSA ranges from 6 to 57) of CASP-19 (with higher scores 
indicating better quality of life) was used. 
Table 2.1 CESD-8 item wording   
Item statements 
Much of the time during the past week, 
1  you felt depressed? 
2  you felt that everything you did was an effort? 
3  your sleep was restless? 
4
a
  you were happy? 
5  you felt lonely? 
6
a
  you enjoyed life? 
7  you felt sad? 
8  you could not get going? 
a
 Item reverse coded for scoring 
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Table 2.2 CASP-19 item wording arranged by domain categories 
Item statements 
Control 
1 My age prevents me from doing the things I would like to do  
2 I feel that what happens to me is out of my control  
3 I feel free to plan for the future Item reverse coded for scoring 
4 I feel left out of things  
Autonomy 
5 I can do the things I want to do Item reverse coded for scoring 
6 Family responsibilities prevent me from doing the things I want 
to do 
 
7 I feel that I can please myself what I do Item reverse coded for scoring 
8 My health stops me from doing the things I want to do  
9 Shortage of money stops me from doing things I want to do  
Pleasure 
10 I look forward to each day Item reverse coded for scoring 
11 I feel that my life has meaning Item reverse coded for scoring 
12  I enjoy the things that I do Item reverse coded for scoring 
13  I enjoy being in the company of others Item reverse coded for scoring 
14  On balance, I look back on my life with a sense of happiness Item reverse coded for scoring 
Self-realisation 
15 I feel full of energy these days Item reverse coded for scoring 
16 I choose to do things that I have never done before Item reverse coded for scoring 
17 I feel satisfied with the way my life has turned out Item reverse coded for scoring 
18 I feel that life is full of opportunities Item reverse coded for scoring 
19 I feel that the future looks good for me Item reverse coded for scoring 
Table adapted from Wiggins et al, 2008 
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2.2.2 Main exposure: coronary heart disease 
 
During the interview participants were asked whether a doctor had ever told them that 
they suffered from angina or myocardial infarction/heart attack, and if so, whether they 
had angina symptoms or myocardial infarction in the past two years. This information 
was complemented with information on the age at which the respondents first had 
angina or myocardial infarction. 
 
Having had coronary heart disease (first or recurrent angina and/or myocardial 
infarction) in the two years preceding the baseline interview (2002-03) is the main 
exposure variable. In addition to CHD, it would have been ideal to consider angina and 
myocardial infarction as two separate exposures. However, due to the small number of 
cases and the lack of power that this would introduce in the analyses, only CHD is used. 
 
People with CHD are compared with a reference population of healthy individuals  
(Well group) defined as people that at baseline (2002-2003) had never had CHD, stroke, 
diabetes, pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting 
longstanding illness. 
 
2.2.3 Covariates 
 
The covariates considered in this study were identified from the literature as potentially 
influencing each outcome and as potentially being correlated with the exposure. 
Bivariate analyses of baseline data were used to confirm whether each covariate 
considered was related to the outcomes and also correlated to the exposure (CHD). The 
covariates are described in detail below. 
Socio-demographic variables 
Socio-economic status, employment status and marital status have all been found to 
relate to well-being among older adults. Low educational qualification, poorest wealth 
and living without a partner were found to decrease quality of life among older people 
(Netuveli et al., 2006; Zaninotto et al., 2010; Webb et al., 2009). Several studies have 
also reported that older women are more likely than men to be exposed to factors 
associated with depression such as lower education, lower income, less skilled 
occupations and to widowhood (Arber and Cooper, 1999; Barefoot et al., 2001).  Socio-
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economic status, employment status and marital status have also been shown to 
correlate with coronary heart disease (Bunker et al., 2003; Sproston and Primatesta, 
2004). 
 
During the face-to-face interview information regarding age, gender, marital status, 
educational attainment, occupational status as well as total wealth were collected. From 
the questions on marital status and cohabitation status (contained in the self-completion 
questionnaire) a cohabiting status variable with three categories was derived as follows: 
living with a partner (married or not), not living with a partner (previously married), 
never married and not cohabiting; the variable was then recoded as 0”living with a 
partner (married or not)” and 1 ”not living with a partner (including never married)”. 
The “never married” cases were only 5% of the sample for that reason they were 
grouped with the “not cohabiting” cases. 
 
The compulsory school-leaving (CSL) age has increased steadily since state-sponsored 
education was first recognised as a right for all children in the UK. CSL age was 
originally set at 10, which increased to 13 in 1899 and then to 15 in 1944 (which took 
effect in 1947). To account for different durations in compulsory education when 
determining the educational attainment of the sample, I used information on the self-
reported age of first leaving full-time education. From responses to these questions I 
derived a variable of education with three categories: those leaving at or after age 19 
(referred to as ‘high’ education), those leaving school after CSL but before age 19 
(referred to as defined as ‘mid’ education) and those who left at or before CSL (referred 
to as ‘low’ education). The variable was then coded as 0 “high and medium education” 
and 1 “low education”. High and medium education categories were grouped because 
only about 13% of the sample was in the “high” education category. 
 
From the questions on employment status a variable was derived to describe people in 
paid employment (full-time, part-time, self-employed or semi-retired), completely 
retired and other (permanently unable to work, not currently in paid employment, 
looking after home or family).  
 
Total non-pension wealth is defined as the sum of financial worth, physical worth (such 
as business wealth, land or jewellery), and housing wealth after deducting debts; it 
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represents a better measure of the permanent economic status of older people than 
income (Marmot, 2003; Banks et al., 2006; Banks et al., 2008). 
 
Health covariates 
 
There is established evidence of decreased physical functioning following CHD 
(Mendes de Leon et al., 1998; Brown et al., 1999; van Jaarsveld et al., 2001) and 
increased bodily pain (Brown et al., 1999). Also, limitations in physical functioning 
(activity of daily living) has been found to predispose older adults to a decreased quality 
of life (Netuveli et al., 2006) and increased risk of depression (Stuart-Shor et al., 2003; 
Stek et al., 2004). Smoking, alcohol consumption and physical inactivity are risk factors 
for cardiovascular disease (Sproston and Primatesta, 2004). There is evidence of a 
positive relationship between physical activity and quality of life (Bize et al., 2007) and 
both inverse and positive relationships between physical activity and depression (van 
Gool et al., 2003). Among older people alcohol consumption has been found to 
positively relate to quality of life and negatively relate to depression (Zaninotto et al., 
2010). Smoking was found to decrease quality of life (Zaninotto et al., 2010) and 
increase the risk of depression (Zaninotto et al., 2010; Colman et al., 2011).   
 
A dichotomous variable (no and yes) was used to assess whether respondents were often 
troubled by pain. Respondents were also asked to report whether because of a physical, 
mental, emotional or memory problem they have any difficulty with Activities of Daily 
Living (ADLs), such as dressing (including putting on shoes and socks), walking across 
a room, bathing or showering, eating (such as cutting up food), getting out of bed, using 
toilet (including getting up or down). From this question a variable was derived to count 
the number of difficulties with ADLs (range 0 to 6).  
 
From information collected on smoking status a variable was derived with three 
categories: never smoked, ex-smoker, current smoker. The mean quality of life and the 
prevalence of depressive symptoms did not differ significantly between those that never 
smoked and ex-smokers, therefore for simplicity the variable was then coded as 0 
“never smoked and ex-smoker” and 1 “current smoker”.  
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From the questions on frequency of alcohol consumption a variable with three 
categories was derived as follows: “not at all or occasionally”, “once or twice a week”, 
and “three and more times a week and daily”. The prevalence of those not drinking or 
drinking occasionally was about 27% , for that reason this the variable was then recoded 
as 0”less than three times a week” and 1”three times a week and more”. 
 
Lastly, from questions on frequency of leisure-time physical activity a variable was 
derived according to the definition given by McMunn et al., (2003, chapter 6: 212-213) 
which summarised leisure-time physical activity into three ordinal categories defined as 
“high activity (vigorous activity)”, “medium (moderate and low moderate activity)”, 
and “inactive (sedentary)”. Only 16% of people were in the medium category of 
physical activity, therefore the variable was then recoded as 0 “physically active (high 
activity and medium)” and 1 “inactive”. 
 
Social support and social networks 
 
There is evidence that lack of social support and poor social networks are associated 
with CHD risk and recurrence (Brezinka and Kittel, 1996; Wang et al., 2005). On the 
other hand, evidence has also shown that lack of social support, and social network, 
independent from CHD, are risk factors for well-being (Victor, 2005; Netuveli et al., 
2006).  
 
The self-completion questionnaire included a series of detailed items on the quality of 
the respondent’s social relationships. Specifically, respondents were asked about the 
closeness of their marital relationship on a scale from “not at all close”=1 to “very 
close”=4; about the presence of positive support from their spouse, children, other 
relatives and friends (how much they understand the way the respondent feels about 
things, how much they can be relied on if the respondent has a serious problem and how 
much the respondent can open up to them to talk about worries). Positive support items 
were scored as 1=”not at all” and 4=”a lot”, such that higher numbers indicate more of 
each type of support. Responses were summed to create a positive aspects of social 
relations scale (based on perceptions of empathy, availability of help and being able to 
confide, Cronbach’s alpha 0.68). The total score ranges from 0 to 36, with higher scores 
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indicating greater positive support (Stafford et al., 2011). Those respondents without a 
spouse or children were given the lowest value of positive support from that source.  
 
Respondents were also asked to indicate the number of family members and friends 
with whom they had a close relationship. From this question a continuous variable was 
derived that indicates the number of close friends/family in the respondent’s social 
networks, at baseline 1% of people did not have any close friends/family. 
 
2.3 Sample characteristics at baseline (wave 1, 2002-03) 
2.3.1  Sample description  
 
This section describes the samples that are being analysed in this thesis, those with 
CHD and the comparison group of Well people. The group of people reporting CHD in 
the two years preceding the baseline interview (2002-03) is composed of 518 men and 
376 women. The Well group is defined as people that at baseline did not report CHD, 
stroke, diabetes, pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting 
longstanding illness (1,701 men and 1,892 women).  
 
In descriptive analyses shown in next section age-standardisation has been used in all 
tables in which age is not included as a break variable. In comparing categories of the 
break variable, age-standardisation reweights the sample in each category of the break 
variable so as to give all categories the same age profile. In this way it is possible to 
remove the effect of age from comparisons between groups. Direct standardisation was 
applied for both men and women, with the standards being the age distribution of core 
members of the whole ELSA sample at baseline (consisting of 11,391 individuals).  
 
All descriptive analyses have also been weighted for non-response and account for the 
complex survey design. The statistical package used was Stata version 10. 
 
Prevalence of CHD 
 
Figure 2.1 presents the age-standardised gender distribution in the CHD and Well 
groups. A higher prevalence of men report having had a CHD event in the two years 
preceding the baseline interview, compared to women (27%, and 19% respectively, 
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p<0.01); while more women than men were in the Well group (81% and 73% 
respectively, p<0.001).  
 
 
Figure 2.1 Age-standardised gender distribution of the CHD and Well groups (2002-03) 
 
 
Table 2.3 reports prevalence of CHD by age and gender. The prevalence of CHD 
increases significantly with age in men and women. For men the prevalence of CHD is 
highest from the age of seventy, while for women it is highest from the age of eighty. 
 
 
 
Table 2.3 Prevalence of CHD, by age and gender 
(2002-03)    
 
Men 
% (95% CI) 
Women 
% (95% CI) 
50-54 9.5 (7.2,12.5) 6.0 (4.2,8.4) 
55-59 16.6 (13.5,20.3) 8.7 (6.4,11.6) 
60-64 19.8 (15.8,24.6) 14.9 (11.4,19.4) 
65-69 26.6 (22.1,31.6) 21.7 (17.3,26.8) 
70-74 36.8 (31.1,42.9) 27.1 (22.0,32.9) 
75-79 36.0 (29.1,43.6) 26.2 (20.3,33.0) 
80+ 36.1 (29.6,43.2) 29.0 (23.4,35.3) 
Total 22.1 (20.4,23.8) 16.6 (15.1,18.3) 
Bases 
unweighted 
518 376 
The CHD group is defined as people reporting the first 
or recurrent angina or myocardial infarction event in the 
two years preceding the baseline interview.  
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2.3.2 Quality of life and depressive symptoms 
Quality of life 
 
The age-standardised mean quality of life for the ELSA general sample (based on 
11,391 respondents) at baseline was 42.3 (S.D. 8.7) in men and 42.8 (S.D. 8.7) in 
women. Among people with CHD the age-standardised mean quality of life of men was 
39.8 (S.D. 11.0) and that of women was 39.9 (S.D. 8.8). Men and women in the Well 
group had higher mean quality of life than people with CHD (p<0.001). There were no 
gender differences in either group in mean quality of life (Table 2.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Linear regression was performed to look at the association between quality of life at 
baseline and disease status interacted with gender and adjusted for age. Men and women 
in the CHD group had quality of life that was around four points lower than people in 
the Well group (β=-4.4 [95% CI:-5.4;-3.4] for men and β=-4.8 [95% CI: -5.9;-3.8] for 
women). The interaction term between gender and disease group was not significant, 
suggesting that the association between the disease groups (CHD and Well group) and 
quality of life did not differ by gender.  
 
Depressive symptoms 
 
At baseline the overall prevalence of depressive symptoms in the general sample was 
20.1% in men (95% CI: 18.9; 21.2) and 28.1% in women (95% CI: 26.9; 29.4). 
 
Table 2.4 Mean quality of life, by disease status and gender 
(2002-03) 
 CHD group Well group 
 Mean (S.D) Mean (S.D) 
Men 39.8 (11.0)           44.7 (8.7) 
Women                39.9 (8.8) 44.5 (10.2) 
   
Bases unweighted   
Men  456 1,516 
Women 304 1,699 
Age-standardised figures.   
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Among women with CHD the age-adjusted prevalence of depressive symptoms was 
significantly higher than in men (36% and 27% respectively); in the Well group women 
also reported higher prevalence of depressive symptoms than men.  
 
The prevalence of depressive symptoms of men and women with CHD was over 10 
percentage points higher than men and women in the Well group (p<0.001) (Table 2.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Logistic regression was performed to examine the association between depressive 
symptoms and disease status interacted with gender, adjusted for age. Men and women 
with CHD had higher odds (OR=1.6 [95% CI:1.3; 2.1] in men and OR=1.8 [95% 
CI:1.4; 2.3] in women) of reporting depressive symptoms than people in the Well 
group. However, the interaction term between disease status and gender was not 
significant.  
  
2.3.3 Socio-demographic characteristics 
 
Women with CHD were on average two years older than men. Also in the Well group 
women were on average older than men (Table 2.6). Among those with CHD 47% of 
women were not cohabiting with a partner, a prevalence that was 16 percentage points 
higher than that of men in the same group (p<0.001). These gender differences were 
also found in the Well group. Men with CHD were more likely than women to be in 
Table 2.5 Prevalence of depressive symptoms, by disease 
status and gender (2002-03) 
 CHD group Well group 
 % (95% CI) % (95% CI) 
Men 27.3 
(23.2,31.8) 
17.1 
(15.1,19.3) 
Women 36.1 
(31.2,41.3) 
25.6 
(23.1,28.2) 
Bases unweighted   
Men 518 1,701 
Women 376 1,892 
Age-standardised figures.  
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paid employment (p<0.001), and less likely to be in the poorest quintile of wealth 
(p<0.01). In the Well group men were more likely than women to be in paid 
employment (p<0.001), but there were no gender differences in wealth. Among people 
with CHD, 62% of men and 65% of women were retired. The proportion of retired 
people did not differ significantly by gender neither in the CHD nor in the Well group. 
 
 
 
 
 
Table 2.6 Socio-demographic characteristics of the sample, by disease status and gender 
(2002-03) 
     CHD group Well group 
 Men Women Men Women 
Mean Age (S.D) 67.9(11.7) 70.3 (11.6) 62.1 (9.6) 63.5 (10.3) 
Bases unweighted 518 376 1,701 1,892 
 %(95% CI)  %(95% CI)  %(95% CI)  %(95% CI)  
Cohabiting status     
Not living with partner 30.7 
(26.5,35.3) 
46.5 
(41.6,51.4) 
27.3 
(25.1,29.6) 
31.9 
(30.2,33.7) 
Bases unweighted 518 376 1701 1892 
     
Educational  level     
Low education 61.3 
(57.0,65.4) 
56.3 
(50.8,61.6) 
51.4 
(48.8,54.0) 
50.2 
(47.7,52.8) 
Bases unweighted 518 376 1697 1889 
     
Employment status     
In paid employment 25.4 
(21.7,29.4) 
11.9 
(8.8,16.1) 
49.5 
(47.3,51.7) 
42.0 
(39.8,44.4) 
Completely retired 61.8 
(58.3,65.2) 
65.3 
(59.9,70.3) 
43.7 
(41.5,45.9) 
42.5 
(40.2,44.9) 
Other 12.8 
(9.9,16.3) 
22.7 
(18.6,27.4) 
6.9 
(5.6,8.3) 
15.4 
(13.7,17.3) 
Bases unweighted 518 376 1701 1892 
     
Total Wealth quintile     
Poorest quintile 22.8 
(19.1,27.0) 
31.7 
(27.4,36.4) 
15.8 
(13.6,18.4) 
18.2 
(16.1,20.6) 
2nd 24.4 
(20.5,28.8) 
18.8 
(15.0,23.3) 
17.2 
(15.2,19.5) 
17.6 
(15.6,19.7) 
3rd 20 
(16.6,24.0) 
20.8 
(16.8,25.6) 
20.5 
(18.4,22.7) 
19.9 
(17.9,22.0) 
4th 17.2 
(14.0,21.0) 
16.2 
(12.7,20.5) 
21.7 
(19.6,23.9) 
21.2 
(18.9,23.6) 
Richest quintile 15.6 
(12.4,19.4) 
12.4 
(9.2,16.6) 
24.8 
(22.3,27.4) 
23.2 
(20.9,25.6) 
Bases unweighted 517 371 1,688 1,865 
Age-standardised figures.  N figures are unweighted 
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Men with CHD differed from men in the Well group in that they were more likely to 
have a low educational qualification, more likely to be completely retired, substantially 
less likely to be in paid employment and more likely to be in the poorest and second 
quintile of wealth. Compared to women in the Well group, women with CHD were less 
likely to be cohabiting with a partner, more likely to have a low educational 
qualification, less likely to be in paid employment, more likely to be completely retired, 
and more likely to be in the poorest and second quintile of wealth (Table 2.6).  
 
2.3.4 Health characteristics 
 
Among those with CHD 41% of men and 50% of women reported being often troubled 
with pain (p<0.001). Similarly, women from the Well group were more likely than men 
to be often troubled with pain. In the group with CHD the gender difference in the 
prevalence of pain was greater than the Well group (Table 2.7).  
 
Twenty nine percent of men and 34% women with CHD reported having one or more 
difficulties in performing activities of daily living (ADLs). There was no gender 
difference in the prevalence of difficulties with ADLs in either the CHD group or in the 
Well group. There were no gender differences for people with CHD in physical activity, 
smoking status and alcohol consumption. In the Well group men were significantly less 
likely than women to be physically inactive and more likely to consume alcohol on 
three or more days a week. 
 
Men and women with CHD differed from the Well group in that they were more likely 
to be often troubled with pain, to report one or more difficulty with ADLs, more likely 
to be physically inactive and to drink alcohol on three or more days a weeks (except for 
women) (Table 2.7). 
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2.3.5 Social networks 
 
Figure 2.2 reports the age-standardised average number of family members and friends 
with whom respondents have a close relationship. On average, men and women with 
CHD had 8 close relatives and friends. Similar results were found in the Well group. 
Table 2.7 Health characteristics of the sample by disease status and gender (2002-03) 
 
    CHD group Well group 
 Men Women Men Women 
 %(95% CI)  %(95% CI)  %(95% CI)  %(95% CI)  
Pain     
Often troubled with pain 40.9 
(36.3,45.6) 
49.9 
(44.4,55.3) 
17.3 
(15.5,19.3) 
21.5 
(19.3,23.9) 
N 506 363 1,679 1,871 
ADL     
No difficulties 71.3 
(67.4,74.9) 
66.4 
(61.4,71.0) 
91.7 
(89.7,93.4) 
91.0 
(88.9,92.7) 
1 14.0 
(11.3,17.4) 
16.2 
(12.6,20.6) 
6.4 
(4.9,8.4) 
5.6 
(4.4,7.2) 
2 5.6 
(3.8,8.4) 
7.5 
(5.3,10.5) 
0.8 
(0.5,1.3) 
1.9 
(1.1,3.2) 
3 3.0 
(1.8,4.9) 
5.5 
(3.7,8.1) 
0.6 
(0.3,1.3) 
0.6 
(0.2,1.4) 
4 3.4 
(2.1,5.5) 
2.7 
(1.4,5.3) 
0.3 
(0.1,0.6) 
0.7 
(0.2,2.3) 
5 2.2 
(1.7,2.9) 
1.5 
(0.6,3.3) 
0.1 
(0.0,0.4) 
0.1 
(0.0,0.4) 
6 0.3 
(0.1,1.3) 
0.3 
(0.1,1.3) 
0.1 
(0.0,0.5) 
0.1 
(0.0,0.3) 
N 506 363 1,679 1,871 
Physical Activity     
Inactive 70.7 
(66.4,74.8) 
74.3 
(69.2,78.9) 
58.7 
(56.2,61.1) 
66.4 
(64.3,68.4) 
N 508 363 1,679 1,875 
Smoking status     
Current smoker 15.5 
(12.4,19.2) 
17.8 
(13.9,22.5) 
16.5 
(14.8,18.3) 
19.0 
(17.2,20.9) 
N 508 363 1,678 1,875 
Alcohol consumption     
≥3 days a week 27.8 
(23.7,32.2) 
23.1 
(18.9,28.0) 
33.1 
(30.6,35.6) 
25.8 
(23.6,28.1) 
N  505 363 1,679 1870 
Age-standardised figures.  N figures are unweighted 
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There were no gender differences in the number of close relatives and friends, in either 
group. 
 
 
 
Figure 2.2 Mean number of close family and friends (2002-03) 
 
Age-standardised figures 
 
Women received on average more social support from their spouse, children, immediate 
relatives or friends, regardless to whether they were in the CHD or Well group. The 
age-standardised mean social support in people with CHD was similar to that of people 
in the Well group (Figure 2.3). 
 
Figure 2.3 Mean score of social support*, by gender (2002-03) 
 
Age-standardised figures. *Higher scores indicate more social support 
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2.4 Summary 
 
This chapter described the English Longitudinal Study of Ageing (ELSA) in terms of 
data collection, sample, and variables being used. Baseline characteristics of the sample 
under study were presented. It was found that at baseline (2002-03) men were more 
likely than women to have CHD. Results showed that woman with CHD (but also 
women in the Well group) were more likely than men to report depressive symptoms, 
while there were no gender differences in the mean score of quality of life neither in 
people with CHD nor in the Well group.  
 
The descriptive analysis has also identified some gender differences in socio-
demographic characteristics of men and women with CHD such as cohabiting status, 
employment status and wealth. With the exception of wealth, the Well group also 
presented gender differences in cohabiting status and employment status. In terms of 
health characteristics, the main difference between men and women with CHD was in 
the prevalence of being often troubled with pain, which was higher in women; a finding 
that was also true for the Well group. Men and women with CHD did not differ in 
health behaviours while gender differences in physical activity and alcohol consumption 
were found in the Well group. Women received more social support than men; this was 
true in both the CHD and Well groups. Preliminary unadjusted results support the 
hypothesis that there are gender differences in depressive symptoms of people with 
CHD but equally to that of men and women in the Well group. However, the hypothesis 
of gender differences in quality of life of people with CHD was not supported by the 
cross-sectional analysis of baseline data.  
 
The hypotheses and objectives of this thesis will be tested using three waves of data 
from ELSA in Chapter 4. Before that the next chapter sets out to compare three recently 
developed with suitable software techniques for handling missing data in order to find 
the best technique that can be applied to the ELSA data.  
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Chapter 3: A simulation study to evaluate three key strategies 
to handle missing data  
 
The previous chapter described the ELSA data and presented baseline characteristics of 
the sample under investigation. This chapter aims at finding the best technique to deal 
with the problem of missing data in the ELSA data set.  
 
3.1 Review of the methods for handling missing data 
 
It has already been highlighted in Chapter 1 that missing data can pose serious problems 
for researchers because missingness can affect properties of estimators and inferences. 
The choice of the appropriate method to handle missing data strongly depends on the 
data available (Durrant, 2005). Several methods for dealing with missing data have been 
developed and are not mutually exclusive. These methods are grouped into 
“unprincipled and principled” methods. 
 
Unprincipled methods are: 
1. Procedures based on completely recorded units: these are called complete-case 
and available-case methods. Complete-case analysis is limited to observations 
for which all values are completely recorded (Little and Rubin, 2002). 
2. Last observation carried forward (LOCF): this method is specific to longitudinal 
data problems. For each individual, missing values are replaced by the last 
observed value of that variable.  
3. Single-imputation procedures: with these procedures the missing values are 
filled in and the completed data is analysed using standard methods. The most 
commonly used single-imputation methods are mean (or median) imputation 
which replaces missing values with means (or medians)  and regression 
imputation where missing values are replaced by single predicted values from 
the regression analysis (Little and Rubin, 2002). 
 
A key problem of unprincipled methods is that inferences about parameters do not 
account for uncertainty therefore the standard errors are systematically underestimated, 
p-values of tests are too small and confidence intervals are too narrow (Little and Rubin, 
2002). 
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Principled methods are based on a well-defined statistical model for the complete data 
and on assumptions about the missing data mechanism (MCAR or MAR). The 
subsequent analysis, inferences and conclusions are valid under these assumptions. This 
does not mean the assumptions are necessarily true but it does allow the dependence of 
the conclusions on these assumptions to be investigated (Kenward and Carpenter, 
2007).   
 
Principled methods include: 
1. Weighting procedures: in this approach, a model for the probability of 
missingness is fit, and the inverse of these probabilities are used as weight for 
the complete-case analysis.  
2. Simple stochastic imputation: instead of replacing a value with a mean, this 
method uses a random draw from a suitable distribution. Provided the 
distribution is chosen appropriately, consistent estimators can be obtained from 
methods that would work with the whole data set. In the large survey setting 
draws are made from units with complete data that are 'similar' to the one with 
missing values. There are several variations of this approach which use non-
parametric estimates of the distribution of the missing data. 
3. Maximum likelihood estimation: this approach assumes multivariate normality 
and MCAR or MAR.  Maximum likelihood uses all of the available data to 
identify parameter values that have the higher probability of producing the 
sample data (Baraldi and Enders, 2010). Inferences are based on the observed 
data likelihood that links the observed data and the parameters. Formally this is 
obtained from the complete data likelihood by adding together the likelihood 
contribution over all possible values of the missing data, also known as 
integration (averaging) over the missing data from the joint density of the 
observed values and the missing values (Sinharay et al., 2001). This approach is 
most commonly known as full information maximum likelihood (FIML), 
because by using direct ML estimation, parameter estimates are obtained for 
cases with complete and incomplete data. 
4. Multiple-imputation (MI): is a likelihood-based method that incorporates the 
uncertainty into the imputation process. MI is based on a Bayesian paradigm 
where the model parameters are independently drawn from the posterior 
distribution for each imputed data set (Rubin, 1987, 1996). In the frequentist 
56 
 
approach, MI fixes the model parameters at the maximum likelihood estimates 
for all imputed data sets (Robins and Wang, 2000). MI is comprised of three 
stages: imputation stage, which generates a specified number of data sets (m), 
each of which contains different estimates of the missing values; analysis stage, 
in which each of the imputed data set is analysed using the same technique that 
would have been used had the data been complete; and the pooling stage where 
the estimates and their standard errors are averaged into a single set of values. 
The pooling stage is done according to Rubin’s formula (Rubin, 1987), in order 
to yield a final result that combines the uncertainty in the data and the 
uncertainty due to missing values. Let iˆ , )
ˆvar( i ,  i=1, …, M  be the M 
complete-data estimators and their associated variances, Rubin’s rules for the 
combined estimate is: 
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To illustrate the pooling stage, I use a data set consisting 20 subjects for which 
the quality of life score was calculated (first column of Table 3.1). The score of 
quality of life is missing for 8 subjects. The last five columns of the table show 
five imputed data sets for quality of life. The multiple imputation mean is the 
average of the five estimates in Table 3.1, which is  
 
5.41
5
43.6+41.7+39.9+41.8+40.6ˆ   
 
The variance is: 
8.65
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It is therefore easy to see that the variance is the average variance of the 5 
imputed data sets plus a correction factor that quantifies the extent to which the 
estimates vary across data sets. The pooled standard deviation is simply the 
square root of the variance (S.D.= 8.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In epidemiologic research missing data are common; however, despite continuing 
methodological development, most of the studies in the literature do not report the 
handling of missing data (Chan and Altman, 2005). Traditionally, the analysis of 
incomplete data has been dominated by unprincipled methods (Enders, 2001; Klebanoff 
and Cole, 2008). As these approaches lack a principled foundation, it follows that these 
methods often behave unexpectedly in different settings (Kenward and Carpenter, 
2007). For example, procedures based on completely recorded units assume that all 
Table 3.1 Example of an observed variable with missing data and 
five imputed data sets 
Observed data  Imputed quality of life 
 
Quality 
of life  
Data 
set 
1 
Data set 
2 
Data 
set 
 3 
Data 
set 
4 
Data 
set 
5 
 52  52 52 52 52 52 
 -  46 36 42 39 49 
 50  50 50 50 50 50 
 49  49 49 49 49 49 
 47  47 47 47 47 47 
 -  18 54 26 51 51 
 45  45 45 45 45 45 
 -  34 45 45 33 53 
 41  41 41 41 41 41 
 -  51 37 32 51 48 
 44  44 44 44 44 44 
 43  43 43 43 43 43 
 38  38 38 38 38 38 
 -  42 41 48 42 54 
 36  36 36 36 36 36 
 -  40 40 40 42 43 
 -  42 42 31 46 42 
 33  33 33 33 33 33 
 -  36 39 31 28 30 
 24  24 24 24 24 24 
Mean 41.8  40.6 41.8 39.9 41.7 43.6 
S.D. 8.0  8.7 7.0 8.2 7.9 8.1 
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incomplete data arise from a MCAR process. If the missing data mechanism is MCAR, 
then using these methods in certain settings may result in nonbiased parameter 
estimates, although there might be loss of precision (Little and Rubin, 2002) and 
additionally “such settings are typically narrow and often unrealistic and difficult to 
establish” (Kenward and Carpenter, 2007:202). Therefore if any data are missing due to 
a MAR or NMAR mechanism, results will be biased and inferences invalid. In single 
imputation procedures only one value is imputed for each missing item. It follows that 
the most obvious limitation of single imputation is the underlying assumption that the 
imputed value is the true value. This limitation leads to underestimation of the variance, 
which affects confidence intervals and statistical tests.  
 
Principled methods are usually preferred to unprincipled ones because they produce 
estimates that are superior and also because unprincipled methods have no theoretical 
rationale. However, these methods are infrequent in published epidemiologic 
manuscripts (Klebanoff and Cole, 2008). Among the principled methods that have 
received considerable attention in the methodological literature of the past 20 years are 
full information maximum likelihood (FIML) and Multiple Imputation (MI). They are 
considered the “state of the art” missing data techniques (Shafer and Graham, 2002) and 
are highly recommended in the methodological literature (Shafer and Olsen, 1998; 
Enders, 2006). These techniques give unbiased estimates with MCAR and MAR data, 
therefore they are superior to unprincipled methods (such as deletion and single 
imputation approaches) (Baraldi & Enders, 2010). Amongst the main MI techniques, 
the multivariate normal imputation (MVNI) and fully conditional specification (FCS) 
have been widely used and tested in different settings. For this reason they will be 
reviewed together with FIML. 
 
The FIML technique does not impute, or fill in missing values, but directly estimates 
model parameters. Cases with incomplete data are included in computations and all 
available data are employed by the ML algorithm to obtain optimal parameter estimates 
under the assumption of multivariate normality. FIML estimation is available in 
structural equation modelling software (e.g., AMOS, MPLUS). In recent years several 
studies have been reporting the efficiency of FIML estimation relative to unprincipled 
methods (procedures based on completely recoded units and single imputation) when 
the missing data is MCAR and MAR (Artbuckle; 1996; Baraldi and Enders, 2010; 
Enders and Bandalos, 2001; Shin et al., 2009; Wotke, 2000). Others also recommend 
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the use of FIML when data are MNAR (Enders 2001; Wiggins and Sacker, 2001). It has 
also been shown that FIML yields superior performance to traditional unprincipled 
methods in multiple regression analyses. Thus the use of FIML can be extended to 
statistical analysis other than structural equation modelling (Enders 2001; Baraldi and 
Enders, 2010). However, to date and to my knowledge, the performance of the FIML 
has not been explored in the context of clustered data, such as multilevel modelling in 
the presence of missing data in both outcome and independent variables.  
 
The MVNI procedure is based on the assumption that the data arise from a multivariate 
normal distribution. Findings arising from analyses of multiply imputed data sets when 
the joint multivariate normality assumption is violated are robust to this assumption 
violation, as long as the statistical models used to subsequently analyze the imputed 
data properly account for the data’s non-normality. Schafer (1997) cites simulation 
studies and provides his own simulation evidence to illustrate the robustness to non-
normality of imputation generating models that assume joint multivariate normality 
when the number of missing data is moderate (eg, < 50%) and the amount of non-
normality in variables not severe. Recent development of computer packages 
performing MVNI (such as SAS and NORM) include variable transformation and 
categorical variable rounding utilities that may further improve the performance of 
multiple imputation conducted under the assumption of joint multivariate normality. 
Shafer (1999) states that MVNI can be easily applied to longitudinal data set with 
missing values. One study found in the literature supported the MVNI approach in the 
longitudinal setting with a monotone pattern of missing data (Newman, 2003). A data 
set is said to have a monotone missing pattern when a variable Yj is missing for the 
individual i implies that all subsequent variables Yk, k>j, are also missing for the 
individual i. It was shown that MVNI outperformed traditional approaches to missing 
data (Newman, 2003). However, to date and to my knowledge, no previous studies 
explored the performance of MVNI in a multilevel modelling setting with non-
monotone missing data in continuous and binary outcomes. 
 
The FCS approach does not start from an explicit multivariate density. Instead, it 
involves a variable-by-variable approach using chained equations (van Buuren et al. 
1999; van Buuren et al. 2007). The imputation model is specified separately for each 
variable according to its type (linear regression for continuous variables, logistic 
regression for binary variables, ordinal logistic regression for ordinal variables and so 
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forth), involving the other variables as predictors. This is the main advantage of this 
approach (Molenberghs and Kenward, 2007).  The FCS procedure is useful when the 
specification of a joint multivariate distribution of all the variables with missing values 
is difficult. However, from a theoretical standpoint this technique is problematic 
because the sequence of regression models might not be consistent with a true joint 
distribution (Shafer and Graham, 2002). This means that the iterative algorithm might 
never converge because the joint distribution to which they might converge does not 
exist. Despite the lack of a satisfactory theory, FCS seems to work quite well in many 
applications. A number of simulation studies provide evidence that FCS generally 
yields estimates that are unbiased and that possess appropriate coverage, at least in the 
variety of cases investigated (Brand et al., 2003; Brand, 1999; Raghunathan et al., 2001; 
van Bureen et al., 2006; Horton and Lipsitz, 2001). Recently, Nevaleinen et al., (2009) 
proposed an extension of the FCS to repeated measurement settings, the so called two-
fold fully conditional specification, which increases the imputation model by 
conditioning also on variables measured at other times. Using a simulation study on 
dietary data the authors demonstrate that the two-fold FCS is a suitable approach for 
imputing time dependent covariates or repeated measurements (Nevaleinen et al., 2009). 
Despite the fact that could be computationally intensive in the presence of many follow-
up years, the efficiency in recovering parameter estimates makes this approach 
appealing and investigating its performance in the presence of missing data with 
continuous and categorical variables (both outcomes and covariates) represents an 
innovative area of research that can contribute to the literature of missing data in the 
longitudinal setting.  
 
This review is not exhaustive; there are in fact several approaches that can be used to 
generate MI data sets. For example, it has been suggested that if a data set to be imputed 
is multilevel, then the imputation model should be multilevel too (Carpenter and 
Goldstein, 2004). In recent years Carpenter and Goldstein have developed macros that 
implement multiple imputation in a multilevel data setting in MLwiN for normal and 
non-normal models of interest under the assumption of missing at random (Carpenter 
and Goldstein, 2004; Goldstein et al., 2009). The macros set up a multilevel multivariate 
imputation model with the partially observed variables as responses, and fit this model 
in a Bayesian framework with uninformative priors using Markov Chain Monte Carlo 
methods to impute a number of complete data sets. However, one of the main 
limitations is that the macros cannot handle missing categorical variables. For this and 
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other reasons that are discussed in details in the final discussion of this chapter, this 
method has not been considered in this thesis. 
 
3.1.2 Summary of review 
 
Until recently, the analysis of data with missing observations has been dominated by 
unprincipled methods (Enders, 2001; Klebanoff and Cole, 2008).  However, alternative 
approaches for treating missing data have become increasingly common and are now 
available in many software packages, including two “state of the art” missing data 
methods: maximum likelihood and multiple imputation (Shafer and Graham, 2002). 
These methods have been recommended by the methodological literature as 
advantageous techniques that yield unbiased estimates with MCAR and MAR data 
(Baraldi & Enders, 2010). As a consequence, a large volume of methodological research 
is devoted to the application of these techniques to missing data that arise in several 
settings and under different assumptions. Amongst the “state of the art” missing data 
methods, the most widely used and recommended are full information maximum 
likelihood (FIML), multivariate normal imputation (MVNI) and fully conditional 
specification (FCS). To summarise, the FIML and MVNI methods assume multivariate 
normality, while two-fold FCS has the ability to handle different variable types 
(continuous, binary, unordered and ordered categorical) since each variable is imputed 
using its own imputation model. FIML does not impute missing values; instead it uses 
all available data (complete and incomplete) to identify the parameter values that have 
the highest probability of producing the sample data. FIML is relatively easy for the 
analyst to use and is widely available in structural equation programs. It is therefore 
important to understand whether when applying FIML to repeated measures and in 
particular in the presence of a non-continuous outcome it performs as well as more 
complex MI techniques.  
 
Recently, the use of the FIML, MVNI and FCS has become increasingly popular in the 
literature and a number of comparisons between them under different settings and 
assumptions have been published (Collins et al., 2001; Newman, 2003; Acock, 2005; 
Ibrahim et al., 2005; van Bureen et al., 2006; van Buuren, 2007; Yu et al., 2007; Buhi et 
al., 2008; Marshall et al., 2010; Peyre et al., 2011). The FIML has been widely used 
with longitudinal data; the MVNI can be easily extended to repeated measures and 
recently the two-fold fully conditional specification has been proposed as an extension 
62 
 
of the FCS to repeated measures (Nevaleinen et al., 2009). Despite this, no recent 
studies have examined and compared the performance of the FIML, MVNI and FCS 
techniques in the repeated measures setting. Therefore investigating the performance of 
these techniques in a repeated measure setting represents an innovative area of research. 
In particular, the comparisons of performance of these techniques in the presence of 
missing data in continuous and binary outcomes, as well as in covariates, in a multilevel 
modelling analysis, can contribute to the literature of missing data in the longitudinal 
setting.  
 
In order to investigate the usefulness of the ML and MI methods in the context of 
repeated measures, a simulation study is set up, where full information maximum 
likelihood (FIML) is compared against two MI techniques: multivariate normal 
imputation (MVNI) and two-fold fully conditional specification (two-fold FCS). The 
missing data techniques are explained in detail in the next section.  
 
Based on the results of the simulation study, the technique that performs best will be 
applied to the original data set for the longitudinal analysis reported in Chapter 4.  
 
3.2 Methods 
3.2.1 Description of the data set  
 
For the purpose of making the computation of the simulation study less intensive, a sub-
set of covariates where selected from those that will be used in the final analysis of 
Chapter 4. The data consist of two incomplete dependent variables quality of life and 
depressive symptoms; two complete independent variables (age and gender) and seven 
incomplete covariates (CHD, cohabiting status, wealth, depressive symptoms, physical 
activity, smoking status and alcohol consumption) (Table 3.2). In this chapter 
cohabiting status, wealth, physical activity, smoking status and alcohol consumption are 
recoded with three categories (as described in Chapter 2, section 2.2.3) and depressive 
symptoms is used in the original scale when it is a covariate (see Table 3.2). This choice 
was made to overcome a problem that arises in Mplus when specifying the variance of 
dichotomous variables, such as the model may not be identified and the standard errors 
may not be trustworthy due to a non-positive first order derivative product matrix. The 
problem is further discussed in section 3.2.4. 
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In order to make the three techniques as comparable as possible, in the analyses 
(substantive and imputed) all non-continuous covariates are treated as continuous. As 
explained in Chapter 2, the sample size is restricted to participants with CHD and to 
healthy participants (Well group), the total sample size is 4,496 in wave 1 (2002-03); 
3,465 in wave 2 (2004-05) and 3,031 in wave 3 (2006-07). Table 3.3 shows the 
prevalence of missing values due to mortality and unit non-response at each wave of the 
study. Only 1,998 participants had complete data on all variables at the 3 waves (44.4% 
of the sample in wave 1). Table 3.4 reports the prevalence of missing values (item non-
response) for each of the incomplete variables. 
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Table 3.2 Prevalence and sample size at each wave of the covariates used in the 
simulation study 
  Wave 1 Wave 2 Wave 3  
 % N % N % N 
       
Cohabiting status       
Cohabiting 71.7 3,221 70.7 2,448 68.8 2,085 
Not cohabiting 23.2 1,045 24.7 857 26.3 798 
Never married not 
cohabiting 
5.1 229 4.6 160 4.9 148 
Total 100 4,495 100 3,465 100 3,031 
Wealth       
Richest 16.4 732 16.9 576 15.7 462 
Middle 59.8 2,660 60.5 2,057 60.2 1,769 
Poorest 23.8 1,057 22.6 768 24.1 709 
Total 100 4,449 100 3,401 100 3,031 
Smoking status       
Never smoked 36.0 1,596 36.8 1,274 40.2 1,217 
Ex-smoker 45.2 2,001 47.2 1,632 45.7 1,385 
Current smoker 18.8 832 16.0 553 47.1 426 
Total 100 4,429 100 3,459 100 3,028 
Physical activity       
Active 16.1 711 24.7 856 23.0 699 
Moderate activity 23.0 1,021 16.3 565 16.0 484 
Low activity or inactive 60.9 2,699 59.0 2,044 61.0 1,847 
Total 100 4,431 100 3,465 100 3,030 
Alcohol consumption      
Drinks occasionally 27.7 1,223 23.8 724 24.8 627 
Once or twice a week 42.7 1,888 38.5 1,172 37.1 940 
≥3 days a week 29.6 1,309 37.7 1,146 38.1 964 
Total 100 4,420 100 3,042 100 2,531 
Depressive symptoms       
0 46.9 2,047 44.8 1,539 47.8 1,409 
1 22.7 989 24.8 854 24.6 725 
2 10.3 448 11.1 383 9.7 286 
3 6.8 298 6.5 223 6.1 179 
4 5.0 216 4.7 160 4.0 117 
5 3.5 152 2.9 100 2.9 86 
6 2.2 97 2.9 98 1.9 56 
7 1.7 76 1.5 51 1.9 55 
8 0.9 40 0.9 30 1.1 33 
Total 100 4,363 100 3,438 100 2,946 
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Table 3.3 Unit non-response and deaths 
  N % 
Present all waves 2,880 64.1 
Missed wave 2 876 19.5 
Deaths before wave 2 151 3.4 
Missed wave 3 431 9.6 
Deaths before wave 3 158 3.5 
   
Total 4,496 100 
Table 3.4 Prevalence of missing values for each variable of interest, by wave 
  Wave 1   Wave 2   Wave 3   
 N % N % N % 
CHD       
Complete 4,487 99.8     
Item non-response 9 0.2     
Total 4,496 100     
       
Quality of life       
Complete 3976 88.4 2,987 86.2 2,581 85.2 
Item non-response 520 11.6 478 13.8 450 14.8 
Total 4,496 100 3,465 100 3,031 100 
       
Depressive 
symptoms       
Complete 4,363 97.0 3,438 99.2 2,946 97.2 
Item non-response 133 3.0 27 0.8 85 2.8 
Total 4,496 100 3,465 100 3,031 100 
       
Cohabiting status       
Complete 4,495 100.0 3,465 100.0 3,031 100.0 
Item non-response 1 0.0 0 0.0 0 0.0 
Total 4,496 100 3,465 100 3,031 100 
       
Wealth       
Complete 4,449 99.0 3,401 98.2 2,940 97.0 
Item non-response 47 1.1 64 1.8 91 3.0 
Total 4,496 100 3,465 100 3,031 100 
       
Smoking status       
Complete 4,429 98.5 3,459 99.8 3,028 99.9 
Item non-response 67 1.5 6 0.2 3 0.1 
Total 4,496 100 3,465 100 3,031 100 
       
Physical activity       
Complete 4,431 98.6 3,465 100.0 3,030 100.0 
Item non-response 65 1.5 0 0.0 1 0.0 
Total 4,496 100 3,465 100 3,031 100 
       
Alcohol consumption      
Complete 4,420 98.3 3,042 87.8 2,531 83.5 
Item non-response 76 1.7 423 12.2 500 16.5 
Total 4,496 100 3,465 100 3,031 100 
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3.2.2 Complete case analysis 
 
The complete data of 1,998 individuals was treated as if it were the underlying 
population, and the regression coefficients obtained from random intercepts models are 
the target parameters of interest I wish to recover. Random intercept models were 
estimated as follows: 
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Where yij is the quality of life for individual j at time i, xpj are time-invariant factors 
such as gender, CHD (at wave 1), and the interaction term between CHD and gender; 
xpij are time-varying factors such as age (a linear and quadratic term), cohabiting status, 
depressive symptoms, wealth, smoking status, alcohol consumption and physical 
activity.  
 
A logit model was estimated for depressive symptoms as follows: 
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Where 
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log  is the odds that yij=1 (i.e. the probability of having depressive 
symptoms) at occasion i for individual j, xpj are time-invariant factors such as gender, 
CHD (at wave 1), and the interaction term between CHD and gender; xpij are time-
varying factors such as age, cohabiting status, wealth, smoking status, alcohol 
consumption and physical activity. uj denotes the random error associated with the 
individual level variation with residual variance equal to 2u . Model (4) does not include 
a level-one residual because it is an equation for the probability 
ij
ij


1
 rather than for 
the outcome yij (Goldstein, 2003). The level-one residual variance 
2
e  cannot change 
and is conventionally fixed at π
2
/3= 3.29. 
 
In order to compare trajectories of quality of life and depressive symptoms of men and 
women, the following random intercept models were estimated: 
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Where yij is the quality of life for individual j at time i, x1j is gender, tij denotes time and 
takes three discrete values denoting the baseline, the second and third waves, tij* xij 
denotes the interaction term between time and gender; xpij are time-varying factors 
described in equation 3). The model is run separately for people with CHD and people 
in the Well group because the interaction term between CHD, gender and time was 
statistically significant, and also to facilitate the interpretation of results. 
 
The same model as in equation 5) was estimated for depressive symptoms as follows: 
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Where x1j is gender, tij denotes time and takes three discrete values, tij* x1j denotes the 
interaction term between time and gender; xpij are time-varying factors described in 
model 4). The model is run separately for people with CHD and people in the Well 
group. 
 
All models are estimated in Stata (version 10).  
 
3.2.3 Simulation strategy 
 
To evaluate the performance of the three techniques for handling missing data, an 
artificial simulation study was set up (Figure 3.1). From the complete data of 1,998 
individuals (the reference population for the complete-case analysis), ∼55.6% of 
missing values were generated using random uniform and binomial numbers to 
reproduce similar probabilities of missingness as occurred in the original data (4,496 
individuals). Deletion was repeated 1,000 times to generate 1,000 replicates in which 
the prevalence of missing values obtained ranged between 54% and 57%. Deletion was 
performed for each wave as follows:  
 
- For wave 1, the pattern of missing values for the variables of interest was 
examined, only patterns with over 1% missing values were replicated and these 
are reported in Table 3.5. In order to create missing values, random uniform 
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numbers were used (Burton et al., 2006). If the rank of the random number was 
equal to or less than the proportion specified, a missing value was generated for 
the variable of interest (Table 3.5). For the remaining proportions of missing 
values (those patterns with less than 1% coverage reported in italics in Table 
3.5) and for the variables not included in the patterns reading across the rows in 
Table 3.5, cases were deleted using random binomial variables, with the 
probability of having a missing value being the same as for the original data.  
 
- For wave 2, cases were first deleted to generate missing values due to unit non-
response (19.5%) and mortality (3.5%) using random uniform numbers. Then 
the pattern of missing values for the variables of interest was examined and 
missing values for item non-response were generated using random uniform 
number according to the patterns described in Table 3.5. If the rank of the 
random number was equal to or less than the proportion specified, a missing 
value was generated for the variable of interest (Table 3.6). For the remaining 
proportion of missing values (those patterns with less than 1% coverage) and for 
the remaining variables, missing values were generated using random binomial 
variables using the same proportion of missing values as for the original data.  
 
- For wave 3, the same procedure as for wave 2 was used to generate missing 
values (Table 3.7). First missing values were generated to reproduce unit non-
response (25.6%) and mortality (7%) using random uniform numbers. Then the 
pattern of missing values for the variables of interest was examined and missing 
values for item non-response were generated using random uniform number 
according to the patterns described in Table 3.7. If the rank of the random 
number was equal to or less than the proportion specified, a missing value was 
generated for the variable of interest (Table 3.7). For the remaining proportion of 
missing values (those patterns with less than 1% coverage) and for the 
remaining variables, missing values were generated using random binomial 
variables using the same proportion of missing values as for the original data. 
The full code used to generate missing values is available in Appendix 3.1. 
 
The deletion procedure was repeated 1,000 times in order to generate 1,000 replicates. 
Each replication was then analyzed as follows: 
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1) In Mplus to perform the FIML estimation. 
2) In SAS, using the MI procedure to obtain five imputed data sets under MVNI. 
3) In Stata, to perform the two-fold FCS to obtain five imputed data sets. 
Steps 1 to 3 are described in detail in the following section. Steps 2 and 3 are followed 
by analysis of the imputed data sets to obtain overall estimate according to Rubin’s 
formula (Rubin, 1987).  
 
The choice of imputing five data sets was made to make the simulation less 
computationally intensive. Most literature (Rubin, 1987; van Buuren et al.,, 1999) 
suggests that good inferences can be made with the number of imputed data sets (m) as 
few as m = 5. Rubin (1987) showed that the efficiency of an estimate based on m 
imputations, relative to one based on an infinite number, is (1 +λ/m)−1 where λ  is the 
rate of missing information. In my case, with 56% missing information, m =5 
imputations is 90% efficient. 
 
 
 
 
Figure 3.1 Design of simulation study 
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Table 3.5 Missing values patterns, wave 1 
Marital  
status 
Wealth 
 
Smoking 
 
Physical  
Activity 
Alcohol  
consumption 
QoL 
 
Depressive 
symptoms 
 
CHD 
 
Missing 
values 
N 
 
% 
 
+ + + + + + + + 0 3888 86.48 
+ + + + + . + + 1 402 8.94 
+ + . . . . . + 5 47 1.05 
+ . + + + + + + 1 37 0.82 
+ + + + + + . + 1 34 0.76 
+ + + + + . . + 2 31 0.69 
+ + + + . . + + 2 21 0.47 
+ + . . + + . + 3 14 0.31 
+ . + + + . + + 2 8 0.18 
+ + . . . . . . 6 3 0.07 
+ + + + . + + + 1 2 0.04 
+ + + + . . + . 3 2 0.04 
+ + + + + + + . 1 1 0.02 
+ + . + + . + + 2 1 0.02 
+ + + + + . . . 3 1 0.02 
+ . + + + . . + 3 1 0.02 
+ + . + + . . . 4 1 0.02 
+ + . . + . . + 4 1 0.02 
. . + + . . + . 5 1 0.02 
A plus sign indicates that the variable was observed; a dot indicates that the data on the variable were missing. 
Missing values patterns in italics were not replicated because missing values <1%. 
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3.2.4 Full information maximum likelihood (FIML)  
Table 3.6 Missing values patterns, wave 2 
Wealth 
 
Smoking 
 
Alcohol 
consumption 
QoL 
 
Depressive 
symptoms 
 
Missing 
values 
N 
 
% 
 
+ + + + + 0 2871 82.9 
+ + . . + 2 348 10.0 
+ + + . + 1 103 3.0 
+ + . + + 1 50 1.4 
. + + + + 1 49 1.4 
+ + . . . 3 12 0.3 
. + . . + 3 11 0.3 
+ + + + . 1 10 0.3 
+ . + + + 1 4 0.1 
. + + + . 2 3 0.1 
+ + + . . 2 1 0.0 
. + + . + 2 1 0.0 
+ . . . + 3 1 0.0 
+ . . . . 4 1 0.0 
A plus sign indicates that the variable was observed; a dot indicates that the data on the variable 
were missing. Missing values patterns in italics were not replicated because missing values <1%. 
Table 3.7 Missing values patterns, wave 3 
Wealth 
 
Smoking 
 
Physical 
Activity 
Alcohol 
consumption 
QoL 
 
Depressive 
symptoms 
 
Missing 
values 
N 
 
% 
 
+ + + + + + 0 2421 79.9 
+ + + . . + 2 311 10.3 
+ + + . + + 1 91 3.0 
+ + + . . . 3 62 2.0 
. + + + + + 1 58 1.9 
+ + + + . + 1 44 1.5 
. + + . . + 3 16 0.5 
. + + . . . 4 15 0.5 
+ + + + + . 1 7 0.2 
. + + . + + 2 2 0.1 
+ . + + + + 1 1 0.0 
+ . + . + + 2 1 0.0 
+ . + . . + 3 1 0.0 
+ + . . . . 4 1 0.0 
A plus sign indicates that the variable was observed; a dot indicates that the data on the variable were 
missing. Missing values patterns in italics were not replicated because missing values <1%. 
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The FIML method estimates model parameters and standard errors using all available 
raw data. It does not involve imputation of missing items but directly estimates the 
parameters from available items (Enders, 2001). The FIML estimator maximizes a 
likelihood function that is the sum of n casewise likelihood functions (where n in the 
number of respondents). Enders (2001) describes the method as follows: assuming 
multivariate normality, the casewise likelihood of the observed data is obtained by 
maximising the function: 
 
    (7) 
 
such that xi is the vector of complete data for case i, µi is the vector of mean estimates 
for those variables that are observed for case i, and Ki is a constant that depends on the 
number of complete points for case i. The determinant and inverse of the covariance 
matrix Σi are based only on those variables that are observed for case i. Summing over 
the n casewise functions yields the discrepancy function for the entire sample: 
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To illustrate of FIML works consider a model with four observed variables: X1, X2, X3 
and X4. The parameters of interest are 
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The likelihood value for a subject with missing X1 would be a function of the values on 
the observations for the other three variables, X2, X3 and X4, as well as the parameter 
estimates that involved these three variables. The relevant parameters are shown in the 
following: 
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By contrast the likelihood value for a subject with missing X2 and X4 would be a 
function of the two other observations (X1, and X3) as well as the parameter estimates 
that involved X1, and X3. The relevant parameters are shown in the following: 
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Then the value of the overall discrepancy function is obtained by summing the 
likelihood functions for each individual.  
Enders (2001) explains that at a more conceptual level, it is assumed that missing values 
on a variable X are conditionally dependent on other variables in the data (missing at 
random (MAR)), and incorporating vectors of partially complete data in the individual 
level likelihood functions (7) implies probable values for the missing data during the 
parameter estimation process. Conceptually this is analogous to generating predicted 
scores for the missing data by regressing X on other variables used in the analysis.  
 
FIML in Mplus 
 
Random intercept models with FIML were performed on each of the 1,000 replicates in 
Mplus, using a Monte Carlo simulation. Mplus has extensive Monte Carlo simulation 
facilities for both data generation and data analysis. Since the replicates were generated 
in Stata, the external Monte Carlo simulation study was used, whereby multiple data 
sets are generated in a first step using another computer program (in my case Stata). The 
data sets (or replicates) are analysed in a second step in Mplus and the results are 
summarised (Muthén and Muthén, 2007). In an external Monte Carlo simulation in 
Mplus it is possible to provide population values (β and SE(β)) for each parameter when 
specifying the random interaction model. These parameters are used as the population 
parameter values (i.e. the targeted parameters) for the analysis model (see Mplus coding 
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in Appendix 3.2). The population parameter values obtained from the complete case 
analysis are those that I wish to recover. In the logistic random intercept model for 
depressive symptoms, the variable was specified as being a dummy variable (total score 
ranged from 0 to 8, cut off 3); while in the linear random intercept model for quality of 
life the variable measuring depressive symptoms was used as continuous covariate. 
When using FIML each model is estimated conditioned on the independent variables, 
therefore cases that are missing on the independent variables will be excluded from the 
analyses. It is possible to include these cases by treating these variables as dependent 
variables and distributional assumptions are made about them (i.e. normality). This is 
achieved by mentioning the variances of the independent variables in the MODEL 
command. One problem that commonly arises in Mplus when specifying the variance of 
dichotomous variables is that the model may not be identified and the standard errors 
may not be trustworthy due to a non-positive first order derivate product matrix. One 
way to get round this problem is to use independent variables with more than two 
categories (especially when their variances need to be specified) and treat them as 
continuous. This is the solution adopted for this simulation study. In some analyses 
Mplus allows the inclusion of auxiliary variables that are known to predict missingness, 
for example ethnicity and region of residence. However, when using a multilevel model 
in Mplus, this option is not available. 
 
In the Monte Carlo simulation setting, random intercept models for continuous 
outcomes are estimated using maximum likelihood; for binary outcomes random 
intercept models are estimated using a Monte Carlo algorithm for integration.  
 
3.2.5 Multivariate Normal imputation (MVNI) 
 
Multiple imputations under the normal model assume a joint multivariate normal 
distribution for all variables. With the multivariate normal model missing data are 
imputed using simultaneous linear regression models in which each variable potentially 
depends on all other variables (Schafer and Olsen, 1998). Various methods can be used 
to fit and make Bayesian draws from the joint distribution. The method of choice 
depends on the type of missing data pattern, i.e. monotone or arbitrary. A data set is said 
to have a monotone missing pattern when a variable Yj is missing for the individual i 
implies that all subsequent variables Yk, k>j, are also missing for the individual i. For 
data sets with arbitrary or non-monotone missing patterns, a Markov Chain Monte Carlo 
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(MCMC) method (Schafer 1997) can be used.  A Markov chain is a sequence of random 
variables in which the distribution of each element depends only on the value of the 
previous one. MCMC creates multiple imputations by drawing simulations from a 
Bayesian predictive distribution for normal data. A regression model is fitted for each 
variable with missing values, with other variables as covariates. Based on the fitted 
regression coefficients, a new regression model is simulated from the posterior 
predictive distribution of the parameters and is used to impute the missing values for 
each variable (Rubin 1987). The process is repeated sequentially for variables with 
missing values. 
 
MVNI  in SAS  
 
For each of the 1,000 replicates, 5 imputed data sets were generated using PROC MI 
available in SAS (SAS OnlineDoc
TM
: Version 8; Vargas-Chanes et al., 2003). The 
missing values were imputed using a Markov Chain Monte Carlo (MCMC) method 
which is suitable for arbitrary missing data patterns, and which assumes multivariate 
normality. In MCMC, one constructs a Markov Chain long enough for the distribution 
of elements to stabilize to a common, stationary distribution.  By repeatedly simulating 
steps of the chain, it simulates draws from the distribution of interest.  
 
In Bayesian inference, information about unknown parameters is expressed in the form 
of a posterior distribution. MCMC has been applied as a method for exploring posterior 
distributions in Bayesian inference. That is, through MCMC, one can simulate the entire 
joint distribution of the unknown quantities and obtain simulation-based estimates of 
posterior parameters that are of interest. Assuming that the data are from a multivariate 
normal distribution, data augmentation is applied to Bayesian inference with missing 
data by repeating a series of imputation and posterior steps. In the Imputation (I) step 
the missing data are imputed by drawing values from the conditional distribution, given 
the observed values and the parameters; in the Posterior (P) step new values for the 
parameters are imputed by drawing them from a Bayesian posterior distribution given 
the observed data and the most recent estimates (from the I step) for the missing data 
(Vargas-Chanes et al., 2003). These two steps are iterated long enough for the results to 
be reliable for a multiply imputed data set (Schafer 1997).  
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By default, the SAS procedure uses the MCMC method with a single chain to create 
five imputations. I have specified multiple chains meaning that a separate chain is used 
for each imputation (data set), because using multiple chains may be computationally 
more efficient than a single long chain. The posterior mode, the highest observed-data 
posterior density, with a non-informative prior, is computed from the Expectation 
Maximization (EM) algorithm and is used as the starting value for the chain. The EM 
algorithm starts with randomly assigning values to all the parameters to be estimated. It 
then iterately alternates between two steps, called the expectation step (E-step) where it 
computes the expected likelihood for the complete data, and the maximization step (M-
step) where it re-estimates all the parameters by maximizing the likelihood function for 
the complete data (Little and Rubin, 2002). The MI procedure takes 200 burn-in 
iterations before the first imputation and 100 iterations between imputations. In a 
Markov chain, the information in the current iteration has influence on the state of the 
next iteration. The burn-in iterations are iterations at the beginning of each chain that 
are used to eliminate the series of dependence on the starting value of the chain and to 
achieve a stationary distribution.  
 
In order to monitor the convergence in MCMC to assess whether the number of 
iterations is enough to achieve convergence, I looked at the time-series and 
autocorrelation function plots for means of the independent variables. For quality of life 
and depressive symptoms at each wave, I requested the time-plot of the mean against 
the iterations, and the autocorrelations (with 95% confidence limits) for the means at 
various lags in the sequence of iterations. The time-series plots showed that for both 
variables the series of iterations had converged, as each resembled a horizontal band 
without long upward or downward trends. Similarly, the autocorrelation plots showed 
no significant negative or positive correlations. 
 
The imputation model included the same variables as the substantive models (including 
the interaction term between CHD and gender). Categorical and binary variables were 
imputed under the normal model and imputed values were rounded to the nearest 
category. The variable for depressive symptoms was imputed under the normal model, 
which was then transformed into a dummy variable for use as an outcome variable. 
Although the regression and MCMC methods assume multivariate normality, inferences 
based on multiple imputation can be robust to departures from the multivariate 
normality assumption if the amount of missing information is not large. It often makes 
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sense to use a normal model to create multiple imputations even when the observed data 
are somewhat non-normal, as supported by simulation studies described in Schafer 
(1997) and the original references therein. The imputation of the quality of life measure 
(CASP-19) and of the depressive symptoms measure (CESD-8) were performed at the 
level of each summed index and not for the individual items that constitute the two 
measures. 
 
Imputation of the 1,000 replicates was performed in blocks of 100 (SAS coding for 
imputation is available in Appendix 3.3). Imputed data sets were then saved and 
transferred to Stata for the estimation of the random intercept models using Rubin’s 
rules. Because of system limitations, analysis of each random intercept model was also 
run in blocks of 100 imputed replicates and the estimates stored.  
 
3.2.6 Fully conditional specification (FCS) and two-fold FCS 
 
Van Buuren et al., (2007:1051-1052) describe the fully conditional specification as 
follows: suppose Y=(Y1, Y2,…,Yp) is a vector of p random variables (explanatory and or 
dependent) with p-variate distribution P(Y|θ). We assume that the joint distribution of Y 
is completely specified by θ, a vector of unknown parameters. For example if Y is 
multivariate normally distributed, θ=(μ,Σ), with μ a p-dimensional mean vector and Σ a 
p x p covariance matrix. Let the matrix y=(y1, …yn) with yi=(yi1, yi2…, yip), i=1,…,n be 
an independently and identically distributed (i.i.d.) sample of the vector Y. The matrix y 
is partially observed, in the sense that each column in y has missing data.  
 
The standard procedure for creating multiple imputations y* of y
mis
 is as follows: 
1. Calculate the posterior distribution p(θ|yobs) of θ based in the observed data yobs; 
2. Draw a value of θ* from p(θ|yobs);  
3. Draw a value of y* from the conditional posterior distribution of ymis given θ= 
θ*,  p(ymis |yobs, θ= θ*). 
 
Steps 2 and 3 are repeated several times for more imputations. FCS proposes to obtain 
the posterior distribution of θ by sampling iteratively from conditional distribution of 
the form:  
P(Y1| Y-1,  θ1), 
…                                                  (9) 
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P(Yp| Y-p,  θp). 
Y-p is defined as Y1....Yn excluding Yp. 
 
The parameters θ1,…,θp are treated as specific to the respective conditional densities and 
are not necessarily the product of some factorization of the true joint distribution P(Y|θ). 
The process is iterative, starting with some simple initial values, and cycles through all 
variables, with possibly different conditional specifications, a number of times. More 
precisely, the t
th
 iteration of the method consists of the following successive draws of 
the Gibbs sampler: 
θ1
*(t)  
~ P(θ1|y1
obs
 , y2
(t-1)
 , …, yp
(t-1)
) 
y1
*(t)  
~ P(y1
mis
|y1
obs
 , y2
(t-1)
 , …, yp
(t-1)
 , θ1
*(t)
) 
…                     (10) 
θp
*(t)  
~ P(θp|yp
obs
 , y1
(t)
, y2
(t)
 , …, yp-1
(t)
) 
yp
*(t)  
~ P(yp
mis
|yp
obs
 , y1
(t)
, y2
(t)
 , …, yp-1
(t)
, θ1
*(t)
) 
 
“No information about yj
mis
 is used to draw θj
*(t)
 which differs from MCMC approaches 
to joint modelling. The iterations of (10) are executed m times in parallel to generate m 
multiple imputations. This procedure simply assumes that the joint distribution is 
specified by (9), and that the Gibbs sampler in (10) provides draws from it” (van 
Buuren et al., 2007:1051-1052). 
 
The great advantage of this approach is that each type of variable (continuous, binary, 
unordered and ordered categorical) is modelled separately (Molenberghs and Kenward, 
2007).  However, from a theoretical standpoint of view this technique is problematic, 
because the sequence of regression models might not be consistent with a true joint 
distribution (Shafer and Graham, 2002), meaning that the iterative algorithm may never 
converge because the joint distribution to which they may converge does not exist. 
Nevertheless, simulation work (Brand, 1999) suggests that in some practical 
applications the method can work well despite the theoretical problems.  
 
The FCS approach differs from the MVNI in that it does not start with the construction 
of a well-defined joint distribution for the variables to be imputed. FCS starts with a 
collection of univariate conditional distributions for variables with missing data in terms 
of all other variables. The main idea is that a univariate conditional model is constructed 
for each potentially missing variable (dependent and/or explanatory) which is 
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appropriate to the type. This means that logistic regression can be used for binary 
variables, linear regression for continuous, ordinal logistic regression for categorical 
variables and so forth. The other potentially missing variables are used as explanatory 
variables in each univariate imputation model. The conditional density for the j
th
 
missing variable (of p) would be 
),...,,,...,|( 111 pjjj YYYYYf   j=1....p                                  (11) 
 
Univariate posterior draws are made one variable at a time by cycling through all p 
models given current values of the other variables (Molenberghs and Kenward, 2007). 
After sufficient cycles (10-20), the imputations are taken from one final cycle through 
the univariate model. 
 
This approach can be extended to q repeated waves, in which case equation (11) 
becomes 
),...,,,...,|( )1()1(1 ipkijiiij YYYYYf   j=1....p  i=1...q                                (12) 
Nevalainen et al., (2009) proposed using an imputation strategy which is doubly 
iterative, the so called two-fold fully conditional specification. At time i, Yi is imputed 
conditional on the same variable observed at time i-1 and i+1, and the other variables at 
time i. One iteration runs over the variables j=1....p, called within-times iterations. The 
past and future observations (Yi-1 and Yi+1) are not imputed at this stage, they serve only 
in the role of predictors in the imputation model. There is also second imputation 
iteration over waves (i=1...q), called among-times iterations.  
 
Two-fold FCS  in Stata 
 
For each of the 1,000 replicates, five imputed data sets were generated using the Stata’s 
user-written program ice.  The acronym, ice, stands for Imputation by Chained 
Equations (Royston, 2005, 2007, 2009; Carlin et al., 2008; Royston et al., 2009).  The 
two-fold FCS is an extension of the FCS method of ice, programming was required to 
implement the doubly iterative procedure. The imputation model included the same 
variables as the substantive models (including the interaction term between CHD and 
gender). For each variable with missing data a univariate conditional model was 
constructed which was appropriate to the type. The default option for a variable is 
logistic regression when there are two distinct values, multinomial logistic regression 
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when there are three to five categories, and linear regression otherwise. It is possible to 
define the regression command to be used with a specific variable when this is to be 
imputed. Variables with three to five categories are modelled as linear terms when they 
are covariates for other variables to be imputed. This choice was made to make the 
treatment of these variables in the same way as FIML and MVNI. For depressive 
symptoms, an ordered logistic regression was chosen to be used when it was a 
dependent variable. For all other variables with three categories, multinomial logistic 
regression was chosen when these were dependent variables. However, use of 
multinomial logistic regression may produce unstable estimates or perfect prediction 
may arise when a predictor variable perfectly predicts success or failure in the outcome 
variable. In the former situation it is not possible to use multinomial logistic regression, 
so instead the ordered logistic regression is used, that was the case for cohabiting status, 
physical activity and smoking status. If perfect prediction arises ice temporarily 
augments the data with a few extra observations with low weight, in such a way as to 
remove the perfect prediction.  
 
The two-fold FCS was performed as follows: 
1) Variables with missing data at wave 1 were imputed using as predictors all other 
variable at the same wave, plus the future observation (at wave 2) of the same 
variable.  Although this latter variable is imputed by default in Stata, it is then 
dropped as it serves only the role of a predictor in the imputation model. For 
example to impute missing values for quality of life (QoL) at wave 1, the 
following linear regression model is used: 
 
21111
11
2
111111 )*(
wavewavewavewavewave
wavewavewavewavewavewavewavewave
QoLDepressionAlcoholtPhysicalacSmoking
WealthCohabitingAgeAgeCHDSexCHDSexQoL


 
2) Variables with missing data at wave 2 were imputed using as predictors all other 
variable at the same wave, plus the past (wave 1 imputed in the previous step) 
and future observations of the same variable (wave 3 not imputed). These 
variables from wave 1 and wave 3 are then dropped after the imputation as they 
serve only the role of predictors in the imputation model.  
 
3) Variables with missing data at wave 3 were imputed using as predictors all other 
variable at the same wave, plus the past observations (wave 2 only imputed in 
81 
 
the previous step) of each variable to be imputed. Again, the wave 2 variable are 
then dropped after the imputation as serves only the role of a predictor in the 
imputation model. One imputed data set is generated. 
 
Figure 3.2 gives a graphical explanation of steps 1) 2) and 3). 
Within step 1) 2) and 3) it is possible to decide how many within-times iterations are 
needed to reach convergence. The default option in ice is 10 iterations. Convergence 
was explored on one of the replicates (simulated data set), by plotting the mean values 
of the outcomes variables (at each wave) against 100 iterations. From graphical 
inspection it could be concluded that the pattern of the imputed means of depressive 
symptoms and quality of life occurred randomly; also the mean estimates obtained from 
10 iterations and those obtained from 100 iterations did not differ significantly (Table 
A3.1, Appendix 3.4). Therefore for all replicates the number of within-times iterations 
was set to 10. 
 
Steps 1) to 3) form one among-times iteration. It can be decided how many among-
times iterations are needed, Nevalainen et al., (2009) showed that increasing the number 
of iterations from one to five improved the performance of the estimators although the 
gain due to the increase was relatively small. To establish the number of among-times 
iterations to be used in this study I used three among-times iterations on one replicate 
and imputed 5 data sets. The means of the imputed variables at each wave were then 
compared with the means of the complete case data (Table A3.2 Appendix 5.4). Since 
the estimates from the five imputed data sets were very close to those of the complete 
case data (consisting of 1,998 cases), three among-times iterations were used to impute 
all 1,000 replicates. The imputation of the quality of life measure (CASP-19) and of the 
depressive symptoms measure (CESD-8) were performed at the level of each summed 
index and not for the individual items that constitute the two measures. 
 
To summarise, steps 1) to 3) were repeated three times (three among-times iterations) to 
generate one imputed data set, the procedure was then repeated four more times to 
obtain five imputed data sets on one replicate. In order to generate five imputed data 
sets for all 1,000 replicates, loops were used, and replicates were imputed in blocks of 
100 at each time. The imputation stage can be computationally intensive especially if 
repeated on 1,000 replicates. Stata code for two-fold FCS is available in Appendix 
3.4.3.  
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Random intercept model estimates were obtained from the imputed replicates. Because 
of system limitations, analysis of each random intercept model was also run in blocks of 
100 imputed replicates and the estimates stored. 
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Figure 3.2 Two-fold fully conditional specification  
 
 
 
 
 
 
 
Results  
 
 
 
A) First among-times 
iteration  
B) Second among-times 
iteration  
The * indicates the variable with missing data at the specific wave that is to be imputed. 
C) Third among-times 
iteration  
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3.2.7 Evaluation criteria 
 
After the missing data strategies had been performed on the 1,000 replicates, the 
estimates from the analysis stage were stored. From these stored estimates, some 
summary measures were calculated to assess each strategy to handle missing data as 
follows: 
The (average) estimate of interest: n
n
i
i
 1
ˆ
ˆ


 where n is the number of replicates 
(1,000), and i
ˆ
 is the estimate of interest within each of the i=1,…,n replicates. When 
MI is performed, each i
ˆ
 is the overall estimate obtained according to Rubin’s formula 
(Rubin, 1987), which is just the average of the i
ˆ
, from the 5 combined estimates 
within each of the i=1,…,n replicates. 
 
The (average) standard error of the estimate of interest: n
SE
SE
n
i
i
 1
)ˆ(
)ˆ(


 where 
)ˆ( iSE   is the standard error of the estimate of interest within each of the i=1,…,n 
replications. When MI is performed, each 
)ˆ( iSE   is the overall standard error of the 
estimate of interest obtained from the five combined estimates according to Rubin’s 
formula (Rubin, 1987), within each of the i=1,…,n replicates. 
 
In order to evaluate the performance of each procedure employed to deal with missing 
data and to evaluate to what extent the targeted coefficients (estimates of interest) are 
recovered, I used assessments of accuracy and precision. Accuracy indicates the degree 
of closeness of the estimated value to the targeted parameter; precision refers to the 
repeatability or reproducibility of the measurement. 
 
For the assessment of accuracy the following were used: 
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Bias: )
ˆ(    which is the difference between the average estimate and the population 
parameter. A bias that varies between 
)ˆ(
2
1
iSE 
 to 
)ˆ(2 iSE   is considered troublesome 
(Shafer and Graham, 2002; Sinharay et al., 2001). 
 
The Mean Square Error (MSE): 
22 ))ˆ(()ˆ(  SD is the average squared difference 
between the estimate and its target plus its variance, therefore can be seen as a summary 
of both bias and variability. A value of the MSE close to zero indicates that the average 
estimator predicts the targeted parameter with good accuracy. 
 
For the assessment of precision the following were used: 
 
Standardised bias percent: )
ˆ(
)ˆ(
100


SE


 which is the bias as a percentage of the 
standard error. A standardised bias is considered to have a large impact on the precision 
if it exceeds 40 per cent in either direction (Collins et al., 2001). 
 
The (average) standard deviation of the estimate of interest: n
SD
SD
n
i
i
 1
)ˆ(
)ˆ(


 where 
)ˆ( iSD   is the standard error of the estimate of interest within each of the i=1,…,n 
replicates. When MI is performed, each 
)ˆ( iSD   is the overall standard error of the 
estimate of interest obtained from the five combined estimates within each of the 
i=1,…,n replicates. The standard deviation of estimates represents the variability across 
replicates of the parameter estimates. 
 
3.3 Results  
3.3.1 Quality of life 
 
The results of the comparisons of missing data techniques for the analysis of the first 
model of quality of life (linear random intercept model with an interaction between 
gender and CHD) are shown in Tables 3.8 to 3.10. The bias of the coefficients for CHD 
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and gender were small and close to zero for all the techniques, although MVNI seemed 
to recover the parameter for gender slightly better than FIML and two-fold FCS; the 
standard error of the estimate for gender (target value, 0.27) was fully recovered by two-
fold FCS. Largest bias in the coefficient for the interaction term between CHD and 
gender was obtained under FIML and smallest bias was obtained under MVNI and FCS  
 
although the values of the MSE were similar; this was due to the larger values of the 
standard deviation under MVNI and FCS. MI techniques recovered the coefficient for 
the interaction term better than the FIML. This is probably due to the fact that the 
imputation models of FCS, two-fold FCS and MVNI included the interaction term and 
in that sense they reflected the substantive models. 
 
 
Table 3.8 FIML technique for QoL, linear random intercept model with gender and 
CHD interaction (model 1) 
FIML 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand 
Bias MSE 
         
CHD 
 
-1.48 0.44 -1.54 0.48 0.18 -0.06 -12.5 0.04 
Gender 
 
1.09 0.27 1.14 0.29 0.11 0.05 18.6 0.02 
CHD*Gender 
 
-0.38 0.68 -0.54 0.72 0.28 -0.16 -22.0 0.10 
Age 
 
-0.06 0.01 -0.03 0.02 0.01 0.03 183.4 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting 
status 
 
-0.29 0.20 -0.40 0.22 0.11 -0.10 -45.9 0.02 
Wealth 
 
1.94 0.17 1.95 0.19 0.10 0.00 2.6 0.01 
Smoking 
 
-0.31 0.17 -0.29 0.19 0.07 0.02 10.3 0.01 
Physical 
Activity 
 
-0.55 0.10 -0.58 0.12 0.06 -0.03 -22.5 0.00 
Alcohol 
consumption 
 
0.61 0.13 0.64 0.15 0.08 0.03 23.1 0.01 
Depressive 
symptoms 
 
-1.30 0.05 -1.38 0.06 0.04 -0.08 -121.0 0.01 
Abbreviations: QoL= quality of life. FIML=full information maximum likelihood 
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The FIML and two-fold FCS methods did not recover the coefficient for depressive 
symptoms as well as MVNI, as indicated by the values of the bias (-0.08 in FIML and -
0.05 in two-fold FCS) and mainly by the large values of the standardised bias percent 
(over 40% in both techniques). All three methods failed to recover the coefficient for 
cohabiting status and the MVNI and two-fold FCS did not perform as well as the FIML 
in recovering the coefficient for wealth and physical activity. 
 
 
 
 
Table 3.9 MVNI technique for QoL, linear random intercept model with gender and CHD 
interaction (model 1) 
MVNI  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
CHD 
 
-1.48 0.44 -1.42 0.49 0.21 0.06 12.7 0.05 
Gender 
 
1.09 0.27 1.08 0.29 0.13 -0.01 -2.2 0.02 
CHD*Gender 
 
-0.38 0.68 -0.40 0.73 0.32 -0.02 -3.3 0.10 
Age 
 
-0.06 0.01 -0.06 0.02 0.01 0.01 35.2 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting 
status 
 
-0.29 0.20 -0.39 0.22 0.12 -0.10 -43.9 0.02 
Wealth 
 
1.94 0.17 1.81 0.19 0.11 -0.13 -68.8 0.03 
Smoking 
 
-0.31 0.17 -0.32 0.19 0.08 -0.01 -5.8 0.01 
Physical 
Activity 
 
-0.55 0.10 -0.49 0.12 0.06 0.06 45.9 0.01 
Alcohol 
consumption 
 
0.61 0.13 0.60 0.15 0.09 -0.01 -6.3 0.01 
Depressive 
symptoms 
 
-1.30 0.05 -1.32 0.07 0.05 -0.02 -26.1 0.00 
Abbreviations: QoL=quality of life. MVNI=multivariate normal imputation 
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Results from the second model of quality of life (linear random intercept model with an 
interaction between gender and time) for the CHD group are shown in Table 3.11 to 
Table 3.13. The bias of the coefficient for gender was reasonably small for all three 
methods, and the values of the standardised bias percent were within the acceptable 
range. The bias and the standardised bias percent of the coefficients for wave 2 and 
wave 3 were slightly larger in MVNI and two-fold FCS compared to those obtained by 
the FIML method, but still fairly small. The recovery of the coefficients for the two 
interaction terms was slightly better under FIML and MVNI compared to two-fold FCS 
for which the standardised bias percentages were also highest. Also, in all three 
techniques the values of the MSE of the two interaction terms were not close to zero.  
As for the recovery of the parameters for the covariates, FIML and two-fold FCS did 
not recover the coefficient for depressive symptoms with good accuracy and precision, 
Table 3.10 Two-fold FCS technique for QoL, linear random intercept model with gender 
and CHD interaction (model 1) 
 
Two-fold FCS 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
CHD 
 
-1.48 0.44 -1.47 0.45 0.26 0.02 3.6 0.07 
Gender 
 
1.09 0.27 1.13 0.27 0.16 0.04 15.8 0.03 
CHD*Gender 
 
-0.38 0.68 -0.42 0.69 0.41 -0.04 -6.0 0.17 
Age 
 
-0.06 0.01 -0.05 0.02 0.01 0.01 89.9 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting status 
 
-0.29 0.20 -0.39 0.21 0.14 -0.09 -46.0 0.03 
Wealth 
 
1.94 0.17 1.78 0.17 0.13 -0.16 -91.0 0.04 
Smoking 
 
-0.31 0.17 -0.29 0.18 0.10 0.02 9.0 0.01 
Physical Activity 
 
-0.55 0.10 -0.60 0.11 0.08 -0.05 -50.0 0.01 
Alcohol 
consumption 
 
0.61 0.13 0.60 0.14 0.11 -0.01 -6.5 0.01 
Depressive 
symptoms 
 
-1.30 0.05 -1.35 0.06 0.06 -0.05 -84.6 0.01 
Abbreviations: QoL is quality of life. FCS=fully conditional specification 
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as shown by the bias (-0.14 for both techniques) and the large values of the standardised 
bias percent (-87.0% in FIML and -98.8% in two-fold FCS) MVNI recovered the 
coefficient for depressive symptoms with good accuracy and precision (bias -0.04, 
standardised percent bias -27.3%). The MVNI and two-fold FCS methods failed to 
recover the targeted parameter for wealth, the bias was -0.39 for MVNI and -0.41 for 
two-fold FCS and the corresponding values of standardised bias were -83.4% and -
92.9% respectively, also the values of the MSE (0.20 and 0.25 respectively) suggested 
together with the bias values lack of accuracy in recovering the targeted parameters. All 
three techniques showed large bias values for cohabiting status, although the values of 
the standardised bias were below 40%.  
Table 3.11 FIML technique for QoL, linear random intercept model with gender and time 
interaction, CHD group (model 2) 
FIML  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.28 0.80 0.35 0.83 0.29 0.07 8.4 0.09 
Wave 2 
 
-0.43 0.53 -0.44 0.63 0.33 -0.01 -1.6 0.11 
Wave 3 
 
-2.65 0.55 -2.67 0.67 0.38 -0.02 -2.9 0.15 
Wave 2*Gender 
 
0.90 0.82 0.96 0.98 0.57 0.06 5.9 0.33 
Wave 3*Gender 
 
1.11 0.82 1.16 1.03 0.60 0.04 4.3 0.37 
Age 
 
0.05 0.04 0.04 0.05 0.02 -0.01 -11.7 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting 
status 
 
-0.32 0.47 -0.48 0.52 0.26 -0.16 -31.2 0.09 
Wealth 
 
2.53 0.42 2.40 0.49 0.25 -0.13 -27.6 0.08 
Smoking 
 
-0.02 0.47 -0.02 0.51 0.21 0.00 0.9 0.04 
Physical Activity 
 
-0.79 0.29 -0.83 0.33 0.17 -0.04 -12.3 0.03 
Alcohol 
consumption 
 
1.05 0.32 1.18 0.37 0.21 0.13 35.0 0.06 
Depressive 
symptoms 
 
-1.19 0.13 -1.33 0.16 0.10 -0.14 -87.0 0.03 
Abbreviations: QoL is quality of life. FIML=full information maximum likelihood 
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Table 3.12 MVNI technique for QoL, linear random intercept model with gender and time 
interaction, CHD group (model 2) 
MVNI  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.28 0.80 0.23 0.84 0.29 -0.05 -6.2 0.09 
Wave 2 
 
-0.43 0.53 -0.52 0.62 0.34 -0.09 -14.5 0.12 
Wave 3 
 
-2.65 0.55 -2.70 0.66 0.40 -0.05 -7.0 0.16 
Wave 2*Gender 
 
0.90 0.82 0.97 0.96 0.56 0.07 7.4 0.32 
Wave 3*Gender 
 
1.11 0.82 1.13 1.01 0.60 0.02 1.7 0.36 
Age 
 
0.05 0.04 0.05 0.05 0.02 0.00 7.0 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting 
status 
 
-0.32 0.47 -0.45 0.52 0.24 -0.13 -25.0 0.08 
Wealth 
 
2.53 0.42 2.14 0.47 0.21 -0.39 -83.4 0.20 
Smoking 
 
-0.02 0.47 -0.04 0.51 0.19 -0.02 -3.9 0.04 
Physical 
Activity 
 
-0.79 0.29 -0.72 0.32 0.16 0.07 22.2 0.03 
Alcohol 
consumption 
 
1.05 0.32 1.07 0.36 0.19 0.02 5.6 0.04 
Depressive 
symptoms 
 
-1.19 0.13 -1.23 0.15 0.09 -0.04 -27.3 0.01 
Abbreviations: QoL is quality of life. MVNI=multivariate normal imputation 
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Results of the comparisons of missing data techniques of the quality of life model for 
the Well group are shown in Tables 3.14 to 3.16. The FIML method recovered well the 
main targeted parameters (gender, wave 2, wave 3 and the two interaction terms) as 
shown by the small bias values and values of standardised bias well below 40%; also 
the values of the MSE were fairly close to zero, indicating good accuracy. MVNI did 
not recover with good accuracy and precision the targeted parameters for wave 2 and 
wave 3, the values of the bias and standardised bias were large; in contrast the method 
recovered the coefficients for gender and for the two interaction terms quite well.  
 
 
Table 3.13 Two-fold FCS technique for QoL, linear  random intercept model with gender 
and time interaction, CHD group (model 2) 
Two-fold FCS  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.28 0.80 0.23 0.82 0.37 -0.06 -6.7 0.14 
Wave 2 
 
-0.43 0.53 -0.39 0.57 0.42 0.04 7.7 0.18 
Wave 3 
 
-2.65 0.55 -2.59 0.60 0.49 0.06 10.6 0.25 
Wave 2*Gender 
 
0.90 0.82 1.06 0.90 0.69 0.16 17.9 0.51 
Wave 3*Gender 
 
1.11 0.82 1.24 0.91 0.77 0.13 13.9 0.61 
Age 
 
0.05 0.04 0.05 0.05 0.02 0.00 -1.1 0.00 
Age
2 
 
0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 
Cohabiting status 
 
-0.32 0.47 -0.47 0.48 0.31 -0.15 -30.9 0.12 
Wealth 
 
2.53 0.42 2.12 0.44 0.29 -0.41 -92.9 0.25 
Smoking 
 
-0.02 0.47 -0.04 0.48 0.25 -0.02 -4.1 0.06 
Physical Activity 
 
-0.79 0.29 -0.76 0.30 0.18 0.03 9.4 0.03 
Alcohol 
consumption 
 
1.05 0.32 1.07 0.34 0.24 0.02 6.9 0.06 
Depressive 
symptoms 
 
-1.19 0.13 -1.33 0.14 0.11 -0.14 -98.8 0.03 
Abbreviations: QoL is quality of life. FCS=fully conditional specification 
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The two-fold FCS method performed reasonably well, but failed to recover the 
coefficient for wave 3, the bias was -0.14 and the standardised bias was -48.6%.  
 
In terms of the covariates, the values of standardised bias of depressive symptoms 
suggested that FIML and MVNI did not achieve a good precision, however, the average 
standard errors were close to the targeted standard errors and the values of the MSE 
were also close to zero, indicating good accuracy. The two-fold FCS method recovered 
the coefficient for depressive symptoms well; the value of the standardised bias for 
physical activity (-42.6%) suggests that this parameter is not recovered with good 
precision, however, the bias is not to be considered troublesome and the standard error 
Table 3.14 FIML technique for QoL, linear random intercept model with gender and time 
interaction, Well group (model 2) 
FIML  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
1.02 0.33 1.05 0.34 0.11 0.03 9.0 0.01 
Wave 2 
 
-0.83 0.25 -0.87 0.29 0.16 -0.03 -11.2 0.03 
Wave 3 
 
-2.33 0.26 -2.42 0.31 0.18 -0.09 -27.6 0.04 
Wave 2*Gender 
 
0.19 0.33 0.21 0.40 0.22 0.02 4.4 0.05 
Wave 3*Gender 
 
0.00 0.33 0.00 0.41 0.25 0.00 NA 0.06 
Age 
 
0.03 0.02 0.04 0.02 0.01 0.02 75.7 0.00 
Age
2 
 
0.00 0.00 -0.01 0.00 0.00 0.00 NA 0.00 
Cohabiting 
status 
 
-0.34 0.22 -0.41 0.24 0.12 -0.07 -27.1 0.02 
Wealth 
 
1.78 0.18 1.78 0.20 0.11 0.00 0.1 0.01 
Smoking 
 
-0.39 0.18 -0.37 0.20 0.08 0.02 10.3 0.01 
Physical Activity 
 
-0.47 0.11 -0.49 0.13 0.06 -0.02 -15.7 0.00 
Alcohol 
consumption 
 
0.62 0.14 0.64 0.16 0.09 0.02 12.5 0.01 
Depressive 
symptoms 
 
-1.32 0.06 -1.38 0.07 0.05 -0.06 -79.1 0.01 
Abbreviations: QoL is quality of life. FIML=full information maximum likelihood 
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is fully recovered. Neither two-fold FCS nor MVNI recover well the targeted parameter 
for wealth. 
 
 
 
 
 
 
 
Table 3.15 MVNI technique for QoL, linear random intercept model with gender and time 
interaction, Well group (model 2) 
MVNI  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
1.02 0.33 1.00 0.34 0.12 -0.02 -5.4 0.01 
Wave 2 
 
-0.83 0.25 -1.00 0.29 0.17 -0.17 -58.1 0.06 
Wave 3 
 
-2.33 0.26 -2.54 0.31 0.19 -0.21 -66.7 0.08 
Wave 2*Gender 
 
0.19 0.33 0.18 0.39 0.23 -0.02 -4.1 0.05 
Wave 3*Gender 
 
0.00 0.33 -0.03 0.41 0.25 -0.02 NA 0.06 
Age 
 
0.03 0.02 0.04 0.02 0.01 0.02 90.5 0.00 
Age
2 
 
0.00 0.00 -0.01 0.00 0.00 0.00 -114.2 0.00 
Cohabiting 
status 
 
-0.34 0.22 -0.38 0.24 0.13 -0.04 -15.8 0.02 
Wealth 
 
1.78 0.18 1.65 0.21 0.12 -0.13 -61.0 0.03 
Smoking 
 
-0.39 0.18 -0.38 0.20 0.09 0.01 3.1 0.01 
Physical 
Activity 
 
-0.47 0.11 -0.47 0.13 0.08 0.00 0.2 0.01 
Alcohol 
consumption 
 
0.62 0.14 0.61 0.16 0.09 -0.02 -9.7 0.01 
Depressive 
symptoms 
 
-1.32 0.06 -1.28 0.07 0.05 0.04 61.3 0.00 
Abbreviations: QoL=quality of life. MVNI=multivariate normal imputation 
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3.3.2 Depressive symptoms 
 
Before proceeding with the results of the depressive symptoms logistic random intercept 
models it must be noted that parameter estimates obtained using FIML are compared 
with the complete case analysis run in Stata. Random intercept models for binary 
outcomes in Mplus are estimated using a Monte Carlo algorithm for integration while 
Stata by default uses maximum likelihood estimation with adaptive Gaussian quadrature 
to approximate the integrals (with 7 integration points). The two technique produced 
Table  3.16 Two-fold FCS technique for QoL, linear random intercept model with gender 
and time interaction, Well group (model 2) 
Two-fold FCS  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
1.02 0.33 1.01 0.33 0.14 -0.01 -3.2 0.02 
Wave 2 
 
-0.83 0.25 -0.90 0.27 0.20 -0.07 -24.6 0.05 
Wave 3 
 
-2.33 0.26 -2.47 0.28 0.24 -0.14 -48.6 0.08 
Wave 2*Gender 
 
0.19 0.33 0.24 0.36 0.28 0.05 13.8 0.08 
Wave 3*Gender 
 
0.00 0.33 0.05 0.37 0.33 0.06 NA 0.11 
Age 
 
0.03 0.02 0.04 0.02 0.01 0.02 96.2 0.00 
Age
2 
 
0.00 0.00 -0.01 0.00 0.00 0.00 -119.5 0.00 
Cohabiting 
status 
 
-0.34 0.22 -0.39 0.22 0.15 -0.05 -21.3 0.03 
Wealth 
 
1.78 0.18 1.65 0.19 0.14 -0.13 -70.4 0.04 
Smoking 
 
-0.39 0.18 -0.37 0.19 0.11 0.02 10.9 0.01 
Physical 
Activity 
 
-0.47 0.11 -0.52 0.11 0.08 -0.05 -42.6 0.01 
Alcohol 
consumption 
 
0.62 0.14 0.62 0.15 0.11 0.00 0.6 0.01 
Depressive 
symptoms 
 
-1.32 0.06 -1.34 0.06 0.06 -0.02 -29.0 0.00 
Abbreviations: QoL is quality of life. FCS=fully conditional specification 
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results that were very close if not the same, therefore for the comparisons with FIML 
estimates, the targeted parameters reported in the tables are those obtained in Stata. 
However, to show that the ability of FIML to recover targeted parameters did not 
depend on the estimation procedure for the random intercept models, results of FIML 
with the targeted parameters obtained using a Monte Carlo algorithm for integration are 
presented in Appendix 3.5, but will not be discussed below as the conclusions are 
exactly the same. 
 
It must also be noted that the treatment of the dependent variable differed in each of the 
missing data technique as follows: with FIML, depressive symptoms was treated as 
binary, since there was not an imputation model but only a substantive model; with two-
fold FCS depressive symptoms was imputed in its original scale using ordered logistic 
regression in the imputation model, then recoded into a binary variable for the 
substantive model when it was used as an outcome; lastly, with MVNI depressive 
symptoms was treated as continuous (normal) in the imputation model and then recoded 
into a binary variable when used as an outcome in the substantive model.  
 
Tables 3.17 to 3.19 report the results of comparisons of missing data techniques for the 
analysis of the first model for depressive symptoms (logistic random intercept model 
with an interaction between gender and CHD). FIML failed to recover the targeted 
parameters (coefficients and standard errors) for gender, CHD and the interaction term 
between gender and CHD, as shown by the large biases and large values of the 
standardised bias percent. Recovery of the parameter estimates of the covariates under 
FIML was acceptable, with the exception of cohabiting status (Table 3.17). Two-fold 
FCS recovered the targeted coefficients and standard errors for gender, CHD and the 
interaction term between gender and CHD to an impressive extent, with good levels of 
precision and accuracy as shown by the MSE and standardised bias percent. MVNI did 
not perform as well as two-fold FCS in recovering the coefficients for gender and CHD, 
while the recovery of the targeted coefficient and standard error for the interaction term 
between gender and CHD was acceptable. Both the two-fold FCS and the MVNI 
techniques did not recover the coefficients for cohabiting status and physical activity 
with good precision (Tables 3.18 and 3.19).  
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Table 3.17 FIML technique for depressive symptoms, logistic random intercept model 
with gender and CHD interaction (model 1) 
FIML 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
CHD 
 
0.65 0.25 0.44 0.24 0.14 -0.21 -90.1 0.06 
Gender 
 
0.74 0.16 0.50 0.14 0.12 -0.24 -176.3 0.07 
CHD*Gender 
 
0.03 0.36 0.20 0.34 0.15 0.18 51.7 0.05 
Age 
 
-0.02 0.01 -0.02 0.01 0.00 0.00 29.9 0.00 
Cohabiting 
status 
 
0.53 0.11 0.47 0.11 0.05 -0.05 -49.1 0.01 
Wealth 
 
-0.31 0.10 -0.33 0.10 0.05 -0.02 -23.0 0.00 
Smoking 
 
0.39 0.10 0.36 0.09 0.05 -0.03 -30.8 0.00 
Physical 
Activity 
 
0.43 0.07 0.40 0.07 0.04 -0.03 -38.7 0.00 
Alcohol 
consumption 
 
-0.14 0.08 -0.15 0.08 0.04 -0.01 -17.2 0.00 
Abbreviation: FIML=full information maximum likelihood 
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Table 3.18 MVNI technique for depressive symptoms, logistic random intercept model with 
gender and CHD interaction (model 1) 
MVNI  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
CHD 
 
0.65 0.25 0.56 0.26 0.10 -0.09 -34.7 0.02 
Gender 
 
0.74 0.16 0.66 0.16 0.06 -0.08 -48.3 0.01 
CHD*Gender 
 
0.03 0.36 0.00 0.37 0.13 -0.02 -6.7 0.02 
Age 
 
-0.02 0.01 -0.01 0.01 0.00 0.01 119.8 0.00 
Cohabiting status 
 
0.53 0.11 0.45 0.12 0.05 -0.08 -64.9 0.01 
Wealth 
 
-0.31 0.10 -0.29 0.11 0.05 0.02 17.1 0.00 
Smoking 
 
0.39 0.10 0.36 0.10 0.04 -0.02 -24.7 0.00 
Physical Activity 
 
0.43 0.07 0.33 0.08 0.03 -0.10 -126.3 0.01 
Alcohol 
consumption 
-0.14 0.08 -0.13 0.09 0.04 0.01 12.0 0.00 
Abbreviation: MVNI=multivariate normal imputation 
Table 3.19 Two-fold FCS technique for depressive symptom, logistic random intercept model 
with gender and CHD interaction (model 1) 
Two-fold FCS  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
CHD 
 
0.65 0.25 0.64 0.25 0.12 -0.01 -4.5 0.02 
Gender 
 
0.74 0.16 0.74 0.16 0.08 -0.01 -3.6 0.01 
CHD*Gender 
 
0.03 0.36 -0.01 0.35 0.17 -0.03 -9.9 0.03 
Age 
 
-0.02 0.01 -0.02 0.01 0.00 0.00 47.9 0.00 
Cohabiting status 
 
0.53 0.11 0.46 0.11 0.06 -0.06 -57.9 0.01 
Wealth 
 
-0.31 0.10 -0.27 0.10 0.07 0.04 34.9 0.01 
Smoking 
 
0.39 0.10 0.37 0.10 0.04 -0.02 -17.8 0.00 
Physical Activity 
 
0.43 0.07 0.39 0.07 0.04 -0.03 -48.2 0.00 
Alcohol 
consumption 
-0.14 0.08 -0.13 0.08 0.05 0.01 13.3 0.00 
Abbreviation: FCS=fully conditional specification 
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Results from the second model of depressive symptoms (logistic random intercept 
model with an interaction between gender and time) for the CHD group are shown in 
Table 3.20 to Table 3.22. FIML recovered the coefficients for wave 2, wave 3 and the 
two interaction terms with acceptable accuracy and precision, although the other two 
technique produced smaller biases.  
 
 
 
 
 
 
Table 3.20 FIML technique for depressive symptoms, logistic random intercept model with 
gender and time interaction, CHD group (model 2) 
FIML  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.80 0.44 0.65 0.42 0.39 -0.15 -35.5 0.17 
Wave 2 
 
0.01 0.34 -0.06 0.37 0.19 -0.07 -17.8 0.04 
Wave 3 
 
-0.41 0.36 -0.50 0.41 0.24 -0.08 -20.3 0.06 
Wave 2*Gender 
 
-0.08 0.49 0.02 0.54 0.33 0.09 17.5 0.12 
Wave 3*Gender 
 
-0.14 0.51 -0.04 0.59 0.38 0.09 16.1 0.15 
Age 
 
-0.01 0.02 0.00 0.02 0.01 0.01 48.6 0.00 
Cohabiting 
status 
 
0.52 0.24 0.54 0.26 0.16 0.02 7.2 0.02 
Wealth 
 
-0.22 0.25 -0.33 0.26 0.14 -0.11 -41.5 0.03 
Smoking 
 
0.43 0.25 0.38 0.26 0.14 -0.05 -18.6 0.02 
Physical 
Activity 
 
0.49 0.18 0.50 0.19 0.11 0.01 4.2 0.99 
Alcohol 
consumption 
 
-0.24 0.19 -0.22 0.20 0.11 0.02 10.9 0.01 
Abbreviation: FIML=full information maximum likelihood 
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MVNI failed to recover the coefficients for wave 2 and wave 3 with good accuracy and 
precision (Table 3.21). 
 
 
Two-fold FCS achieved the smallest biases of the parameters for gender, wave 2, wave 
3 and interaction term between wave 2 and gender, compared with the FIML and 
MVNI, also the standard errors were very close to, if not the same as, the targeted 
values. MVNI estimated a slightly smaller bias than two-fold FCS for the interaction 
term between gender and wave 3 (-0.04 in MVNI and 0.06 in two-fold FCS), however, 
the standard error is larger in MVNI. Two-fold FCS recovered the targeted parameters 
of the other covariates very well, while FIML failed to recover the coefficient for wealth 
and MVNI the coefficient for physical activity with good accuracy and precision. 
 
 
Table 3.21 MVNI technique for depressive symptoms, logistic random intercept model with 
gender and time interaction, CHD group (model 2) 
MVNI  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.80 0.44 0.73 0.43 0.08 -0.07 -15.6 0.01 
Wave 2 
 
0.01 0.34 0.22 0.37 0.16 0.21 57.0 0.07 
Wave 3 
 
-0.41 0.36 -0.09 0.40 0.19 0.32 79.9 0.14 
Wave 2*Gender 
 
-0.08 0.49 -0.14 0.54 0.22 -0.06 -11.8 0.05 
Wave 3*Gender 
 
-0.14 0.51 -0.18 0.58 0.27 -0.04 -6.6 0.07 
Age 
 
-0.01 0.02 0.00 0.02 0.01 0.01 55.1 0.00 
Cohabiting status 
 
0.52 0.24 0.52 0.26 0.10 0.00 -0.2 0.01 
Wealth 
 
-0.22 0.25 -0.27 0.26 0.10 -0.06 -21.5 0.01 
Smoking 
 
0.43 0.25 0.35 0.26 0.08 -0.08 -28.8 0.01 
Physical Activity 
 
0.49 0.18 0.38 0.19 0.07 -0.11 -56.4 0.02 
Alcohol 
consumption 
 
-0.24 0.19 -0.21 0.20 0.08 0.04 18.1 0.01 
Abbreviation: MVNI=multivariate normal imputation 
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Results of the comparisons of missing data techniques for the model for the Well group 
are shown in Tables 3.23 to 3.25. In this model FIML did not recover the targeted 
parameters for gender, wave 2, wave 3 and the two the interaction terms, while the 
MVNI failed to recover the coefficients for wave 2 and wave 3. Two-fold FCS 
performed exceptionally well, compared to FIML and MVNI, it recovered the targeted 
parameters for gender, wave 2, wave 3 and the two interaction terms, to an impressive 
extent. Standard errors were almost the same as the targeted standard errors. All three 
techniques did not perform very well in recovering the coefficients for cohabiting status 
and physical activity; although for physical activity, the bias produced by two-fold FCS 
techniques was somewhat less troublesome than the biases produced by FIML and 
MVNI. 
Table 3.22 Two-fold FCS technique for depressive symptoms, logistic random intercept model 
with gender and time interaction, CHD group (model 2) 
Two-fold FCS  
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.80 0.44 0.74 0.43 0.10 -0.06 -14.3 0.01 
Wave 2 
 
0.01 0.34 -0.01 0.34 0.19 -0.02 -5.2 0.03 
Wave 3 
 
-0.41 0.36 -0.41 0.37 0.24 0.01 2.0 0.06 
Wave 2*Gender 
 
-0.08 0.49 -0.09 0.50 0.27 -0.02 -3.1 0.07 
Wave 3*Gender 
 
-0.14 0.51 -0.08 0.53 0.35 0.06 10.6 0.13 
Age 
 
-0.01 0.02 0.00 0.02 0.01 0.01 62.5 0.00 
Cohabiting status 
 
0.52 0.24 0.53 0.24 0.12 0.01 3.7 0.02 
Wealth 
 
-0.22 0.25 -0.27 0.24 0.14 -0.05 -21.4 0.02 
Smoking 
 
0.43 0.25 0.36 0.25 0.11 -0.06 -25.4 0.02 
Physical Activity 
 
0.49 0.18 0.45 0.18 0.09 -0.04 -21.0 0.01 
Alcohol 
consumption 
 
-0.24 0.19 -0.20 0.19 0.10 0.05 24.8 0.01 
Abbreviation: FCS=fully conditional specification 
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Table 3.23 FIML technique for depressive symptoms, logistic random intercept model 
with gender and time interaction, Well group (model 2) 
FIML 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.97 0.22 0.58 0.17 0.19 -0.38 -229.1 0.19 
Wave 2 
 
0.39 0.20 0.20 0.19 0.12 -0.19 -97.5 0.05 
Wave 3 
 
0.05 0.21 -0.08 0.21 0.14 -0.13 -61.7 0.03 
Wave 2*Gender 
 
-0.37 0.25 -0.12 0.24 0.18 0.25 101.9 0.10 
Wave 3*Gender 
 
-0.26 0.26 -0.04 0.26 0.20 0.22 84.2 0.09 
Age 
 
-0.02 0.01 -0.02 0.01 0.00 0.00 -7.5 0.00 
Cohabiting 
status 
 
0.54 0.13 0.46 0.12 0.06 -0.07 -60.9 0.01 
Wealth 
 
-0.31 0.12 -0.32 0.11 0.05 -0.01 -13.1 0.00 
Smoking 
 
0.38 0.11 0.36 0.10 0.05 -0.02 -25.3 0.00 
Physical 
Activity 
 
0.43 0.08 0.39 0.08 0.04 -0.04 -55.2 0.00 
Alcohol 
consumption 
 
-0.12 0.09 -0.13 0.09 0.05 -0.01 -14.0 0.00 
Abbreviation: FIML=full information maximum likelihood 
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Table 3.24 MVNI technique for depressive symptoms, logistic random intercept model 
with gender and time interaction, Well group (model 2) 
 
MVNI 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.97 0.22 0.90 0.21 0.05 -0.06 -29.3 0.01 
Wave 2 
 
0.39 0.20 0.57 0.21 0.09 0.18 85.8 0.04 
Wave 3 
 
0.05 0.21 0.40 0.23 0.10 0.34 150.8 0.13 
Wave 2*Gender 
 
-0.37 0.25 -0.34 0.27 0.10 0.03 9.6 0.01 
Wave 3*Gender 
 
-0.26 0.26 -0.32 0.28 0.12 -0.06 -20.0 0.02 
Age 
 
-0.02 0.01 -0.02 0.01 0.00 0.00 27.3 0.00 
Cohabiting status 
 
0.54 0.13 0.45 0.14 0.05 -0.09 -68.0 0.01 
Wealth 
 
-0.31 0.12 -0.27 0.12 0.05 0.04 33.9 0.00 
Smoking 
 
0.38 0.11 0.37 0.11 0.04 -0.01 -10.9 0.00 
Physical Activity 
 
0.43 0.08 0.34 0.08 0.03 -0.09 -108.4 0.01 
Alcohol 
consumption 
 
-0.12 0.09 -0.12 0.10 0.04 -0.01 -7.4 0.00 
Abbreviation: MVNI=multivariate normal imputation 
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Table 3.25 Two-fold FCS technique for depressive symptoms, logistic random intercept 
model with gender and time interaction, Well group (model 2) 
 
Two-fold FCS 
 
  )(SE  
 
ˆ  )ˆ(SE  )ˆ(SD  
 
Bias 
Stand. 
Bias MSE 
         
Gender 
 
0.97 0.22 0.92 0.21 0.05 -0.04 -21.1 0.00 
Wave 2 
 
0.39 0.20 0.33 0.20 0.10 -0.06 -29.3 0.01 
Wave 3 
 
0.05 0.21 0.07 0.21 0.12 0.01 5.1 0.02 
Wave 2*Gender 
 
-0.37 0.25 -0.29 0.25 0.12 0.08 31.9 0.02 
Wave 3*Gender 
 
-0.26 0.26 -0.25 0.27 0.16 0.02 6.4 0.03 
Age 
 
-0.02 0.01 -0.02 0.01 0.00 0.00 20.9 0.00 
Cohabiting 
status 
 
0.54 0.13 0.46 0.13 0.06 -0.08 -63.4 0.01 
Wealth 
 
-0.31 0.12 -0.27 0.12 0.07 0.04 34.0 0.01 
Smoking 
 
0.38 0.11 0.38 0.11 0.05 -0.01 -7.5 0.00 
Physical 
Activity 
 
0.43 0.08 0.40 0.08 0.04 -0.03 -40.9 0.00 
Alcohol 
consumption 
 
-0.12 0.09 -0.11 0.09 0.06 0.00 4.3 0.00 
Abbreviation: FCS=fully conditional specification 
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3.4 Discussion 
 
This simulation study used a large, national longitudinal survey to assess the problem of 
handling an arbitrary pattern of missing data. The data set for this study had incomplete 
time-dependent outcomes (one continuous and one binary) and incomplete time-
dependent and time-independent covariates (of different types). Therefore it was 
necessary to accommodate missingness for each follow-up survey, as well as unit non-
response at each time. In order to investigate which technique could be suitable with 
this structure of data, the FIML technique was compared with two MI techniques: 
MVNI and the recently proposed two-fold FCS technique. The performance of each of 
the technique appeared to vary according to the type of outcome and to the amount of 
missing data. The results of the comparisons among the missing data techniques for 
quality of life (continuous outcome) and depressive symptoms (binary outcome) seemed 
to draw different conclusions on which of the three techniques for dealing with missing 
data was most suitable.  
 
Table 3.26 summarises the performance of each technique in terms of accuracy and 
precision (assessed by the bias, MSE and the standardised bias percent) for the main 
targeted parameters obtained from the three models for quality of life. Although in the 
models for quality of life, the outcome variable was the variable with the largest 
proportion of missing data, the three techniques all performed well in recovering the 
targeted parameters (model 1 with gender and CHD interaction term), even though the 
two MI techniques outperformed FIML in recovering the interaction term with good 
precision and smaller bias values. This is an advantage of multiple imputation 
techniques: the interaction term can and should be accommodated in the imputation 
model thus reflecting the substantive model.  
 
In model 2 (CHD group), the three techniques produced small biases for gender, wave 2 
and wave 3, however, for the interaction terms accuracy was not within acceptable 
range in all three techniques (Table 3.26). In the model for the Well group the three 
techniques recovered the targeted parameters for gender and the two interaction terms 
with good accuracy and precision. MVNI did not perform as well as FIML and two-
Fold FCS in recovering with good accuracy and precision the targeted parameters for 
wave 2 and wave 3 in the model for the Well group (Table 3.26). 
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A different picture was given by the results involving the binary outcome (depressive 
symptoms). Table 3.27 summarises the performance of each technique in terms of 
accuracy and precision for the main targeted parameters obtained from the models for 
depressive symptoms. MVNI generally performed better than the FIML. However, two-
fold FCS performed exceptionally well in all models compared to both FIML and 
MVNI, in terms of accuracy and precision. The relatively lower performance of FIML 
was observed in particular in the model with the interaction term between gender and 
time for the Well group, in which the precision and accuracy of the main targeted 
parameters (gender, wave 2 and 3, and interaction terms) were poor. Although MVNI 
performed better than FIML, it failed to achieve good precision and accuracy especially 
in the models with the interaction terms between gender and time (for both the CHD 
and Well groups). It seemed that both techniques that assumed a multivariate normal 
Table 3.26 Summary of performance of the three missing data techniques for the models of 
quality of life 
 FIML MVNI 2-FOLD FCS 
 Accuracy Precision Accuracy Precision Accuracy Precision 
Model 1       
CHD       
Gender       
CHD*Gender       
Model 2 CHD group      
Gender       
Wave 2       
Wave 3       
Wave 2*Gender       
Wave 3*Gender       
Model 2 Well group 
     
Gender       
Wave 2       
Wave 3       
Wave 2*Gender       
Wave 3*Gender       
The symbol indicates that the estimates were close enough to infer that the targeted parameter 
estimates were recovered while the symbol  indicates that the opposite was true. 
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distribution did not perform well with a binary outcome. The flexibility of two-fold FCS 
became obvious in the presence of a binary outcome for which an appropriate 
conditional distribution was specified in the imputation stage; also the doubly iterative 
procedure for imputing each wave of missing data seemed to work better, especially 
when the amount of missing data increased with time. 
 
 
Given that the performance of each missing data technique was perfectly acceptable for 
the models involving the continuous outcome, while for the models involving the binary 
outcome two-fold FCS outperformed the other two techniques, the decision regarding 
which technique should be used for the analysis of Chapter 4 can be made on the basis 
of several considerations. First, it is recommended to include auxiliary variables 
predictive of missingness in the imputation model, even if they are not of interest in the 
substantive model, to reinforce the MAR assumption and to reduce the bias (Sterne et 
al., 2009). However, in this simulation study it was not possible to add any auxiliary 
Table 3.27 Summary of performance of the three missing data techniques for the models of 
depressive symptoms 
 FIML MVNI 2-FOLD FCS 
 Accuracy Precision Accuracy Precision Accuracy Precision 
Model 1       
CHD       
Gender       
CHD*Gender       
Model 2 CHD group      
Gender       
Wave 2       
Wave 3       
Wave 2*Gender       
Wave 3*Gender       
Model 2 Well group      
Gender       
Wave 2       
Wave 3       
Wave 2*Gender       
Wave 3*Gender       
The symbol indicates that the estimates were close enough to infer that the targeted parameter 
estimates were recovered while the symbol  indicates that the opposite was true. 
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variables because this option is not available in Mplus when using a hierarchical model. 
If auxiliary variables were used in the imputation of missing data with the two MI 
techniques, true comparisons with FIML would not have been possible. Choosing one 
of the MI techniques over FIML in this particular setting has the advantage of allowing 
the inclusion of auxiliary variables. Also, when using FIML each model is estimated 
conditioned on the independent variables, therefore cases that are missing on the 
independent variables will be excluded from the analyses. In order to include these 
cases, independent variables were treated as dependent variables. In doing so, 
dichotomous variables may not always be identified and the standard errors. In the 
simulation study presented here this problem was solved by using independent variables 
with more than two categories and by treating them as continuous. However, 
distributional assumptions were made about them (i.e. normality). When a model 
includes several independent variables, many of which are binary, the FIML is not 
recommended.  
 
Second, a further consideration should be made when choosing a technique that 
assumes multivariate normality. When MVNI was used, categorical and binary 
variables were imputed under the normal model and imputed values were rounded off to 
the nearest category. Although multivariate normality was assumed, it has been 
suggested that inferences based on multiple imputation can be robust to departures from 
the multivariate normality assumption if the amount of missing information is not large. 
This is because it often makes sense to use a normal model to create multiple 
imputations even when the observed data are somewhat non-normal, as supported by 
simulation studies described in Schafer (1997) and the original references therein. 
However, in this simulation study, the MVNI technique did not perform at its best in the 
case of a binary outcome probably due to the fact that the amount of missing data was 
relatively large (between 54% and 57%).  
 
In the light of these considerations, I will apply the two-fold FCS technique for the 
treatment of missing data in the analysis of the original data set (presented in Chapter 
4). Although the procedure could be computationally time-consuming in the presence of 
many variables and many waves, and it lacks theoretical underpinnings, its advantages 
are clear, especially in the presence of a non-continuous outcome, binary and 
categorical covariates and repeated measures. 
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Strengths and limitations 
A major strength of this study is the use of a real data set to provide a suitable structure 
for simulating the 1,000 replicates, which simplifies the data generation procedures and 
avoids arbitrary choices. Also by replicating the patterns of missingness seen in the 
incomplete data set, a realistic framework was provided for simulating the missing data 
(Marshall et al., 2010).  
 
Another major strength is that, to date and to my knowledge, this is the first study that 
compares simultaneously techniques for dealing with missing data in the presence of 
both continuous and binary outcomes. Furthermore this study addresses missing data (in 
the outcomes as well as covariates) due not only to item non-response but also to drop-
out. This is also the first study that applies the recently proposed two-fold FCS to 
longitudinal data from a national survey and compares it with the FIML and the MVNI. 
Most of the studies that have compared FIML with MVNI and FCS used cross-sectional 
data.  
 
One of the possible limitations of this simulation study is that MAR was assumed. The 
plausibility of the MAR assumption could have been affected by the fact that auxiliary 
variables were by design not included in the imputation model. In an earlier version of 
the simulation study, auxiliary variables were used to impute missing data under MVNI 
and two-fold FCS. It must be mentioned that the ability to recover the targeted 
parameters by the MVNI and two-fold FCS techniques did not depend upon the addition 
of these variables; rather they helped reinforce the MAR assumption. However, for the 
purpose of choosing the best technique to deal with missing data it was necessary to not 
use auxiliary variables in order to make the three techniques as comparable as possible 
as recommended by Mike Kenward (personal communication). Researchers that wish to 
strengthen the MAR assumptions may decide to opt for one of the MI techniques 
presented here for this type of analysis rather that FIML which does not allow the 
inclusion of auxiliary variables in the two-level modelling framework.  
 
Another limitation is that in dealing with attrition, no distinction was made between 
drop-out due to death and other reasons for loss to follow-up. In longitudinal studies on 
ageing, an important concern is the potential for bias caused by individuals non-
randomly dropping out of the study over time. It is known that selective attrition and 
mortality selection are intrinsically related to many ageing-related changes introducing 
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potential bias, and it has been suggested that a key distinction should be made between 
attrition and mortality selection (Harel et al., 2007). Attrition affects characteristics of 
the particular sample under study, whereas mortality affects both the definition of the 
population as well as the sample (Harel et al., 2007). Consequently, there has been an 
increasing interest in developing techniques for missing data in longitudinal studies that 
distinguish between attrition and mortality (Dufouil et al., 2004; Harel et al., 2007; 
Chang et al., 2009). Most of these approaches focus on attrition and death as the only 
source of missingness in the data. It must be noted that in this study, as in many other 
longitudinal studies, item-non response is also a considerable source of missingness. 
This topic is an area of research that is still developing; therefore it was decided that it 
was beyond the scope of this thesis to deal with the problem of distinguishing between 
deaths and attrition. Nevertheless, the limitation should be acknowledged and the 
problem addressed in future research.  
 
In this simulation study by treating death and attrition as the same form of drop-out, I 
implicitly assumed that trajectories continue beyond death and therefore that the panel is 
immortal. Another possible approach could have been to exclude deaths from the 
sample and only deal with missing data due to item non-response and attrition. This 
approach was not adopted for two reasons: first the number of deaths was a much 
smaller proportion of missingness compared to drop-out. However, while the 
prevalence of those dropping out did not differ between the CHD group and the Well 
group neither at wave 2 (19.4% CHD and 19.5% Well) nor at wave 3 (31.8% CHD and 
28.4% Well), the prevalence of death occurring after baseline was significantly higher 
in the CHD group (13.8%) compared to the Well group (5.3%). Therefore excluding 
deaths from the analysis could have introduced some bias. Second, the research 
question of this thesis was to explore gender differences in quality of life and depressive 
symptoms over time, therefore it seemed appropriate to consider the possible outcome a 
participant could have had if he or she had not died.  
 
Longitudinal data can be thought of as clustered or two-level data (Goldstein, 2003). It 
has been suggested that if a data set to be imputed is multilevel, then the imputation 
model should be multilevel too (Carpenter and Goldstein, 2004). In recent years 
Carpenter and Goldstein have developed macros that implement multiple imputation in 
a multilevel data setting in MLwiN for normal and non-normal models of interest under 
the assumption of missing at random (Carpenter and Goldstein, 2004; Goldstein et al., 
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2009; Carpenter et al., 2011). The macros set up a multilevel multivariate imputation 
model with the partially observed variables as responses, and fit this model in a 
Bayesian framework with uninformative priors using Markov Chain Monte Carlo 
techniques to impute a number of complete data sets. The choice not to use a multilevel 
model structure was made on the basis of the following limitations of the technique: 
first, although in theory the macros can handle missing data in the all the variables in 
the model of interest, in practice this may cause convergence difficulties (Carpenter et 
al., 2011). Therefore using the macros when there are missing data in almost all 
variables of the model of interest can cause problems. Second, the macros cannot handle 
missing categorical variables, not ideal especially for the imputation of the outcome 
depressive symptoms which is categorical. Only recently, the authors have developed 
REALCOM-IMPUTE software which performs multilevel multiple imputation and 
handles ordered and unordered categorical data (Carpenter et al., 2011).  In the light of 
these limitations, it was decided not to use this technique to handle missing data in this 
study.  
 
Only in more recent versions of Stata (11.1 and 12) it is possible to impute missing data 
under the MVNI technique, which can also be used to impute clustered data. 
Unfortunately when the analyses of this chapter were undertaken, only version 10 of 
Stata was available, hence SAS was used.  
 
A last consideration to note is that the theory of multiple imputation for missing data 
requires that imputations be made conditional on the sampling design. As described in 
Chapter 2 (Section 1.1) the ELSA sample was drawn using a stratified multi-stage 
design which was clustered within postal sectors. However, the multiple imputation 
approaches considered in this study did not account for complex sampling design 
features, such as stratification and clustering. The choice not to condition on sample 
design was based on the fact that the outcome variables were not correlated with the 
design variables. It has been suggested that when this is the case, disregarding the 
design in multiple imputation models may provide acceptable inference (Reiter et al., 
2006). 
 
To conclude, the advantages of two-fold FCS over the FIML and MVNI techniques, 
especially when dealing with non-continuous variables, justify the required time and 
effort in implementing this technique for dealing with missing data. Based on the results 
111 
 
of this simulation study the two-fold FCS technique will be used in next chapter to deal 
with missing data when exploring longitudinally gender differences in quality of life 
and depressive symptoms in people with CHD. 
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Appendix 3 
 
Appendix 3.1 Stata code for the generation of missing data  
 
forvalues i = 1/1000 { 
*****************WAVE 1 MISSING ITEMS****************************** 
****replicate the patterns of missing values*** 
gen x=runiform() 
gen patt1mis=0 if x>0.089 
replace patt1mis=1 if x<=0.089 
tab patt1mis 
replace  casp191=. if patt1mis==1 
gen patt2mis=0 if x>0.011 
replace patt2mis=1 if x<=0.011 
tab patt2mis 
replace cigst1=. if patt2mis==1 
replace physact1=. if patt2mis==1  
replace alcoh1=. if patt2mis==1 
replace casp191=. if patt2mis==1 
replace totcesd1=. if patt2mis==1 
***use random binomial numbers  to replicate the remaining patterns of missing values*** 
gen qolw1=rbinomial(1, 0.016) 
tab qolw1 
replace  casp191=. if qolw1==1 
gen totw1=rbinomial(1, 0.010) 
tab totw1 
replace  totwq5_b1=. if totw1==1 
gen cigw1=rbinomial(1, 0.004) 
tab cigw1 
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replace  cigst1=. if cigw1==1 
gen paw1=rbinomial(1, 0.003) 
tab paw1 
replace  physact1=. if paw1==1 
gen alw1=rbinomial(1, 0.006) 
tab alw1 
replace  alcoh1=. if alw1==1 
gen csdw1=rbinomial(1, 0.016) 
tab csdw1 
replace  totcesd1=. if csdw1==1 
*************WAVE 2 DROP OUT AND MORTALITY****** 
gen j=runiform() 
gen missw2=0 if j>0.195 
replace missw2=1 if j<=0.195 
tab missw2 
gen m=runiform() 
gen deadw2=0 if m>0.034 
replace deadw2=1 if m<=0.034 
tab deadw2 
replace  indsex2=. if missw2==1 |  deadw2==1  
replace  indager2=.  if missw2==1 |  deadw2==1 
replace marital2=.  if missw2==1 |  deadw2==1 
replace totwq5_b2=.  if missw2==1 |  deadw2==1 
replace cigst2=.  if missw2==1 |  deadw2==1 
replace physact2=.  if missw2==1 |  deadw2==1 
replace alcoh2=.  if missw2==1 |  deadw2==1 
replace casp192=.  if missw2==1 |  deadw2==1 
replace totcesd2=.  if missw2==1 |  deadw2==1 
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***********WAVE 2 ITEM NON RESPONSE******** 
****replicate the patterns of missing*** 
gen y=runiform() 
gen patt1mis2=0 if y>0.100 
replace patt1mis2=1 if y<=0.100 
tab patt1mis2 
replace casp192=. if patt1mis2==1 
replace alcoh2=. if patt1mis2==1 
gen patt2mis2=0 if y>0.030 
replace patt2mis2=1 if y<=0.030 
tab patt2mis2 
replace casp192=. if patt2mis2==1 
gen patt3mis2=0 if y>0.014 
replace patt3mis2=1 if y<=0.014 
tab patt3mis2 
replace alcoh2=. if patt3mis2==1 
gen patt4mis2=0 if y>0.014 
replace patt4mis2=1 if y<=0.014 
tab patt4mis2 
replace totwq5_b2=. if patt4mis2==1 
***use random binomial numbers  to replicate the remaining patterns of missing values*** 
gen tw2=rbinomial(1, 0.004) 
replace  totwq5_b2=. if tw2==1 
gen smw2=rbinomial(1, 0.002) 
replace   cigst2=. if smw2==1 
gen alw2=rbinomial(1, 0.008) 
replace   alcoh2=. if alw2==1 
gen qolw2=rbinomial(1, 0.008) 
115 
 
tab qolw2 
replace  casp192=. if qolw2==1 
gen cesdw2=rbinomial(1, 0.008) 
replace  totcesd2=. if cesdw2==1 
**************WAVE 3 DROP OUT AND MORTALITY************** 
gen missw3=0 if j> 0.256 
replace missw3=1 if j<=0.256 
tab missw3 
gen deadw3=0 if m> 0.070 
replace deadw3=1 if m<=0.070 
tab deadw3 
replace  indsex3=.  if missw3==1 |  deadw3==1 
replace  indager3=.  if missw3==1 |  deadw3==1 
replace marital3=.  if missw3==1 |  deadw3==1 
replace totwq5_b3=.  if missw3==1 |  deadw3==1 
replace cigst3=.  if missw3==1 |  deadw3==1 
replace physact3=.  if missw3==1 |  deadw3==1 
replace alcoh3=.  if missw3==1 |  deadw3==1 
replace casp193=.  if missw3==1 |  deadw3==1 
replace totcesd3=.  if missw3==1 |  deadw3==1 
************WAVE 3 ITEM NON RESPONSE*************** 
****replicate the patterns of missing*** 
gen f=runiform() 
gen patt1mis3=0 if f>0.103 
replace patt1mis3=1 if f<=0.103 
tab patt1mis3 
replace casp193=. if patt1mis3==1 
replace alcoh3=. if patt1mis3==1 
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gen patt2mis3=0 if f>0.030 
replace patt2mis3=1 if f<=0.030 
tab patt2mis3 
replace alcoh3=. if patt2mis3==1 
gen patt3mis3=0 if f>0.021 
replace patt3mis3=1 if f<=0.021 
tab patt3mis3 
replace casp193=. if patt3mis3==1 
replace alcoh3=. if patt3mis3==1 
replace totcesd3=. if patt3mis3==1 
gen patt4mis3=0 if f>0.019 
replace patt4mis3=1 if f<=0.019 
tab patt4mis3 
replace totwq5_b3=. if patt3mis3==1 
gen patt5mis3=0 if f>0.015 
replace patt5mis3=1 if f<=0.015 
tab patt5mis3 
replace casp193=. if patt5mis3==1 
***use random binomial numbers  to replicate the remaining patterns of missing values*** 
gen cesdw3=rbinomial(1, 0.007) 
replace  totcesd3=. if cesdw3==1 
gen tw3=rbinomial(1, 0.011) 
replace  totwq5_b3=. if tw3==1 
gen smw3=rbinomial(1, 0.001) 
replace   cigst3=. if smw3==1 
gen alw3=rbinomial(1, 0.011) 
replace   alcoh3=. if alw3==1 
gen qolw3=rbinomial(1, 0.009) 
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tab qolw3 
replace  casp193=. if qolw3==1 
gen _mj=`i' 
save simulation`i'.dta 
} 
 
Appendix 3.2 Mplus coding for the estimations of the multilevel models 
with FIML 
 
Random intercept model for quality of life with gender and CHD interaction term 
 DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
 
Usevariables are casp19 agec agesq chd marital   
wealth3 cigst physact alcoh3 totcesd indsex  
sexchd; 
 
BETWEEN= chd indsex sexchd; 
WITHIN = agec agesq marital wealth3 cigst physact alcoh3 totcesd; 
CLUSTER = idauniq; 
ANALYSIS: TYPE = TWOLEVEL; 
estimator=ml;         
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MODEL: 
  %WITHIN% 
   casp19 ON agec*-0.06 agesq*-0.00 marital*-0.29 wealth3*1.94  
   cigst*-0.31 physact*-0.55 alcoh3*0.61 totcesd*-1.30; 
agec  marital wealth3 cigst physact alcoh3 totcesd; 
%BETWEEN% 
 casp19 ON chd*-1.48 indsex*1.09 sexchd*-0.38; 
output:tech1; 
 
Random intercept model for quality of life with gender and time interaction term, 
CHD group 
DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
Usevariables are casp19 agec agesq marital   
wealth3 cigst physact alcoh3 totcesd indsex  
wave2  sex  wave3 sex  wave2  wave3; 
 USEOBSERVATIONS =chd EQ 1; 
BETWEEN= indsex ; 
WITHIN = wave2 wave3 wave2sex wave3sex agec agesq marital   
wealth3 cigst physact alcoh3 totcesd; 
CLUSTER = idauniq; 
Define: 
if (wave EQ 2) THEN wave2=1; 
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if (wave EQ 1 OR wave EQ 3)THEN wave2=0; 
if (wave EQ 3)THEN wave3=1; 
if (wave EQ 1 OR wave EQ 2)THEN wave3=0; 
wave2sex=indsex*wave2; 
wave3sex=indsex*wave3; 
 
ANALYSIS: TYPE = TWOLEVEL; 
 estimator=ml;        
MODEL: 
  %WITHIN% 
casp19 ON  wave2*-0.43 wave3*-2.65 wave2sex*0.90 wave3sex*1.11 agec*0.05 agesq*0.00  
    marital*-0.32 wealth3*2.53 cigst*-0.02 physact*-0.79 alcoh3*1.05 totcesd*-1.19; 
agec marital wealth3 cigst physact alcoh3 totcesd; 
%BETWEEN% 
    casp19 ON indsex*0.28; 
output: tech1; 
 
Random intercept model for quality of life with gender and time interaction term, 
Well group 
 
  DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
Usevariables are casp19 agec agesq marital   
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wealth3 cigst physact alcoh3 totcesd indsex  
wave2sex wave3sex wave2 wave3; 
 USEOBSERVATIONS =chd EQ 0; 
BETWEEN= indsex ; 
WITHIN = wave2 wave3 wave2sex wave3sex agec agesq marital   
wealth3 cigst physact alcoh3 totcesd; 
CLUSTER = idauniq; 
Define: 
if (wave EQ 2) THEN wave2=1; 
if (wave EQ 1 OR wave EQ 3)THEN wave2=0; 
if (wave EQ 3)THEN wave3=1; 
if (wave EQ 1 OR wave EQ 2)THEN wave3=0; 
wave2sex=indsex*wave2; 
wave3sex=indsex*wave3; 
ANALYSIS: TYPE = TWOLEVEL; 
 estimator=ml;        
MODEL: 
  %WITHIN% 
    casp19 ON  wave2*-0.83 wave3*-2.33 wave2sex*0.19 wave3sex*-0.00 agec*0.03 
agesq*0.00  
    marital*-0.34 wealth3*1.78 cigst*-0.39 physact*-0.47 alcoh3*0.62 totcesd*-1.32; 
    agec marital wealth3 cigst physact alcoh3 totcesd; 
%BETWEEN% 
    casp19 ON indsex*1.02; 
output: tech1; 
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Random intercept model for depressive symptoms with gender and CHD interaction 
term 
 
DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
Usevariables are agec chd marital   
wealth3 cigst physact alcoh3 cesd indsex  
sexchd; 
CATEGORICAL=cesd; 
BETWEEN= chd indsex sexchd; 
WITHIN = agec marital wealth3 cigst physact alcoh3; 
CLUSTER = idauniq; 
  ANALYSIS: 
    TYPE = TWOLEVEL; 
       estimator=ml; 
        ALGORITHM=INTEGRATION; 
     INTEGRATION=MONTECARLO; 
        PROCESSORS = 2; 
MODEL: 
%WITHIN% 
   cesd ON agec*-0.02  marital*0.53 wealth3*-0.31 cigst*0.39 physact*0.43 alcoh3*-0.140; 
   agec marital wealth3 cigst physact alcoh3; 
%BETWEEN% 
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   cesd ON chd*0.65 indsex*0.74 sexchd*0.03; 
output: tech1; 
 
Random intercept model for depressive symptoms with gender and time interaction 
term, CHD group 
 
DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
Usevariables are agec marital   
wealth3 cigst physact alcoh3 cesd indsex  
 wave2sex wave3sex wave2 wave3; 
 USEOBSERVATIONS =chd EQ 1; 
Categorical=cesd; 
BETWEEN= indsex ; 
WITHIN = wave2 wave3 wave2sex wave3sex agec marital   
wealth3 cigst physact alcoh3; 
CLUSTER = idauniq; 
Define: 
if (wave EQ 2) THEN wave2=1; 
if (wave EQ 1 OR wave EQ 3)THEN wave2=0; 
if (wave EQ 3)THEN wave3=1; 
if (wave EQ 1 OR wave EQ 2)THEN wave3=0; 
wave2sex=indsex*wave2; 
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wave3sex=indsex*wave3; 
  ANALYSIS: 
    TYPE = TWOLEVEL; 
       estimator=ml; 
        ALGORITHM=INTEGRATION; 
     INTEGRATION=MONTECARLO; 
        PROCESSORS = 2; 
MODEL: 
  %WITHIN% 
   cesd ON wave2*0.01 wave3*-0.41 wave2sex*-0.08 wave3sex*-0.14 agec*-0.01  
marital*0.52  wealth3*-0.22 cigst*0.43 physact*0.49 alcoh3*-0.24; 
agec marital wealth3 cigst physact alcoh3; 
%BETWEEN% 
 cesd ON indsex*0.80 ; 
output: tech1; 
 
Random intercept model for depressive symptoms with gender and time interaction 
term, Well group 
 
DATA: FILE = simulonglist.dat; 
TYPE = MONTECARLO; 
Variable: 
  Names are  
     idauniq wave totcesd marital totwq5_b physact al casp19 cigst chd 
     cesd indager agec agesq indsex sexchd hseyr alcoh3 wealth3 gor hotenu 
     hhtot fqethnr; 
  Missing are all (-9999) ;  
Usevariables are agec marital   
wealth3 cigst physact alcoh3 cesd indsex  
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 wave2sex wave3sex wave2 wave3; 
 USEOBSERVATIONS =chd EQ 0; 
Categorical=cesd; 
BETWEEN= indsex ; 
WITHIN = wave2 wave3 wave2sex wave3sex agec marital   
wealth3 cigst physact alcoh3; 
CLUSTER = idauniq; 
Define: 
if (wave EQ 2) THEN wave2=1; 
if (wave EQ 1 OR wave EQ 3)THEN wave2=0; 
if (wave EQ 3)THEN wave3=1; 
if (wave EQ 1 OR wave EQ 2)THEN wave3=0; 
wave2sex=indsex*wave2; 
wave3sex=indsex*wave3; 
  ANALYSIS: 
    TYPE = TWOLEVEL; 
       estimator=ml; 
        ALGORITHM=INTEGRATION; 
     INTEGRATION=MONTECARLO; 
      PROCESSORS = 2; 
MODEL: 
  %WITHIN% 
   cesd ON wave2*0.39 wave3*0.05 wave2sex*-0.37 wave3sex*-0.26 agec*-0.02  
   marital*0.54  wealth3*-0.31 cigst*0.38 physact*0.43 alcoh3*-0.12; 
agec marital wealth3 cigst physact alcoh3; 
%BETWEEN% 
 cesd ON indsex*0.97; 
output: tech1; 
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Appendix 3.3 SAS coding for the imputation of missing data 
 
***The following coding is used for the imputation of the first 100 replicates, it was then 
repeated 9 more times for the remaining 900*** 
options mprint symbolgen mlogic; 
%macro loop(count); 
%do i=1 %to &count; 
 proc mi data=Simulation&i out=midataw&i nimpute=5 seed=1375 
  round=   1   
  minimum= 12 11 12  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 -13 0    0 0 0 
  maximum= 57 57 57  8 8 8 2 2 2 2 2 2 2 2 2 2 2 2 3 3 3  33 1089 1 1 1; 
  mcmc chain=multiple initial=em  outiter=outit  
     timeplot (mean (casp191 casp192 casp193 totcesd1 totcesd2 totcesd3)) 
     acfplot (mean (casp191 casp192 casp193 totcesd1 totcesd2 totcesd3)); 
var casp191 casp192 casp193 totcesd1 totcesd2 totcesd3 marital1 marital2 marital3 cigst1  
cigst2 cigst3 physact1 physact2  physact3 alcoh31 alcoh32 alcoh33  wealth31 wealth32 
wealth33 agec1 agesq1 indsex1 chd1 sexchd; 
run;  
%end; 
%mend; 
%loop(200); 
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Appendix 3.4 Two-fold FCS 
 
Table A3.1 Mean comparisons by number of cycles and wave for the outcome 
variables 
  WAVE 1 WAVE 2 WAVE 3 
 Mean S.D. Mean S.D. Mean S.D. 
Quality of life       
100 cycles 44.9 0.04 44.3 0.1 42.8 0.1 
10 cycles 44.9 0.06 44.3 0.1 42.8 0.1 
Depressive symptoms       
100 cycles 1.12 0.01 1.20 0.02 1.1 0.0 
10 cycles 1.12 0.01 1.18 0.02 1.1 0.0 
       
 
 
 
 
 
 
 
 
 
Table A3.2 Mean comparisons between complete case data and imputed data after 3  
among-times   iterations, by wave  
  WAVE 1 WAVE 2 WAVE 3  
 
Complete 
case 
Imputed 
 
Complete 
case 
Imputed 
 
Complete 
case 
Imputed 
 
 
Mean 
(s.e.) 
Mean* 
(s.e.) 
Mean* 
(s.e.) 
Mean* 
(s.e.) 
Mean* 
(s.e.) 
Mean* 
(s.e.) 
Quality of life 
 
44.9 
(0.17) 
44.8 
(0.17) 
44.3 
(0.17) 
44.2 
(0.18) 
42.7 
(0.18) 
42.6 
(0.21) 
Depressive symptoms 
 
1.1 
(0.04) 
1.1 
(0.04) 
1.2 
(0.04) 
1.2 
(0.04) 
1.1 
(0.04) 
1.2 
(0.04) 
Cohabiting status 
 
0.3 
(0.01) 
0.3 
(0.01) 
0.3 
(0.01) 
0.3 
(0.01) 
0.3 
(0.01) 
0.3 
(0.01) 
Wealth 
 
2.2 
(0.01) 
2.2 
(0.01) 
2.1 
(0.01) 
2.1 
(0.01) 
2.2 
(0.01) 
2.2 
(0.02) 
Cigarette smoking 
 
0.8 
(0.02) 
0.8 
(0.02) 
0.8 
(0.02) 
0.8 
(0.02) 
0.7 
(0.02) 
0.7 
(0.02) 
Physical activity 
 
1.3 
(0.02) 
1.3 
(0.02) 
1.2 
(0.02) 
1.2 
(0.02) 
1.3 
(0.02) 
1.3 
(0.02) 
Alcohol consumption 
 
1.1 
(0.02) 
1.1 
(0.02) 
1.2 
(0.02) 
1.2 
(0.02) 
1.2 
(0.02) 
1.2 
(0.02) 
* Average mean and standard error over 5 imputed data sets obtained  according to Rubin’s 
formula (Rubin, 1987) 
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Stata coding for the imputation of missing data with two-fold FCS 
***The following coding generates only 1 imputed data set for each replicate, it was then 
repeated 4 more times to generate 5 imputed data set for each replicate*** 
forvalues i = 1/1000 { 
**************IMPUTING WAVE1 VARIABLES**************** 
use 
"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
cd "C:\Temp\imput1" 
 *************DRYRUN********************* 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
cmd(totcesd1 physact1 cigst1 cigst2:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd cigst1 physact1 alcoh31 wealth31 casp191 marital1 
agec1, cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 wealth31 
casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  
alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 marital1 
chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 physact1 
cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: casp192 
wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 agesq1) 
dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
cmd(totcesd1 physact1 cigst1 cigst2:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd cigst1 physact1 alcoh31 wealth31 casp191 marital1 
agec1, cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 wealth31 
casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  
alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 marital1 
chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 physact1 
cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: casp192 
wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 agesq1) 
match(casp191) seed(1285964) cycles(10)  m(1) saving(impw1, replace) 
 
use "C:\Temp\imput1\impw1.dta", clear 
tab totcesd1 if _mj==1 
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tab casp191 if _mj==1 
tab alcoh31 if _mj==1 
keep idauniq totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 _mj 
keep if _mj==1 
sum totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 
replace totcesd1= round(totcesd1) 
replace alcoh31= round(alcoh31) 
replace cigst1= round(cigst1) 
replace physact1=round(physact1) 
replace wealth31=round(wealth31) 
 
save "C:\Temp\imput1\impw1.dta", replace 
use 
"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd1 casp191 physact1 cigst1 wealth31 alcoh31  
merge 1:1 idauniq using "C:\Temp\imput1\impw1.dta" 
drop  _mj _merge 
save "C:\Temp\imput1\simulimpw1.dta", replace 
use "C:\Temp\imput1\simulimpw1.dta", clear 
**************IMPUTING WAVE2 VARIABLES**************** 
 *************DRYRUN********************* 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 marital3 cigst2 cigst3:ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
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wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
indsex1 sexchd agec1 agesq1)dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 marital3 cigst2 cigst3:ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
indsex1 sexchd agec1 agesq1) match(casp192) seed(1285964) cycles(10)  m(1) saving(impw2, 
replace) 
use "C:\Temp\imput1\impw2.dta", clear 
tab totcesd2 if _mj==1 
tab casp192 if _mj==1 
tab alcoh32 if _mj==1 
keep idauniq totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  _mj 
keep if _mj==1 
replace totcesd2= round(totcesd2) 
replace alcoh32= round(alcoh32) 
replace cigst2= round(cigst2) 
replace physact2=round(physact2) 
replace wealth32=round(wealth32) 
replace marital2=round(marital2) 
sum totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  
save "C:\Temp\imput1\impw2.dta",replace 
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use 
"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2 
merge 1:1 idauniq using "C:\Temp\imput1\impw2.dta" 
drop  _mj _merge 
save "C:\Temp\imput1\simulimpw2.dta", replace 
use "C:\Temp\imput1\simulimpw2.dta", clear 
**************IMPUTING WAVE3 VARIABLES**************** 
 *************DRYRUN********************* 
ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) match(casp193) seed(1285964) cycles(10)  m(1) saving(impw3, 
replace) 
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use "C:\Temp\imput1\impw3.dta", clear 
tab totcesd3 if _mj==1 
tab casp193 if _mj==1 
sum casp193 
tab alcoh33 if _mj==1 
keep idauniq totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3 _mj 
keep if _mj==1 
replace totcesd3= round(totcesd3) 
replace alcoh33= round(alcoh33) 
replace cigst3= round(cigst3) 
replace physact3=round(physact3) 
replace wealth33=round(wealth33) 
replace marital3=round(marital3) 
sum totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3  
save "C:\Temp\imput1\impw3.dta",replace 
 
***START SECOND ROUND of imputation using the new imputed values**** 
****impute wave1 using new imputed wave2 variables****** 
use 
"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd2 casp192 physact2 cigst2 wealth32 alcoh32   
merge 1:1 idauniq using "C:\Temp\imput1\impw2.dta" 
drop  _mj _merge 
save "C:\Temp\imput1\w2imp.dta" , replace 
use "C:\Temp\imput1\w2imp.dta" , clear 
cd "C:\Temp\imput1\round2"  
 *************DRYRUN********************* 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
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cmd(totcesd1 physact1 cigst1:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd cigst1 physact1 alcoh31 wealth31 casp191 marital1 
agec1,  cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 wealth31 
casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  
alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 marital1 
chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 physact1 
cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: casp192 
wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 agesq1) 
dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
cmd(totcesd1 physact1 cigst1:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd cigst1 physact1 alcoh31 wealth31 casp191 marital1 
agec1,  cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 wealth31 
casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  
alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 marital1 
chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 physact1 
cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: casp192 
wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 agesq1) 
match(casp191) seed(1285964) cycles(10)  m(1) saving(impw1, replace) 
 
replace totcesd1= round(totcesd1) 
replace alcoh31= round(alcoh31) 
replace cigst1= round(cigst1) 
replace physact1=round(physact1) 
replace wealth31=round(wealth31) 
 
use "C:\Temp\imput1\round2\impw1.dta", clear 
keep idauniq totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 _mj 
keep if _mj==1 
sum totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 
save "C:\Temp\imput1\round2\impw1.dta", replace 
use"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
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drop totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 totcesd3 casp193 physact3 cigst3 
wealth33 alcoh33 marital3 
merge 1:1 idauniq using "C:\Temp\imput1\round2\impw1.dta" 
drop  _merge 
merge 1:1 idauniq using "C:\Temp\imput1\impw3.dta" 
drop  _merge 
save "C:\Temp\imput1\round2\w1(r2)w3(r1).dta", replace 
use "C:\Temp\imput1\round2\w1(r2)w3(r1).dta", clear 
**************IMPUTING WAVE2 VARIABLES**************** 
 *************DRYRUN********************* 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 cigst2:ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
indsex1 sexchd agec1 agesq1)dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 cigst2 :ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
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indsex1 sexchd agec1 agesq1) match(casp192) seed(1285964) cycles(10)  m(1) saving(impw2, 
replace) 
use "C:\Temp\imput1\round2\impw2.dta", clear 
tab totcesd2 if _mj==1 
tab casp192 if _mj==1 
tab alcoh32 if _mj==1 
keep idauniq totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  _mj 
keep if _mj==1 
replace totcesd2= round(totcesd2) 
replace alcoh32= round(alcoh32) 
replace cigst2= round(cigst2) 
replace physact2=round(physact2) 
replace wealth32=round(wealth32) 
replace marital2=round(marital2) 
sum totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  _mj 
 
save "C:\Temp\imput1\round2\impw2.dta",replace 
use"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd1 casp191 physact1 cigst1 wealth31 alcoh31  totcesd2 casp192 physact2 cigst2 
wealth32 marital2 alcoh32  
merge 1:1 idauniq using "C:\Temp\imput1\round2\impw1.dta" 
 drop  _mj _merge 
 merge 1:1 idauniq using "C:\Temp\imput1\round2\impw2.dta" 
 drop  _mj _merge 
save "C:\Temp\imput1\round2\w1w2imp.dta", replace 
use "C:\Temp\imput1\round2\w1w2imp.dta", clear 
**************IMPUTING WAVE3 VARIABLES**************** 
 *************DRYRUN********************* 
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ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) match(casp193) seed(1285964) cycles(10)  m(1) saving(impw3, 
replace) 
use "C:\Temp\imput1\round2\impw3.dta", clear 
tab totcesd3 if _mj==1 
tab casp193 if _mj==1 
sum casp193 
tab alcoh33 if _mj==1 
keep idauniq totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3   _mj 
keep if _mj==1 
replace totcesd3= round(totcesd3) 
replace alcoh33= round(alcoh33) 
replace cigst3= round(cigst3) 
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replace physact3=round(physact3) 
replace wealth33=round(wealth33) 
replace marital3=round(marital3) 
sum totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3   
save "C:\Temp\imput1\round2\impw3.dta",replace 
***************ROUND 3******************** 
******impute wave1 variables using wave2 variables imputed in round2*** 
use"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd2 casp192 physact2 cigst2 wealth32 alcoh32  
merge 1:1 idauniq using "C:\Temp\imput1\round2\impw2.dta" 
drop  _mj _merge 
save "C:\Temp\imput1\round3\w2(r2).dta" , replace 
use "C:\Temp\imput1\round3\w2(r2).dta" , clear 
cd "C:\Temp\imput1\round3"  
 *************DRYRUN********************* 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
cmd(totcesd1 physact1 cigst1:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd  cigst1 physact1 alcoh31 wealth31 casp191 
marital1 agec1,  cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 
wealth31 casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 
sexchd  alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 
marital1 chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 
physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: 
casp192 wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 
agesq1) dryrun   
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 chd1 sexchd marital1 cigst1  cigst2 physact1 physact2  alcoh31 alcoh32 
casp191 casp192 wealth31 wealth32  agec1 agesq1 indsex1,  /// 
cmd(totcesd1 physact1 cigst1:ologit) /// 
eq(totcesd1: totcesd2 chd1 indsex1 sexchd  cigst1 physact1 alcoh31 wealth31 casp191 
marital1 agec1,  cigst1: cigst2 totcesd1 marital1 chd1 indsex1 sexchd  physact1 alcoh31 
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wealth31 casp191 agec1 agesq1, physact1: physact2 cigst1 totcesd1 marital1 chd1 indsex1 
sexchd  alcoh31 wealth31 casp191 agec1 agesq1, alcoh31: alcoh32 physact1 cigst1 totcesd1 
marital1 chd1 indsex1 sexchd  wealth31 casp191 agec1 agesq1, wealth31:  wealth32 alcoh31 
physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  casp191 agec1 agesq1, casp191: 
casp192 wealth31 alcoh31 physact1 cigst1 totcesd1 marital1 chd1 indsex1 sexchd  agec1 
agesq1) match(casp191) seed(1285964) cycles(10)  m(1) saving(impw1, replace) 
 use "C:\Temp\imput1\round3\impw1.dta", clear 
tab totcesd1 if _mj==1 
tab casp191 if _mj==1 
tab alcoh31 if _mj==1 
keep idauniq totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 _mj 
keep if _mj==1 
sum totcesd1 casp191 physact1 cigst1 wealth31 alcoh31 
replace totcesd1= round(totcesd1) 
replace alcoh31= round(alcoh31) 
replace cigst1= round(cigst1) 
replace physact1=round(physact1) 
replace wealth31=round(wealth31) 
save "C:\Temp\imput1\round3\impw1.dta", replace 
 
**************IMPUTING WAVE2 VARIABLES**************** 
**use wave1 variables imputed at round3 and wave3 variables imputed at round2***** 
use"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop totcesd1 casp191 physact1 cigst1 wealth31 alcoh31  totcesd3 casp193 physact3 cigst3 
wealth33 alcoh33 marital3 
merge 1:1 idauniq using "C:\Temp\imput1\round3\impw1.dta" 
drop  _merge 
 merge 1:1 idauniq using "C:\Temp\imput1\round2\impw3.dta" 
drop  _merge 
save "C:\Temp\imput1\round3\w1(r3)w3(r2).dta", replace 
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use "C:\Temp\imput1\round3\w1(r3)w3(r2).dta", clear 
**************IMPUTING WAVE2 VARIABLES**************** 
 *************DRYRUN********************* 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 cigst2:ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
indsex1 sexchd agec1 agesq1)dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd1 totcesd2 totcesd3 chd1 sexchd marital1 marital2 marital3 cigst1  cigst2 cigst3 
physact1 physact2  physact3 alcoh31 alcoh32 alcoh33 casp191 casp192 casp193 wealth31 
wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd2 physact2 marital2 cigst2:ologit) /// 
eq(totcesd2: totcesd3 totcesd1 chd1 indsex1 sexchd  cigst2 physact2 alcoh32 wealth32 
casp192 agec1, marital2:marital1 marital3 totcesd2 chd1 indsex1 sexchd cigst2 physact2 
alcoh32 wealth32 casp192 agec1 agesq1,cigst2: cigst1 cigst3 totcesd2 chd1 indsex1 sexchd 
physact2 alcoh32 wealth32 casp192 agec1 agesq1, physact2:  physact3 physact1 cigst2 
totcesd2 chd1 indsex1 sexchd  alcoh32 wealth32 casp192 agec1 agesq1,alcoh32: alcoh31 
alcoh33 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  wealth32 casp192 agec1 agesq1, 
wealth32:  wealth31 wealth33 alcoh32 physact2 cigst2 totcesd2 chd1 indsex1 sexchd  casp192 
agec1 agesq1, casp192: casp191 casp193 wealth32 alcoh32 physact2 cigst2 totcesd2 chd1 
indsex1 sexchd agec1 agesq1) match(casp192) seed(1285964) cycles(10)  m(1) saving(impw2, 
replace) 
use "C:\Temp\imput1\round3\impw2.dta", clear 
keep idauniq totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  _mj 
keep if _mj==1 
replace totcesd2= round(totcesd2) 
replace alcoh32= round(alcoh32) 
replace cigst2= round(cigst2) 
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replace physact2=round(physact2) 
replace wealth32=round(wealth32) 
replace marital2=round(marital2) 
sum totcesd2 casp192 physact2 cigst2 wealth32 alcoh32 marital2  _mj 
save "C:\Temp\imput1\round3\impw2.dta", replace 
**************IMPUTE WAVE3 VARIABLES*********** 
********use wave2 variables imputed at round3************** 
use"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop   totcesd2 casp192 physact2 cigst2 wealth32 marital2 alcoh32  
 merge 1:1 idauniq using "C:\Temp\imput1\round3\impw2.dta" 
 drop _merge 
  save "C:\Temp\imput1\round3\w2(r3).dta", replace 
  use "C:\Temp\imput1\round3\w2(r3).dta", clear 
**************IMPUTING WAVE3 VARIABLES**************** 
 *************DRYRUN********************* 
ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) dryrun 
************REAL RUN 10 CYCLES************** 
ice totcesd2 totcesd3 chd1 sexchd marital2 marital3 cigst2 cigst3 physact2  physact3 alcoh32 
alcoh33 casp192 casp193 wealth32 wealth33  agec1 agesq1 indsex1, /// 
cmd(totcesd3 physact3 marital3 cigst3:ologit) /// 
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eq(totcesd3: totcesd2 marital3 chd1 indsex1 sexchd  cigst3 physact3 alcoh33 wealth33 
casp193 agec1, marital3:marital2 totcesd3 chd1  indsex1 sexchd  cigst3 physact3 alcoh33 
wealth33 casp193 agec1 agesq1, cigst3: cigst2 totcesd3 marital3 chd1 indsex1 sexchd  
physact3  alcoh33 wealth33 casp193 agec1 agesq1, physact3: physact2 cigst3 totcesd3 
marital3 chd1 indsex1 sexchd alcoh33 wealth33 casp193 agec1 agesq1, alcoh33: alcoh32 
physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  wealth33 casp193 agec1 agesq1, 
wealth33: wealth32 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 indsex1 sexchd  casp193 
agec1 agesq1, casp193:casp192 wealth33 alcoh33 physact3 cigst3 totcesd3 marital3 chd1 
indsex1 sexchd  agec1 agesq1) match(casp193) seed(1285964) cycles(10)  m(1) saving(impw3, 
replace) 
use "C:\Temp\imput1\round3\impw3.dta", clear 
tab totcesd3 if _mj==1 
tab casp193 if _mj==1 
tab alcoh33 if _mj==1 
keep idauniq totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3   _mj 
keep if _mj==1 
replace totcesd3= round(totcesd3) 
replace alcoh33= round(alcoh33) 
replace cigst3= round(cigst3) 
replace physact3=round(physact3) 
replace wealth33=round(wealth33) 
replace marital3=round(marital3) 
sum totcesd3 casp193 physact3 cigst3 wealth33 alcoh33 marital3   
save "C:\Temp\imput1\round3\impw3.dta", replace 
use 
"C:\Users\paoletta\Documents\PHD\ANALYSES\longitudinal\simulations\simulation`i'.dta", 
clear 
drop  agec1 agesq1 agec2 agesq2 agec3 agesq3 al1 al2 al3 totwq5_b1 totwq5_b2 totwq5_b3 
sexchd indsex2 indsex3 totcesd1 totcesd2 totcesd3 alcoh31 alcoh32  alcoh33 casp191 casp192 
casp193 physact1 physact2 physact3 cigst1 cigst2 cigst3 wealth31 wealth32 wealth33 alcoh31 
alcoh32 alcoh33 marital2 marital3 
merge 1:1 idauniq using "C:\Temp\imput1\round3\impw1.dta" 
drop _mj _merge 
merge 1:1 idauniq using "C:\Temp\imput1\round3\impw2.dta" 
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drop _mj _merge 
merge 1:1 idauniq using "C:\Temp\imput1\round3\impw3.dta" 
drop _mj _merge 
gen indsex2=indsex1 
gen indsex3=indsex1 
***reshape data*** 
gen cesd1=0 if totcesd1>=0 & totcesd1<=2 
replace cesd1=1 if totcesd1>=3 
replace cesd1=. if totcesd1==. 
tab cesd1 
gen cesd2=0 if totcesd2>=0 & totcesd2<=2 
replace cesd2=1 if totcesd2>=3 
replace cesd2=. if totcesd2==. 
tab cesd2 
gen cesd3=0 if totcesd3>=0 & totcesd3<=2 
replace cesd3=1 if totcesd3>=3 
replace cesd3=. if totcesd3==. 
tab cesd3 
tab alcoh31 
tab alcoh32 
tab alcoh33 
drop fqethnr1 hhtot1 hotenu1 gor1 hseyr1 hseyr2 hseyr3 gor2 gor3 hotenu2 hotenu3 hhtot2 
hhtot3 
reshape long chd cesd totcesd  marital  indsex  indager cigst wealth3 physact casp19 alcoh3, i( 
idauniq ) j( wave ) 
sum indager if wave==3 
sum indager  
sum indager 
gen agec=indager-63 
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gen agesq=agec*agec 
tab indsex 
sum indsex 
lab val indsex sexlab 
tab indsex 
gen sexchd= chd*indsex 
save "C:\Temp\r`i'imputation1.dta", replace 
} 
 
 
Appendix 3.5 Depressive symptoms results of FIML with the targeted 
parameters obtained using a Monte Carlo algorithm for integration 
Table A3.3 Table A3.3 FIML technique for depressive symptoms, random intercept model with 
gender and CHD interaction (model 1) 
 
 

 
)(SE
 
 
ˆ
 
)ˆ(SE
 
)ˆ(SD
 
 
Bias 
Stand. 
Bias MSE 
         
CHD 0.66 0.25 0.44 0.24 0.14 -0.22 -92.5 0.06 
Gender 0.74 0.16 0.50 0.14 0.12 -0.24 -173.4 0.07 
Gender*CHD -0.02 0.36 0.20 0.34 0.15 0.22 64.8 0.07 
Age -0.02 0.01 -0.02 0.01 0.00 0.00 21.5 0.00 
Cohabiting status 0.52 0.11 0.47 0.11 0.05 -0.04 -37.6 0.00 
Wealth -0.31 0.10 -0.33 0.10 0.05 -0.02 -21.7 0.00 
Smoking 0.38 0.10 0.36 0.09 0.05 -0.02 -20.3 0.00 
Physical Activity 0.43 0.07 0.40 0.07 0.04 -0.03 -46.0 0.00 
Alcohol 
consumption 
-0.14 0.08 -0.15 0.08 0.04 -0.01 -15.4 0.00 
Estimates obtained by using Monte Carlo algorithm for integration 
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Table A3.4 FIML technique for depressive symptoms, random intercept model with gender and time 
interaction, CHD group (model 2) 
 
 

 
)(SE
 
 
ˆ
 
)ˆ(SE
 
)ˆ(SD
 
 
Bias 
Stand. 
Bias MSE 
         
Gender 0.82 0.361 0.65 0.42 0.39 -0.17 -40.0 0.18 
Wave 2 0.02 0.333 -0.06 0.37 0.19 -0.08 -21.5 0.04 
Wave 3 -0.40 0.354 -0.50 0.41 0.24 -0.10 -25.0 0.07 
Wave 2*Gender -0.11 0.463 0.01 0.54 0.33 0.12 22.6 0.12 
Wave 3*Gender -0.17 0.478 -0.05 0.59 0.37 0.12 20.9 0.16 
Age -0.01 0.018 0.00 0.02 0.01 0.01 43.5 0.00 
Cohabiting status 0.54 0.236 0.54 0.26 0.16 0.00 -1.7 0.02 
Wealth -0.24 0.24 -0.33 0.26 0.14 -0.08 -31.6 0.03 
Smoking 0.44 0.242 0.38 0.26 0.14 -0.06 -24.6 0.02 
Physical Activity 0.50 0.18 0.50 0.19 0.11 0.00 -1.5 1.01 
Alcohol 
consumption 
-0.26 0.181 -0.22 0.20 0.11 0.04 17.6 0.01 
Estimates obtained by using Monte Carlo algorithm for integration 
 
 
 
Table A3.5 FIML technique for depressive symptoms, random intercept model with gender and time 
interaction, Well group (model 2) 
 
 

 
)(SE
 
 
ˆ
 
)ˆ(SE
 
)ˆ(SD
 
 
Bias 
Stand. 
Bias MSE 
         
Gender 0.85 0.203 0.58 0.17 0.19 -0.26 -156.7 0.11 
Wave 2 0.36 0.194 0.20 0.19 0.12 -0.16 -81.7 0.04 
Wave 3 0.04 0.204 -0.08 0.21 0.14 -0.12 -54.8 0.03 
Wave 2*Gender -0.33 0.242 -0.12 0.24 0.18 0.20 84.7 0.08 
Wave 3*Gender -0.23 0.249 -0.04 0.26 0.20 0.19 71.8 0.08 
Age -0.02 0.009 -0.02 0.01 0.00 0.00 -14.0 0.00 
Cohabiting status 0.54 0.122 0.46 0.12 0.06 -0.07 -58.5 0.01 
Wealth -0.31 0.111 -0.32 0.11 0.05 -0.02 -13.9 0.00 
Smoking 0.37 0.101 0.36 0.10 0.05 -0.01 -8.8 0.00 
Physical Activity 0.42 0.074 0.39 0.08 0.04 -0.03 -34.2 0.00 
Alcohol 
consumption 
-0.13 0.088 -0.13 0.09 0.05 0.00 1.5 0.00 
Estimates obtained by using Monte Carlo algorithm for integration 
 
 
 
 
 
 
 
144 
 
Chapter 4: A study of gender differences in quality of life and 
depressive symptoms among older people with CHD using the 
English Longitudinal Study of Ageing 
 
In the previous chapter three techniques for handling missing data were compared in 
order to find the best technique to be applied to the ELSA data for the analysis of this 
chapter. Results from this comparison supported the two-fold FCS technique. In this 
chapter gender differences in quality of life and depressive symptoms among people 
with CHD are explored using three waves of ELSA, from 2002-03 to 2006-07. First 
gender differences in quality of life and depressive symptoms are explored comparing 
people with CHD to the Well group; second men and women are compared with respect 
to trajectories over four years in quality of life and depressive symptoms once they have 
experienced CHD. The same trajectory model is run in the Well group to understand 
whether similar results are found in a disease-free group.  
4.1 Introduction 
 
Chapter 1 reviewed the literature on gender differences in quality of life and depressive 
symptoms among people with CHD. In this chapter, I summarise briefly the findings 
from studies that have looked at gender differences in quality of life and depressive 
symptoms over time.  
 
One year post-myocardial infarction women scored significantly lower than men on the 
following domains of HRQOL: physical function (Brink et al., 2005; Norris et al., 
2007), bodily pain, social function (Brink et al., 2005), mental health (Westin et al., 
1999; Norris et al., 2007), general health (Westin et al., 1999) and emotional health 
(Bogg et al., 2000). One year post-myocardial infarction the gender differences found at 
one month post-myocardial infarction in self-esteem and family interaction domains of 
HRQOL no longer persisted (Westin et al., 1999). Results from one study shown that 
gender differences in the mental health dimension of HRQOL at one year post-
myocardial infarction did not persist once the model was adjusted for demographic, 
clinical, co-morbid and psychosocial covariates (Norris et al., 2007). Results from other 
studies reported an improvement in HRQOL after one year post-myocardial infarction 
as compared to five months in both men and women (Brink et al., 2005) and between 
four months and one year post-MI (Kristofferzon et al., 2005b). 
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Longitudinal studies exploring gender differences in depressive symptoms among 
people with CHD, did not report any difference between men and women in their 
prevalence of depression at five months (Brink et al., 2005) and at one year (Wiklund et 
al., 1993; Brink et al., 2005) post-myocardial infarction. However, women had 
improved in that they reported less depression than they had at five months post-
myocardial infarction (Brink et al., 2005). Others found that one year post-myocardial 
infarction women were more likely than men to be depressed (Norris et al., 2007). 
 
Bjerkeset et al., (2005) specifically examined gender differences in depression during 
the five years after myocardial infarction. Women had a high initial risk for depression, 
with a significant decrease after two years, while in men the risk for depression was 
only increased in the two to five years post-MI (Bjerkeset et al., 2005).  
 
The review of the literature identified some limitations and gaps in current knowledge. 
To summarise, there are no studies that have addressed gender differences in depression 
following angina. All studies except two (Bjerkeset et al., 2005; Ford et al., 2008), used 
small samples from selected community hospitals which might affect generalisation of 
results and none has specifically focussed on an older population. Only one study had a 
follow-up greater than a year. Lastly, only some of the studies have adjusted their 
analyses for covariates other than age and sex (Norris et al., 2004, 2007; Bjerkeset et al., 
2005; Brink et al., 2005; Ford et al., 2008) and none have accounted for missing data.  
 
The first objective of this chapter is to explore gender differences in quality of life and 
depressive symptoms among men and women with CHD compared to healthy people. It 
is hypothesised that people aged over fifty years who had had a CHD event would be at 
higher risk of experiencing depressive symptoms and poor quality of life than those who 
have not.  
 
The second objective is to compare men and women with respect to trajectories over 
four years of quality of life and depressive symptoms once they have experienced CHD, 
while adjusting for several important covariates such as age, gender, cohabiting status, 
retirement status, education, wealth, smoking status, physical activity, alcohol 
consumption, pain, physical functioning, social support and social networks. These 
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variables were selected from the literature and were found to correlate with CHD and 
quality of life and depressive symptoms. 
 
It is hypothesised that the shapes of trajectories over time of quality of life and 
depressive symptoms are different in men and women following the CHD event. 
Women with CHD are at higher risk than men of reporting depressive symptoms and 
lower quality of life. However, women tend towards a time-limited reaction (in terms of 
depressive symptoms and poor quality of life) to the actual CHD event, while men seem 
less able to adapt to the long-term consequences of the event. The analyses are repeated 
for people in the Well group to understand whether similar gender differences are found 
in their trajectories of quality of life and depressive symptoms.  
 
4.2 Methods 
4.2.1 Data  
 
As explained in Chapter 2, the sample size is restricted to participants with a CHD event 
occurred in the two years preceding the baseline interview (2002-03) and to healthy 
participants (Well group). The total sample size is 4,496 in wave 1 (2002-03); 3,465 in 
wave 2 (2004-05) and 3,031 in wave 3 (2006-07). A total of 894 people were in the 
CHD group and 3,601 in the Well group. Missing data were imputed as described in 
section 4.2.3.  
 
The variables used for the analyses in this chapter have been described in details in 
Chapter 2, in the measures section (2.2). Briefly, the main outcome measures are quality 
of life (measured by the CASP-19) and depressive symptoms (measured by the CESD-
8). For quality of life a total score is used (ranging from 6 to 57 with higher scores 
indicating better quality of life); while depressive symptoms is a dummy variable coded 
as: 0 ‘0-2 symptoms’ of depression and 1 ‘3+ symptoms’ of depression. The use of a 
cut-off point of three or more depressive symptoms to indicate symptomatic depression 
is in line with previous studies that have used this abridged version of the scale 
(Steffick, 2000). Covariates used to adjust the models are: gender, age, cohabiting status 
(cohabiting with a partner vs not cohabiting), employment status (in paid employment, 
completely retired, other such as permanently unable to work, not currently in paid 
employment, looking after home or family), educational attainment (high and medium 
vs low), quintile of non-pension wealth, smoking status (never smoked and ex-smoker 
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vs current smoker), alcohol consumption (less than three times a week vs three times a 
week and more), physical activity (high and medium activity vs sedentary), pain (not 
troubled with pain vs often troubled with pain), ADLs ( 0 to 6 limitations with activities 
of daily living), positive support (score) and number of close friends. 
4.2.2 Models 
 
In longitudinal studies an individual’s responses over time are correlated with each 
other. Ignoring the dependence between observations results in an underestimation of 
the standard error of the parameter estimates and provides inefficient estimates of the 
parameters of interest (Goldstein, 2003). Multilevel models can be used to explicitly 
model the clustered structure of the longitudinal data, which is considered as two-level 
data with i= 1,2,...n denoting occasions and j=1,2,...m denoting individuals (or units); 
the occasions are therefore clustered within individuals that represent the level-two units 
with measurement occasions as the level-one units. To model individual trajectories of 
the outcome variable over time taking into account the hierarchical structure of the data, 
it is possible to fit a two-level multilevel model with a random intercept as follows: 
 
    
(1)                                                                                                                           
  
where uj denotes the random error associated with the individual level variation, and eij 
denotes the random error specific to each occasion i for an individual j. Each of the 
error term is assumed to be identically and independently normally distributed with 
mean 0 and variances equal to 2u  and 
2
e  at the individual and occasion levels. It 
follows that the variance of yij is 
2
u + 
2
e . In model (1)  β0+β1xij is the fixed part and is 
the equation for the overall average line, the slope is not allowed to be random, while 
the intercept β0+ uj  is allowed to vary from individual to individual because it includes 
the parameter uj from the random part (Reise and Duan, 2003). By having a random 
intercept, both the variance between individuals and the variance between repeated 
observations are estimated. The random intercept model (1) only expresses the 
dependent variable yij as a function of a single predictor xij. It is possible to extend the 
model by adding time-constant and time-varying covariates (continuous or categorical), 
interaction terms and also a measure of time (continuous or categorical). The multilevel 
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model (1) can also be fitted when the dependent variable has a distribution other than 
normal. So a model for a binary dependent variable is expressed as follows: 
 
(2) 
where 
ij
ij


1
 is the odds that yij=1 at occasion i for 
individual j, uj denotes the random error associated with the individual level variation 
with residual variance equal to 2u . Model (2) does not include a level-one residual eij 
because it is an equation for the probability 
ij
ij


1
 rather than for the outcome yij 
(Goldstein, 2003). The level-one residual variance 2e  cannot change and is 
conventionally fixed at π
2
/3= 3.29. 
 
Random intercept models were estimated as follows: 
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Where yij is quality of life for individual j at time i, xpj are time-invariant factors gender, 
CHD (at wave 1), and the interaction term between CHD and gender; xpij are time-
varying factors age (a linear and quadratic term), cohabiting status, employment status, 
educational attainment, wealth, smoking status, alcohol consumption, physical activity, 
pain, ADLs, depressive symptoms, positive support and number of close friends. Age, 
number of close friends and positive support were all centred to the mean. 
 
A logit model was estimated for depressive symptoms as follows: 
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Where 
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log  is the log odds of having depressive symptoms, for individual j at 
time i, xpj are time-invariant factors such as gender, CHD (at wave 1), and the 
interaction term between CHD and gender; xpij are time-varying factors such as age, 
cohabiting status, employment status, educational attainment, wealth, smoking status, 
alcohol consumption, physical activity, pain, ADLs, positive support and number of 
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close friends). Age, number of close friends and positive support were all centred to the 
mean. 
 
In order to compare trajectories of quality of life and depressive symptoms of men and 
women, the following random intercept models were estimated: 
 ijj
p
ijppjijijjij
euxxttxy  

14
1
132110 )( 
              
(5)
                                               
 
Where yij is quality of life for individual j at time i, x1j is gender, tij denotes time and 
takes three discrete values denoting the first, second and third wave, tij* x1j denotes the 
interaction term between time and gender; xpij are time-varying factors described in 
model 3). The model was run separately for people with CHD and people in the Well 
group. 
 
The same model as 3) was estimated for depressive symptoms as follows: 
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Where 




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


 ij
ij


1
log is the log odds of having depressive symptoms, for individual j at 
time i, x1j is gender, tij denotes time and takes three discrete values denoting the first, 
second and third wave, tij* x1j denotes the interaction term between time and gender; xpij 
are time-varying factors described in model 4). The model was run separately for people 
with CHD and people in the Well group. 
 
4.2.3 Treatment of missing data 
 
The two-fold FCS technique to impute missing data described in Chapter 3 is used here. 
Five imputed data sets were created and results estimated were combined according to 
Rubin’s rule (1987) which averages the estimates and their standard errors into a single 
set of values. When using a MI method it is recommended to include auxiliary variables 
predictive of missingness in the imputation model even if they are not of interest in the 
substantive model. This strategy helps to reinforce the MAR assumption (Clarke and 
Hardy, 2007) and to reduce the bias (Sterne et al., 2009). Therefore five variables 
150 
 
(measured at wave 1) predictive of non-response (Taylor et al., 2007; Scholes et al., 
2009) were added to the imputation model, these variables are: year of HSE interview, 
Government Office Region (GOR), housing tenure, number of people in the household 
and ethnicity (Table 4.1). These variables were used to create cross-sectional non-
response weights in ELSA (Scholes et al., 2009), non-responders were more likely than 
responders to have the following characteristics: sampled from HSE 1999 (rather than 
1998 or 2001), living in London, renting or other ‘non-owning’ category compared with 
owner-occupiers (recorded in wave 1, or HSE if missing in wave 1), increasing 
household size; non-white ethnicity. 
 
For comparison, results from the augmented samples are presented together with those 
obtained from the observed sample (with missing data). The term “observed” implies 
that the sample has missing data and therefore the panel is unbalanced. Analyses were 
carried out in Stata 10 using xtmixed and xtmelogit commands for multilevel modelling 
which accommodate unbalanced panels using maximum likelihood. All analyses for the 
observed sample were restricted to participants with valid answers on both quality of 
life and depressive symptoms. 
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4.3 Results 
4.3.1 Comparisons of characteristics between the sample with missing data 
and the augmented sample 
 
Table 4.2 compares the characteristics at each wave of the study for the sample with 
missing data and the augmented sample (imputed). The mean quality of life and 
standard deviation of the sample with missing data and augmented samples were very 
similar, if not the same, at all waves. There was also no difference in the means of 
positive support and close friends between the augmented sample and the sample with 
missing data at each wave. These three variables were collected in the self-completion 
booklet, and participants were requested to post it back. Therefore there are usually 
more missing values on these variables than in the variables collected through the face-
Table 4.1 Auxiliary variables used in the imputation 
model 
Year of HSE interview  N % 
1998 and 2001 3,615 80.4 
1999 881 19.6 
Total 4,496 100 
GOR N % 
Other regions 4,064 90.4 
London 431 9.6 
Missing 1 0.0 
Total 4,496 100 
   
Housing tenure N % 
Own it  3,712 82.6 
Renting and other non-owing 784 17.4 
Total 4,496 100 
Number of people in the 
household N % 
1 1,038 23.1 
2 2,490 55.4 
3 600 13.4 
4 269 6.0 
5 71 1.6 
6 23 0.5 
7 and more 5 0.1 
Total 4,496 100 
Ethnicity N % 
White 4,360 97.0 
Non-white 136 3.0 
Total 4,496 100 
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to-face interview. It was expected to see more differences in the sample means obtained 
from the augmented sample and those obtained from the sample with missing data. For 
example, another variable collected in the self-completion booklet was alcohol 
consumption (at wave 2 and wave 3). The prevalence of those drinking on 3 or more 
days a week was the same at wave 1 and wave 2, while at wave 3 was lower in the 
augmented sample (36.6%) than in the sample with missing data (38.1%) but the 
difference was not statistically significant (p>0.05). This is also surprising, given that 
people tend to under-report their alcohol consumption, it was expected that people who 
drink more were less likely to answer this question, and that the prevalence was then 
underestimated. 
 
For depressive symptoms we see no differences in the prevalence at wave 1, but at wave 
2 and wave 3 the prevalence of depressive symptoms is over 1.6 percentage points 
higher for the augmented sample (wave 2: 19.3% sample with missing data and 20.9% 
augmented sample; wave 3: 17.9% sample with missing data and 19.6% augmented 
sample), although the difference is not statistically significant (p>0.05). 
 
Similarly, the prevalence of those not cohabiting, completely retired, and those with 1 
or more ADLs, are on average over 2 percentage points higher in the augmented sample 
at wave 2 and wave 3 compared to the sample with missing data. The differences were 
statistically significant only for not cohabiting at wave 3 (p<0.05). At wave 3 the 
prevalence of those physically inactive is 2.9 percentage points higher in the augmented 
sample than the sample with missing data, although not statistically significant. These 
results are line with what expected.  
At all waves, the prevalence of those in the poorest wealth quintile are significantly 
higher in the augmented sample compared to the sample with missing data (p<0.05), 
while the prevalence of those in the 4
th
 wealth and 3
rd
 wealth quintiles are slightly 
lower, but not significant, for the augmented sample at wave 1 and wave 3.  
 
Surprisingly, the prevalence of people with low education was over 11 percentage 
points lower in the augmented sample than in the sample with missing data at wave 2 
(p<0.05) and wave 3 (p<0.001). This difference is consistent with the higher rates of 
attrition among people in the lowest education category. 
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For all the other variables, figures based on the sample with missing data are very 
similar if not the same of those in the augmented sample. 
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Table 4.2 Comparisons of sample characteristics for the sample with missing data and 
augmented samples 
 Wave 1 Wave 2 Wave 3 
 
Observed  Imputed Observed  Imputed Observed  Imputed 
 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Quality of life 43.8 (8.2) 43.8 (8.0) 42.9 (8.6) 42.7 (8.7) 41.3 (8.8) 41.2 (8.7) 
Positive support  27.1 (5.4) 27.1 (5.4) 27.0 (5.5) 27.1 (5.4) 27.6(5.3) 27.5 (5.4) 
Close friends  8.0 (5.7) 7.9 (5.4) 8.5 (5.8) 8.5 (6.0) 9.4 (7.7) 9.1 (7.4) 
 
%(95%CI) %(95%CI) %(95%CI) %(95%CI) %(95%CI) %(95%CI) 
Depressive 
symptoms 
 
20.3 
(19.1; 21.5) 
20.3 
(19.1; 21.5) 
19.3 
(17.9; 20.6) 
20.9 
(19.7; 22.1) 
17.9 
(16.5; 19.2) 
19.6 
(18.4; 20.7) 
Not cohabiting 
 
28.4 
(27.0; 29.7) 
28.4 
(27.0; 29.7) 
29.4 
(27.8; 30.9) 
31.6 
(30.3; 33.0) 
31.2 
(29.6; 32.9) 
34.4 
(33.0; 35.8) 
Completely 
retired 
42.4 
(41.0; 43.9) 
42.4 
(41.0; 43.9) 
47.7 
(46.0; 49.4) 
49.4 
(47.9; 50.8) 
52.7 
(50.9; 54.5) 
55.4 
(53.9; 56.8) 
Other* 
 
12.5 
(11.6; 13.5) 
12.5 
(11.6; 13.5) 
12.8 
(11.6; 13.9) 
13.3 
(12.3; 14.3) 
11.0 
(9.9; 12.1) 
11.7 
(10.8; 12.7) 
Low education 
 
50.8 
(49.3; 52.2) 
50.8 
(49.3; 52.2) 
48.4 
(46.7; 50.1) 
37.3 
(35.9; 38.7) 
47.3 
(45.5; 49.1) 
34.4 
(33.0; 35.8) 
Wealth 4
th
 
 
18.7 
(17.5; 19.8) 
18.7 
(17.5; 19.8) 
20.7 
(19.4; 22.1) 
19.6 
(18.4; 20.7) 
21.6 
(20.1; 23.1) 
19.7 
(18.5; 20.9) 
Wealth 3
rd
 
 
20.4 
(19.2; 21.6) 
20.4 
(19.2; 21.6) 
20.6 
(19.3; 22.0) 
20.4 
(19.2; 21.6) 
20.7 
(19.2; 22.1) 
19.9 
(18.7; 21.0) 
Wealth 2
nd
 
 
20.7 
(19.5; 21.9) 
20.7 
(19.5; 21.9) 
19.1 
(17.8; 20.4) 
19.9 
(18.8; 21.1) 
17.9 
(16.5; 19.3) 
20.6 
(19.4; 21.7) 
Wealth Poorest 
 
23.8 
(22.6; 25.0) 
23.8 
(22.6; 25.0) 
16.9 
(15.7; 18.2) 
20.5 
(19.3; 21.7) 
15.7 
(14.4; 17.0) 
21.8 
(20.5; 23.0) 
Current smoker 
 
18.7 
(17.6; 19.9) 
18.7 
(17.6; 19.9) 
16.0 
14.8; 17.2 
16.3 
(15.2; 17.3) 
14.1 
(12.8; 15.3) 
14.4 
(13.4; 15.4) 
Physically 
inactive 
61.0 
(59.6; 62.5) 
61.0 
(59.6; 62.5) 
59.0 
(57.4; 60.6) 
60.3 
(58.8; 61.7) 
61.0 
(59.2; 62.7) 
62.9 
(61.5; 64.3) 
Alcohol ≥3 days 
a week 
29.3 
(28.0; 30.7) 
29.3 
(28.0; 30.7) 
37.7 
(36.0; 39.4) 
37.4 
(36.0; 38.8) 
38.1 
(36.2; 40.0) 
36.6 
(35.2; 38.0) 
Often troubled 
with pain 
25.4 
(24.1; 26.7) 
25.4 
(24.1; 26.7) 
15.4 
(14.2; 16.6) 
15.7 
(14.6; 16.8) 
13.2 
(12.0; 14.4) 
14.0 
(13.0; 15.0) 
1 or more ADLs 
 
 
11.8 
(10.8; 12.7) 
 
11.8 
(10.8; 12.7) 
13.5 
(12.4; 14.7) 
15.6 
(14.6; 16.7) 
14.8 
(13.5; 16.1) 
17.3 
(16.2; 18.4) 
Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, Richest 
wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with pain, No ADLs, No 
depressive symptoms. The total sample size of the observed sample is 4,496 in wave 1; 3,465 in wave 
2 and 3,031 in wave 3 (which varies for each variable according to item non-response). 
*Permanently unable to work, not currently in paid employment, looking after home or family 
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4.3.2 Quality of life 
 
Table 4.3 reports the combined results from the five imputed data sets as well as 
observed data, for the linear random intercept model for the quality of life outcome, 
with an interaction term between CHD and gender. The adjusted average quality of life 
(i.e. for someone aged 63, cohabiting, in paid employment, with medium and high 
educational attainment, in the richest quintile of wealth, non-smoker, physically active, 
drinks on less than 3 days a week, not troubled with pain, without ADLs and without 
depressive symptoms) for men in the CHD group, was 45.7, while for women in the 
CHD group the mean quality of life was 47.1. Men and women in the CHD group had 
an adjusted mean quality of life that was on average over one point lower than men and 
women in the Well group (p<0.001) (47.7 and 48.1 respectively). The interaction term 
between CHD and gender was statistically significant (p<0.05).  
 
Covariates in the model negatively related to quality of life were: increasing age, not 
cohabiting, retired and other employment status, poorest wealth, smoking, physical 
inactivity, increasing number of difficulties with ADLs and increasing number of 
depressive symptoms. Low education, increased positive support and number of close 
friends and family were positively related to quality of life. The between-individual 
variance was 19.4 (41% of the total variance), which expresses the variation in quality 
of life due to unobserved differences between individuals after controlling for 
covariates. The within individual variance was 27.5 (59% of the total variance), and 
expresses the variation in quality of life due to differences within individuals over time 
after controlling for covariates. We can conclude that a greater proportion of the 
unexplained variability in quality of life was due to differences within individuals over 
time.  
 
The last two columns of Table 4.3 report the results of the same model based on 
observed data (with missing data), results were consistent with those based on the 
imputed data and of similar magnitude, with the exception of the coefficient for gender 
and the interaction term that were not significant. The standard errors of estimates based 
on observed data were larger than those obtained from the imputed data. Also, in the 
results obtained from the sample with missing data, gender, the quadratic effect of age, 
education, smoking status, alcohol consumption and limitations with ADLs were not 
significantly related to quality of life. 
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Table 4.3 Linear random intercept model for quality of life 
 
Imputed Observed 
  Coef. 
Std. 
Err. P-value Coef. 
Std. 
Err. P-value 
CHD -2.00 0.27 0.000 -2.51 0.40 0.000 
Gender 0.41 0.19 0.027 0.38 0.25 0.123 
CHD*Gender 0.98 0.40 0.016 0.47 0.60 0.431 
Age (centred 63) -0.04 0.01 0.003 -0.03 0.02 0.044 
Age squared 0.00 0.00 0.414 0.00 0.00 0.018 
Not cohabiting  -0.49 0.16 0.002 -0.24 0.25 0.343 
Completely retired -0.87 0.16 0.000 -0.64 0.24 0.009 
Other* -2.09 0.21 0.000 -2.43 0.32 0.000 
Low education 0.61 0.14 0.000 0.14 0.11 0.210 
Wealth 4
th
 -1.03 0.18 0.000 -0.92 0.26 0.000 
Wealth 3
rd
 -1.88 0.19 0.000 -1.61 0.28 0.000 
Wealth 2
nd
 -2.52 0.20 0.000 -2.60 0.31 0.000 
Wealth Poorest -3.95 0.23 0.000 -4.04 0.37 0.000 
Current smoker -0.52 0.20 0.008 -0.32 0.28 0.258 
Physically inactive -1.04 0.13 0.000 -1.05 0.19 0.000 
Drinks alcohol ≥3 days a week 0.43 0.14 0.001 0.30 0.21 0.138 
Often troubled with pain -1.46 0.15 0.000 -1.88 0.24 0.000 
ADLs -1.75 0.07 0.000 -0.00 0.11 0.974 
Positive support (centred at 27) 0.27 0.01 0.000 0.30 0.02 0.000 
Close friends (centred at 8) 0.05 0.01 0.000 0.03 0.01 0.032 
Depressive symptoms -4.25 0.15 0.000 -4.84 0.25 0.000 
Constant 47.69 0.22 0.000 47.98 0.32 0.000 
Model 
      Between variance 19.4 0.03 
 
20.92 1.08 
 Within variance 27.5 0.02 
 
23.75 0.72 
 Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, 
Richest wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with pain, 
No depressive symptoms. 
* Permanently unable to work, not currently in paid employment, looking after home or family 
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Table 4.4 reports the results of the linear random intercept model with gender and time 
interaction, among people with CHD. Results of trajectories over time of quality of life 
by gender among people with CHD and the Well group are also summarised graphically 
in Figure 4.1. Results based on the imputed data showed that among men with CHD the 
adjusted mean quality of life at baseline was 47.4, which decreased significantly to 46.5 
at two year follow-up (p<0.05) and to 44.6 at four year follow-up (wave 3) (p<0.001). 
The adjusted mean quality of life at baseline for women with CHD was 48.2, which 
remained stable at two year follow-up (48.4), and then decreased significantly to 46.5 at 
four year follow-up (p<0.001). The interaction terms between wave and gender were 
not significant, suggesting no gender difference in the rate of change over time in 
quality of life. The p-value for the coefficient of gender was non-significant, indicating 
that at baseline the quality of life of men and women did not differ. However, at two 
year follow-up (wave 2) and at four year follow-up (wave 3) women had significantly 
higher quality of life than men (wave 2: 46.5 [95%CI:45.3; 47.8] men and 48.4 
[95%CI:47.4; 49.3] women Wald Test p<0.001; wave 3: 44.6 [95%CI:43.4; 45.9] and 
46.5 [95%CI:45.5; 47.5] women Wald Test p<0.001).   
 
Increasing age, not cohabiting (vs cohabiting), low educational attainment (vs medium 
and high), 4
th
 quintile of wealth (vs richest wealth quintile) and smoking (vs ex-smoker 
and never smoked) were not significantly related to quality of life. About 60% of the 
unexplained variability in quality of life was due to differences within individuals over 
time (within variance 30.6).  
 
Results from the analysis based on observed data were not all consistent with those 
based on multiple imputations. In general the coefficients obtained from the observed 
data were larger than those obtained from imputed data sets, showing stronger 
relationships. Standard errors were smaller for parameters obtained from imputed data 
sets. In the model of people with CHD obtained from the observed data, wave 2 and the 
interaction term between wave 3 and gender was statistically significant; the quadratic 
effect of age, retirement status, limitations with ADLs and number of close friends were 
not significant while education was significant. The coefficient from smoking was 
positive in the results from the observed data and negative in the imputed results, 
although non-significant in both. 
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* Permanently unable to work, not currently in paid employment, looking after home or family 
 
Table 4.4 Linear random intercept model for quality of life with time for the CHD group 
  Imputed Observed 
 
Coef. 
Std. 
Err. P-value Coef. 
Std. 
Err. P-value 
Gender 0.83 0.50 0.094 0.54 0.77 0.489 
Wave 2 -0.84 0.36 0.020 -0.85 0.65 0.192 
Wave 3 -2.73 0.37 0.000 -3.58 0.73 0.000 
Wave 2*Gender 0.98 0.53 0.065 1.18 1.01 0.243 
Wave 3*Gender 0.98 0.53 0.066 2.56 1.10 0.020 
Age (centred 63) 0.04 0.03 0.248 0.00 0.05 0.941 
Age
2
 -0.01 0.00 0.000 0.00 0.00 0.315 
Not cohabiting  -0.60 0.37 0.102 -0.83 0.64 0.194 
Completely retired -1.28 0.44 0.004 -0.52 0.76 0.491 
Other* -2.30 0.53 0.000 -2.88 0.95 0.002 
Low education -0.47 0.32 0.146 -0.62 0.31 0.047 
Wealth 4
th
 -0.36 0.47 0.440 -0.12 0.80 0.886 
Wealth 3
rd
 -2.28 0.49 0.000 -2.30 0.83 0.006 
Wealth 2
nd
 -2.21 0.51 0.000 -3.45 0.89 0.000 
Wealth Poorest -3.61 0.53 0.000 -3.70 0.95 0.000 
Current smoker -0.27 0.49 0.587 1.41 0.80 0.078 
Physically inactive -1.37 0.34 0.000 -2.02 0.56 0.000 
Drinks alcohol ≥3 days a week 0.76 0.33 0.023 1.58 0.60 0.008 
Often troubled with pain -1.84 0.31 0.000 -2.14 0.57 0.000 
ADLs -1.46 0.12 0.000 -0.07 0.30 0.819 
Positive support (centred at 27) 0.29 0.03 0.000 0.29 0.05 0.000 
Close friends (centred at 8) 0.10 0.02 0.000 0.06 0.04 0.150 
Depressive symptoms -4.32 0.33 0.000 -5.33 0.63 0.000 
Constant 47.38 0.64 0.000 47.39 0.99 0.000 
Model  
      Between variance 20.65 0.04 
 
19.98 3.23 
 Within variance 30.62 0.02 
 
29.92 2.53 
 Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, 
Richest wealth, Non-smoker, Physically active,  Drinks <3 days a week, Not troubled with pain, 
No depressive symptoms. 
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Table 4.5 shows the results of the random intercept model for quality of life with an 
interaction term between time and gender for the Well group. Results are also 
summarised graphically in Figure 4.1. Among men and women in the Well group, 
quality of life decreased significantly between baseline and years two and four of 
follow-up. The interaction terms between wave and gender were not significant 
suggesting no difference by gender in the rate of change over time in quality of life. 
However, at two year follow-up women had higher quality of life compared to men 
(47.9 [95%CI: 47.4; 48.4] men and 48.4 [95%CI: 48.0; 48.9] women p<0.05]. The 
quadratic effect of age and low educational attainment were not significantly related to 
quality of life. With the exception of alcohol consumption, positive support and close 
friends and family, all the other covariates were negatively related to quality of life. 
About 57% of the total unexplained variability in quality of life was due to differences 
within individuals over time.  
 
The main differences between the results based on augmented data and those based on 
observed data were that the interaction term between wave 2 and gender was negative in 
the results based on observed data and positive in the results based on the imputed data 
(although not significant in both models). Also age, cohabiting status, alcohol 
consumption and limitations with ADLs were not significant (Table 4.5), while the 
quadratic effect of age was significant. 
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* Permanently unable to work, not currently in paid employment, looking after home or family 
 
Table 4.5 Linear random intercept model for quality of life with time for the Well group 
  Imputed Observed 
 
Coef. Std. Err. P-value Coef. 
Std. 
Err. P-value 
Gender 0.24 0.23 0.289 0.37 0.30 0.213 
Wave 2 -1.11 0.18 0.000 -1.20 0.27 0.000 
Wave 3 -2.88 0.18 0.000 -3.02 0.29 0.000 
Wave 2*Gender 0.25 0.24 0.299 -0.03 0.36 0.929 
Wave 3*Gender 0.18 0.24 0.443 0.05 0.38 0.896 
Age (centred 63) 0.04 0.01 0.009 0.03 0.02 0.096 
Age
2
 0.00 0.00 0.212 -0.01 0.00 0.000 
Not cohabiting  -0.35 0.18 0.045 -0.15 0.27 0.577 
Completely retired -0.73 0.17 0.000 -0.58 0.25 0.019 
Other* -2.05 0.22 0.000 -2.33 0.34 0.000 
Low education 0.15 0.16 0.335 0.18 0.12 0.129 
Wealth 4
th
 -1.03 0.19 0.000 -0.93 0.27 0.000 
Wealth 3
rd
 -1.58 0.20 0.000 -1.33 0.29 0.000 
Wealth 2
nd
 -2.34 0.21 0.000 -2.31 0.32 0.000 
Wealth Poorest -3.82 0.25 0.000 -3.85 0.39 0.000 
Current smoker -0.73 0.21 0.001 -0.79 0.30 0.008 
Physically inactive -0.96 0.13 0.000 -0.81 0.19 0.000 
Drinks alcohol ≥3 days a week 0.60 0.15 0.000 0.35 0.21 0.099 
Often troubled with pain -1.87 0.17 0.000 -2.18 0.25 0.000 
ADLs -1.68 0.09 0.000 0.03 0.11 0.790 
Depressive symptoms -4.19 0.17 0.000 -4.65 0.27 0.000 
Positive support (centred at 27) 0.27 0.01 0.000 0.31 0.02 0.000 
Close friends (centred at 8) 0.06 0.01 0.000 0.04 0.01 0.004 
Constant 49.03 0.25 0.000 49.11 0.36 0.000 
Model 
      Between variance 19.17 0.02 
 
20.90 1.07 
 Within variance 24.95 0.01 
 
20.68 0.67 
 Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, 
Richest wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with pain, 
No depressive symptoms. 
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In general the gender specific trajectories found in people with CHD were not the same 
as those found in the Well group. Figure 4.1 shows graphically the adjusted mean 
quality of life over time among people in the CHD and Well group (obtained from the 
imputed data), by gender. Women with CHD had stable quality of life between baseline 
and two year follow-up (wave 2), which then decreased at four year follow-up (wave 3) 
to reach a similar quality of life to women in the Well group and a higher quality of life 
than men with CHD. The quality of life of men with CHD decreased significantly over 
time. Men and women in the Well group had similar trajectories of quality of life and 
only at two year follow-up (wave 2) the quality of life of women was significantly 
higher than the quality of life of men, although the difference was small compared to the 
difference in quality of life between men and women with CHD. 
 
 
Figure 4.1 Trajectories over time of quality of life among people with CHD and the Well 
group, by gender (imputed data) 
 
Results adjusted for gender, age, quadratic effect of age, cohabiting status, employment status, 
educational attainment, wealth, smoking status, alcohol consumption, physical activity, pain, 
ADLs, depressive symptoms, positive support and number of close friends and family.  
 
 
In order to understand the effect of covariates on the estimates of trajectories of quality 
of life, five linear random intercept models with an interaction term between gender and 
time were run by sequentially expanding the set of covariates as follows: model 1 is a 
model with interaction term between gender and time plus age and its quadratic effect 
(model 1); model 2 is model 1 plus socio-demographic factors (cohabiting status, 
education and wealth);  model 3 is model 2 plus health behaviour factors (physical 
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activity, smoking, alcohol consumption); model 4 is model 3 plus health factors (pain 
and ADLs); model 5 is model 4 plus psychosocial factors (depressive symptoms, social 
support and social networks). Results are presented in Tables 4.6 and 4.7. 
 
In models adjusted for age (model 1), socio-demographic characteristics (model 2), and 
health behaviours (model 3) quality of life for men with CHD was not significantly 
lower at two year follow-up (wave 2) compared to baseline (wave 1). However, after 
adjusting for psychosocial (model 4) and health factors (model 5), the difference in 
quality of life between baseline and two year follow-up (wave 2) increased in 
magnitude and became significant (Table 4.6). The factor that contributed to the 
increase in the difference in quality of life between baseline and two year follow-up for 
men was pain. After controlling for the effect of this factor, the quality of life of men 
decreased between baseline and two year follow-up. If this factor was not accounted for 
in the model, then we would have concluded that the quality of life of men was not 
decreasing significantly.  
 
At four year follow-up (wave 3), quality of life of men was significantly lower than 
baseline, independent of other covariates. However, the magnitude of the difference in 
quality of life between baseline and four year follow-up (wave 3) increased from -1.55 
(model 1) in the model adjusted for age only to -2.73 in the fully adjusted model (model 
5).  
 
The interaction terms between wave 2 and gender and wave 3 and gender were 
statistically significant in models 1 to 4 and models 2 to 4 respectively. When 
psychosocial factors were accounted for (model 5), these interaction terms were no 
longer significant. The psychosocial factor that contributed to the attenuation of the 
differences in the rate of change of quality of life between men and women at wave 2 
and wave 3 was depressive symptoms.  
 
Among people from the Well group, covariate adjustment did not change the 
conclusions about their trajectories of quality of life (Table 4.7).  The only exception 
was that adjustment for psychosocial factors (model 5) attenuated the gender difference 
in baseline quality of life found in models 1 to 4. In particular, after adjusting for 
positive social support, women no longer had higher quality of life than men at baseline 
(models 1 to 4).  
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Table 4.6 Sequentially adjusted linear random intercept model for quality of life with time for the CHD group, imputed data 
 
Model 1 Model2 Model3 Model4 Model5 
 
b se b se b se b se b    se 
Gender -0.63 0.62 0.19 0.59 0.40 0.59 0.78 0.55 0.83 0.50 
Wave 2 -0.21 0.36 -0.62 0.36 -0.73 0.36 -1.12** 0.36 -0.84*   0.36 
Wave 3 -1.55*** 0.37 -2.08*** 0.38 -2.18*** 0.38 -2.54*** 0.37 -2.73*** 0.37 
Wave 2*Gender 1.30* 0.54 1.50* 0.54 1.59** 0.54 1.29* 0.53 0.98 0.53 
Wave 3*Gender 1.04 0.54 1.31* 0.54 1.44* 0.54 1.12* 0.53 0.99 0.53 
Age (centred 63) 0.03 0.04 0.06 0.04 0.07 0.04 0.07* 0.04 0.04 0.03 
Age
2
 -0.01*** 0.00 -0.01*** 0.00 -0.01*** 0.00 -0.01*** 0.00 -0.01*** 0.00 
Not cohabiting  
  
-1.43** 0.42 -1.38** 0.42 -1.20** 0.40 -0.61 0.37 
Completely retired 
  
-1.51** 0.48 -1.56** 0.48 -1.30** 0.47 -1.28**  0.44 
Other 
  
-2.94*** 0.57 -2.98*** 0.57 -2.35*** 0.56 -2.30*** 0.53 
Low education 
  
-0.79* 0.37 -0.62 0.37 -0.74* 0.35 -0.47 0.32 
Wealth 4
th
 
  
-0.44 0.50 -0.33 0.50 -0.08 0.49 -0.36 0.47 
Wealth 3
rd
 
  
-2.74*** 0.53 -2.54*** 0.53 -2.20*** 0.51 -2.28*** 0.49 
Wealth 2
nd
 
  
-2.96*** 0.55 -2.66*** 0.55 -2.22*** 0.54 -2.21*** 0.51 
Wealth Poorest 
  
-4.79*** 0.58 -4.49*** 0.59 -3.83*** 0.56 -3.61*** 0.53 
Current smoker 
    
-0.06 0.58 -0.32 0.55 -0.27 0.49 
Physically inactive 
    
-1.99*** 0.36 -1.55*** 0.35 -1.38*** 0.34 
Drinks alcohol ≥3 days a week 
    
0.84* 0.37 0.73* 0.36 0.76*   0.33 
Often troubled with pain 
      
-1.98*** 0.33 -1.84*** 0.31 
ADLs 
      
-1.63*** 0.13 -1.46*** 0.12 
Positive support (centred at 27) 
        
0.29*** 0.03 
Close friends (centred at 8) 
        
0.10*** 0.02 
Depressive symptoms 
        
-4.32*** 0.33 
Constant 41.22*** 0.43 45.44*** 0.65 46.19*** 0.72 46.92*** 0.69 47.38*** 0.64 
Model            
Between variance 51.62 1.06 43.12 1.06 40.77 1.06 32.66 1.07 20.66 1.08 
Within variance 32.07 1.03 31.56 1.03 31.63 1.03 30.69 1.03 30.63 1.03 
* for p<.05, ** for p<.01, and ***for p<.001 
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Table 4.7 Sequentially adjusted linear random intercept model for quality of life with time for the Well group, imputed data 
 
Model 1 Model2 Model3 Model4 Model5 
 
b se b se b se b se b    se 
Gender 0.15 0.27 0.58* 0.26 0.74** 0.25 0.64** 0.24 0.24 0.23 
Wave 2 -1.21*** 0.18 -1.02*** 0.18 -1.15*** 0.18 -1.16*** 0.18 -1.11*** 0.18 
Wave 3 -2.61*** 0.19 -2.60*** 0.19 -2.71*** 0.19 -2.62*** 0.18 -2.88*** 0.18 
Wave 2*Gender -0.03 0.25 0.14 0.24 0.22 0.24 0.30 0.24 0.25 0.24 
Wave 3*Gender -0.26 0.25 -0.02 0.24 0.06 0.24 0.09 0.24 0.18 0.24 
Age (centred 63) 0.02 0.01 0.06*** 0.02 0.07*** 0.02 0.06*** 0.01 0.04** 0.01 
Age
2
 -0.01* 0.00 -0.01 0.00 -0.01 0.00 -0.01 0.00 -0.01 0.00 
Not cohabiting  
  
-1.02*** 0.20 -1.01*** 0.19 -0.91*** 0.19 -0.36* 0.18 
Completely retired 
  
-1.02*** 0.18 -1.05*** 0.18 -0.74*** 0.18 -0.73*** 0.17 
Other 
  
-2.90*** 0.24 -2.88*** 0.24 -2.10*** 0.23 -2.05*** 0.22 
Low education 
  
-0.06 0.18 0.12 0.18 0.06 0.17 0.15 0.16 
Wealth 4
th
 
  
-1.04*** 0.20 -0.92*** 0.20 -0.91*** 0.20 -1.03*** 0.19 
Wealth 3
rd
 
  
-1.82*** 0.22 -1.63*** 0.22 -1.54*** 0.21 -1.58*** 0.20 
Wealth 2
nd
 
  
-2.83*** 0.23 -2.52*** 0.23 -2.31*** 0.23 -2.34*** 0.21 
Wealth Poorest 
  
-4.61*** 0.27 -4.20*** 0.27 -3.92*** 0.26 -3.82*** 0.25 
Current smoker 
    
-0.95*** 0.24 -0.96*** 0.23 -0.73** 0.21 
Physically inactive 
    
-1.42*** 0.14 -1.19*** 0.14 -0.96*** 0.13 
Drinks alcohol ≥3 days a week 
    
0.56*** 0.16 0.50** 0.15 0.60*** 0.15 
Often troubled with pain 
      
-2.07*** 0.17 -1.87*** 0.17 
ADLs 
      
-1.87*** 0.10 -1.68*** 0.09 
Positive support (centred at 27) 
        
0.28*** 0.01 
Close friends (centred at 8) 
        
0.06*** 0.01 
Depressive symptoms 
        
-4.19*** 0.17 
Constant 45.73 0.21 48.11 0.26 48.55 0.28 48.64 0.27 49.03 0.25 
Model            
Between variance 36.74 1.03 32.07 1.03 30.69 1.03 27.61 1.03 19.18 1.04 
Within variance 26.95 1.02 26.26 1.02 26.21 1.02 25.28 1.02 24.93 1.02 
* for p<.05, ** for p<.01, and ***for p<.001 
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4.3.3 Depressive symptoms 
 
The results of the logistic random intercept model for depressive symptoms are reported 
in Table 4.8. Overall, women in the CHD group had higher odds for depressive 
symptoms than men with CHD (adjusted OR: 1.65, p<0.01) independent of other 
covariates. Similarly, in the Well group women were more likely than men to have 
depressive symptoms (adjusted OR: 2.2, p<0.001). The adjusted odds of having 
depressive symptoms was 1.40 times higher in men with CHD than men in Well group 
(p<0.01), while women with CHD were as likely as women in the Well group to have 
depressive symptoms. The interaction term between gender and disease status was not 
significant, mainly due to the fact that women in the CHD group are as likely to have 
depressive symptoms as women in the Well group.  
 
Being retired as compared to being in paid employment, being in the 4
th
, 3
rd
 and 2
nd
 
wealth quintiles compared to the richest wealth quintile, drinking on three days a or 
more a week compared to drinking on less than three days a week, and increasing 
number of close friends and family were not significantly related to depressive 
symptoms, while all the other covariates were. The between-individual variance is 5.38 
(62% of the total variance), which expresses the unexplained variation in depressive 
symptoms due to differences between individuals after controlling for covariates. The 
within-individual variance is fixed at 3.29 (38% of the total variance) and expresses the 
variation in depressive symptoms within individuals over time due to unmeasured 
differences after controlling for covariates. We can conclude that a greater proportion of 
the residual variability in depressive symptoms is due to differences between 
individuals.  
 
Results based on observed data show a similar pattern to the results based on values for 
missing data. There are however few exceptions: increasing age, being in the “other” 
category of retirement status (vs in paid employment), poorest wealth quintile (vs 
richest), current smoker (vs ex-smoker and never smoked) and limitations with ADLs 
were not significantly related to depressive symptoms (Table 4.8).  
 
 
 
 
 
 166 
 
 
 
Table 4.8 Logistic random intercept model for depressive symptoms 
 Imputed Observed 
  OR Std. Err. P-value OR Std. Err. P-value 
CHD 1.40 0.19 0.015 1.79 0.42 0.013 
Gender 2.18 0.21 0.000 1.96 0.30 0.000 
CHD*Gender 0.76 0.15 0.146 0.82 0.27 0.549 
Age (centred 63) 1.01 0.00 0.006 1.00 0.01 0.975 
Not cohabiting  2.04 0.17 0.000 2.56 0.37 0.000 
Completely retired 0.92 0.08 0.388 0.86 0.13 0.332 
Other* 1.26 0.14 0.040 1.37 0.26 0.099 
Low education 1.31 0.10 0.000 1.16 0.08 0.027 
Wealth 4
th
 0.86 0.09 0.157 0.77 0.14 0.146 
Wealth 3
rd
 1.12 0.12 0.302 1.25 0.22 0.218 
Wealth 2
nd
 1.23 0.14 0.064 1.25 0.24 0.252 
Wealth Poorest 1.54 0.19 0.000 1.43 0.31 0.093 
Current smoker 1.53 0.15 0.000 1.25 0.20 0.174 
Physically inactive 1.87 0.14 0.000 1.90 0.24 0.000 
Drinks alcohol ≥3 days a week 1.00 0.08 0.977 0.91 0.12 0.488 
Often troubled with pain 2.04 0.16 0.000 2.81 0.39 0.000 
ADLs 1.57 0.06 0.000 1.04 0.07 0.620 
Positive support (centred at 27) 0.93 0.01 0.000 0.94 0.01 0.000 
Close friends (centred at 8) 0.99 0.01 0.155 0.99 0.01 0.249 
Model 
      Between variance 5.38 0.06 
 
3.57 0.55 
 Within variance 3.29 
  
3.29 
  Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, 
Richest wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with pain, No 
limitations with ADLs. 
* Permanently unable to work, not currently in paid employment, looking after home or family 
 
Table 4.9 reports results from the logistic random intercept model with a time and 
gender interaction among people with CHD. Among men with CHD the odds of having 
depressive symptoms did not differ significantly at years two and four of follow-up 
(OR: 1.20 [95%CI: 0.71; 1.8] and OR: 1.06 [95%CI: 0.70; 1.58] respectively) compared 
to baseline (wave 1). At two year follow-up (wave 2) the risk of having depressive 
symptoms did not differ significantly from baseline (wave 1) (OR: 1.06 [95%CI: 0.70; 
1.61]), while at four year follow-up (wave 3) they were significantly less likely to have 
depressive symptoms (OR: 0.63[95%CI: 0.40; 0.97], p<0.05) than at baseline. Women 
with CHD were more likely than men to have depressive symptoms at baseline 
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(p<0.001), and at two year follow-up (OR 1.8 [95%CI: 1.1; 2.9] p<0.05) but there was 
no gender difference at four year follow-up (OR 1.2 [95%CI: 0.7; 1.9] p=0.517).  
 
Only not cohabiting, physical inactivity, pain, limitation with ADLs and positive 
support were significantly related to depressive symptoms.  
 
The results obtained from the sample with missing data (observed) were very similar to 
those obtained from analyses based on augmented samples. However, standard errors 
obtained from analyses based on the augmented samples were smaller. The only 
difference found between observed data results and augmented samples results was that 
limitation with ADLs was not significantly related to depressive symptoms.  
*Permanently unable to work, not currently in paid employment, looking after home or family. 
 
Table 4.9 Logistic random intercept model for depressive symptoms with time for the CHD 
group 
 Imputed Observed 
  OR 
Std. 
Err. P-value OR 
Std. 
Err. P-value 
Gender 1.99 0.48 0.004 2.40 0.99 0.035 
Wave 2 1.20 0.24 0.359 1.48 0.57 0.312 
Wave 3 1.06 0.22 0.779 0.67 0.32 0.397 
Wave 2*Gender 0.88 0.25 0.665 0.55 0.31 0.290 
Wave 3*Gender 0.59 0.17 0.071 0.82 0.53 0.766 
Age (centred 63) 1.01 0.01 0.168 0.99 0.02 0.555 
Not cohabiting  2.17 0.38 0.000 2.62 0.89 0.004 
Completely retired 0.88 0.21 0.579 1.03 0.43 0.935 
Other* 1.22 0.33 0.474 1.03 0.53 0.948 
Low education 1.27 0.20 0.132 1.24 0.21 0.192 
Wealth 4
th
 0.79 0.21 0.374 0.52 0.27 0.212 
Wealth 3
rd
 1.23 0.32 0.423 1.67 0.78 0.274 
Wealth 2
nd
 1.33 0.35 0.282 2.30 1.14 0.093 
Wealth Poorest 1.50 0.41 0.132 1.57 0.80 0.377 
Current smoker 1.17 0.27 0.498 0.60 0.26 0.235 
Physically inactive 2.16 0.41 0.000 2.67 0.92 0.004 
Drinks alcohol ≥3 days a week 0.80 0.14 0.198 0.93 0.32 0.839 
Often troubled with pain 2.11 0.33 0.000 2.49 0.76 0.003 
ADLs 1.53 0.09 0.000 0.74 0.14 0.105 
Positive support (centred at 27) 0.92 0.01 0.000 0.90 0.03 0.000 
Close friends (centred at 8) 0.99 0.01 0.361 1.00 0.02 0.887 
Model  
      Between variance 4.38 0.12
 
3.47 1.41
 Within variance 3.29 
  
  3.29 
  Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, Richest 
wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with pain, No 
limitations with ADLs. 
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Similar results to those of men in the CHD group were found among men in the Well 
group (Table 4.10): there was not a significant difference over time in the odds of 
having depressive symptoms. Women from the Well group were more likely to have 
depressive symptoms than men at each time point (wave 1 OR: 2.31 p<0.001; wave 2 
OR: 1.8 p<0.001; wave 3 OR: 2.6 p<0.001).   
 
Observed sample results and augmented samples results were slightly different, in the 
former results increasing age, low education (vs medium and high) and poorest wealth 
quintile (vs richest) were not significantly related to depressive symptoms.  
 
 
Trajectories of depressive symptoms reported in Table 4.10 are presented graphically in 
Figure 4.2 (imputed data). Men with CHD and men from the Well group did not report 
Table  4.10 Logistic random intercept model for depressive symptoms with time for the 
Well group 
 Imputed Observed 
  OR 
Std. 
Err. P-value OR 
Std. 
Err. P-value 
Gender 2.31 0.30 0.000 1.78 0.35 0.004 
Wave 2 1.17 0.14 0.212 0.97 0.21 0.891 
Wave 3 0.85 0.11 0.203 0.80 0.19 0.343 
Wave 2*Gender 0.77 0.12 0.091 1.08 0.29 0.786 
Wave 3*Gender 1.11 0.18 0.519 1.29 0.38 0.394 
Age (centred 63) 1.01 0.01 0.010 1.00 0.01 0.725 
Not cohabiting  2.04 0.19 0.000 2.60 0.42 0.000 
Completely retired 0.93 0.09 0.472 0.80 0.13 0.185 
Other* 1.27 0.16 0.058 1.41 0.30 0.105 
Low education 1.30 0.11 0.002 1.14 0.08 0.085 
Wealth 4
th
 0.88 0.11 0.296 0.81 0.16 0.273 
Wealth 3
rd
 1.09 0.13 0.475 1.17 0.23 0.430 
Wealth 2
nd
 1.21 0.15 0.138 1.07 0.23 0.733 
Wealth Poorest 1.54 0.21 0.002 1.45 0.35 0.125 
Current smoker 1.62 0.18 0.000 1.42 0.25 0.049 
Physically inactive 1.83 0.15 0.000 1.83 0.25 0.000 
Drinks alcohol ≥3 days a week 1.06 0.09 0.531 0.93 0.13 0.622 
Often troubled with pain 1.98 0.18 0.000 2.88 0.46 0.000 
ADLs 1.60 0.08 0.000 1.10 0.08 0.226 
Positive support (centred at 27) 0.93 0.01 0.000 0.95 0.01 0.000 
Close friends (centred at 8) 0.99 0.01 0.322 0.99 0.01 0.288 
Model  
      Between variance 5.38 0.07 
 
3.62 0.61 
 Within variance 3.29 
  
3.29 
  Reference categories: Well, Male, Cohabiting, In paid employment High/medium education, 
Richest wealth, Non-smoker, Physically active, Drinks <3 days a week, Not troubled with 
pain,  No limitations with ADLs. *Permanently unable to work, not currently in paid 
employment, looking after home or family 
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significant changes over time in the odds of having depressive symptoms. Women with 
CHD were less likely to have depressive symptoms at four year follow-up (wave 3) than 
baseline, while women from the Well group did not report significant changes over time 
in their odds of having depressive symptoms. 
 
Figure 4.2 Trajectories over time of depressive symptoms among people with CHD and 
the Well group, by gender (imputed data) 
 
 
Results adjusted for gender, age, cohabiting status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, positive support 
and number of close friends and family.  
 
 
In order to understand the effect of covariates on the estimates of trajectories of 
depressive symptoms, five logistic random intercept models with an interaction term 
between gender and time were run by sequentially expanding the set of covariates as 
follows: model 1 is a model with interaction term between gender and time plus age and 
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its quadratic effect (model 1); model 2 is model 1 plus socio-demographic factors 
(cohabiting status, education and wealth); model 3 is model 2 plus health behaviour 
factors (physical activity, smoking, alcohol consumption); model 4 is model 3 plus 
health factors (pain and limitation with ADLs); model 5 is model 4 plus social factors 
(social support and social networks). Results are presented in Tables 4.11 and 4.12. 
Results are presented as log odds. 
 
Table 4.11 reports the sequentially adjusted random intercept models for depressive 
symptoms among people with CHD. At baseline, the odds ratio for having depressive 
symptoms in women compared to men was 2.8 (log odds 1.04) in the model adjusted for 
age only (model 1). After full adjustment the odds ratio decreased to 1.99 (log odd 
0.68), but was still significant. Adjustment for covariates did not change the conclusions 
about gender differences in depressive symptoms at baseline and two year follow-up, 
but did change the conclusions at four year follow-up. It was found that women had 
higher odds of having depressive symptoms than men at four year follow-up (OR: 1.9 
[95%CI: 1.1; 3.2]; p<0.05) only in a model adjusted for age (Model 1), when further 
adjustment was made to the model (Models 2 to 5) the gender differences was no longer 
significant. 
 
For people in the Well group, adjustment did not change the conclusions of trajectories 
about depressive symptoms. 
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Table 4.11 Sequentially adjusted random intercept model for depressive symptoms with time for the CHD group, imputed data  
 
Model 1 Model2 Model3 Model4 Model5 
 
b se b se b se b se b    se 
Gender 1.04*** 0.27 0.76** 0.26 0.69** 0.25 0.57* 0.24 0.69**  0.24 
Wave 2 -0.05 0.19 0.06 0.20 0.09 0.20 0.24 0.20 0.18 0.20 
Wave 3 -0.32 0.20 -0.15 0.20 -0.14 0.20 0.03 0.21 0.06 0.21 
Wave 2*Gender -0.17 0.28 -0.24 0.28 -0.27 0.28 -0.19 0.28 -0.12 0.28 
Wave 3*Gender -0.40 0.29 -0.54 0.29 -0.58* 0.29 -0.51 0.29 -0.52 0.29 
Age (centred 63) 0.04*** 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Not cohabiting  
  
0.88*** 0.19 0.85*** 0.18 0.82*** 0.18 0.78*** 0.18 
Completely retired 
  
0.07 0.25 0.07 0.25 -0.08 0.24 -0.13 0.24 
Other 
  
0.56* 0.28 0.51 0.28 0.23 0.27 0.20 0.27 
Low education 
  
0.29 0.17 0.19 0.17 0.23 0.16 0.24 0.16 
Wealth 4
th
 
  
-0.12 0.28 -0.15 0.28 -0.24 0.27 -0.24 0.27 
Wealth 3
rd
 
  
0.46 0.27 0.36 0.27 0.21 0.26 0.21 0.26 
Wealth 2
nd
 
  
0.66* 0.27 0.51 0.28 0.32 0.27 0.29 0.27 
Wealth Poorest 
  
0.93*** 0.28 0.76** 0.28 0.49 0.27 0.41 0.27 
Current smoker 
    
0.17 0.25 0.17 0.24 0.16 0.23 
Physically inactive 
    
1.02*** 0.20 0.79*** 0.19 0.77*** 0.19 
Drinks alcohol ≥3 days a week 
    
-0.24 0.18 -0.19 0.17 -0.22 0.17 
Often troubled with pain 
      
0.71*** 0.16 0.75*** 0.16 
ADLs 
      
0.43*** 0.06 0.43*** 0.06 
Positive support (centred at 27) 
        
-0.09*** 0.02 
Close friends (centred at 8) 
        
-0.01 0.01 
Constant -2.34*** 0.21 -3.16*** 0.33 -3.61*** 0.37 -3.64*** 0.36 -3.62*** 0.36 
Model            
Between variance 2.33 1.07 2.10 1.07 2.02 1.07 1.79 1.08 1.72 1.08 
Within variance 3.29  3.29  3.29  3.29  3.29  
* for p<.05, ** for p<.01, and ***for p<.001. Estimates are expressed in log odds  
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Table 4.12 Sequentially adjusted random intercept model for  depressive symptoms with time for the Well group, imputed data  
 
Model 1 Model2 Model3 Model4 Model5 
 
b se b se b se b se b    se 
Gender 0.87*** 0.14 0.71*** 0.13 0.66*** 0.13 0.67*** 0.13 0.84*** 0.13 
Wave 2 0.12 0.12 0.13 0.12 0.17 0.12 0.17 0.12 0.15 0.12 
Wave 3 -0.26* 0.13 -0.20 0.13 -0.17 0.13 -0.20 0.13 -0.16 0.13 
Wave 2*Gender -0.16 0.16 -0.24 0.16 -0.25 0.16 -0.26 0.16 -0.26 0.16 
Wave 3*Gender 0.20 0.16 0.11 0.16 0.09 0.16 0.11 0.16 0.10 0.16 
Age (centred 63) 0.03*** 0.00 0.02** 0.01 0.01* 0.01 0.009 0.01 0.01**  0.01 
Not cohabiting  
  
0.83*** 0.10 0.82*** 0.10 0.78*** 0.10 0.71*** 0.09 
Completely retired 
  
0.01 0.10 0.03 0.10 -0.06 0.10 -0.07 0.10 
Other 
  
0.53*** 0.13 0.50*** 0.12 0.26* 0.13 0.24 0.12 
Low education 
  
0.29** 0.09 0.23* 0.09 0.25** 0.09 0.26**  0.09 
Wealth 4
th
 
  
-0.09 0.12 -0.14 0.12 -0.14 0.12 -0.13 0.12 
Wealth 3
rd
 
  
0.16 0.13 0.09 0.13 0.07 0.12 0.09 0.12 
Wealth 2
nd
 
  
0.37** 0.13 0.24 0.13 0.16 0.13 0.19 0.13 
Wealth Poorest 
  
0.71*** 0.14 0.51*** 0.14 0.42** 0.14 0.43**  0.14 
Current smoker 
    
0.51*** 0.12 0.51*** 0.11 0.48*** 0.11 
Physically inactive 
    
0.76*** 0.08 0.64*** 0.08 0.60*** 0.08 
Drinks alcohol ≥3 days a week 
    
0.02 0.09 0.06 0.09 0.05 0.09 
Often troubled with pain 
      
0.69*** 0.09 0.68*** 0.09 
ADLs 
      
0.47*** 0.05 0.47*** 0.05 
Positive support (centred at 27) 
        
-0.07*** 0.01 
Close friends (centred at 8) 
        
-0.01 0.01 
Constant -2.97*** 0.12 -3.44*** 0.15 -3.85*** 0.17 -3.84*** 0.17 -3.86*** 0.16 
Model            
Between variance 2.09 0.04 1.94 0.04 1.88 0.04 1.76 0.04 1.68 0.04 
Within variance 3.29  3.29  3.29  3.29  3.29  
* for p<.05, ** for p<.01, and ***for p<.001. Estimates are expressed in log odds  
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4.4 Discussion 
 
This chapter set out to explore longitudinally gender-specific trajectories of quality of 
life and depressive symptoms among people with CHD, and compare the results with 
those from a Well group.  
 
It was hypothesised that people aged over fifty years who had had experienced CHD 
would be at higher risk of experiencing depressive symptoms and poor quality of life 
than those who have not. Results suggested that men and women with CHD reported 
lower levels of quality of life compared to people in the Well group. Men with CHD 
were more likely to have depressive symptoms than men in the Well group. The 
hypothesis was not supported for women: it was found that women with CHD were 
equally likely to have depressive symptoms women from the Well group. A possible 
explanation might be that women are in general more prone to depression irrespective 
of the disease status (Forrester et al., 1992; Freasure-Smith et al., 1999; Mallik et al., 
2006).  
 
Gender differences in quality of life and depressive symptoms among people with 
CHD 
 
It was hypothesised that women with CHD would report lower levels of quality of life 
and be at higher risk of having depressive symptoms compared to men. It was found 
that women with CHD reported the same quality of life as men at baseline (wave 1, 
2002-03), and higher quality of life at years two (wave 2, 2004-05) and four (wave 3, 
2005-07) of follow-up independent of other covariates. No previous studies have 
reported these findings. A possible explanation might lie in the measure of quality of 
life used in this study, the CASP-19, which is neither disease-specific nor health-related. 
Previous studies showing lower quality of life among women used disease-specific 
measures, such as Quality of Life After Myocardial Infarction (Hillers et al, 1994) and 
Quality of Life Index-Cardiac (Ferrans and Powers, 1985; 1992), and a more generic 
measure of health-related quality of life, the SF-36 (Turner-Bowker et al., 2002). It has 
been shown that the problem related to these measures is that when they are applied to a 
cardiac population, they usually lack sensitivity – the ability of a measure to detect 
important changes (Smith et al., 2000). Also health-related measures of quality of life 
aim to measure quality of life through the use of health domains such as mental health, 
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physical functioning, body pain and health perception. These are all dimensions that 
might influence the subjective experience of quality of life of individuals. It has been 
shown that women with CHD are at higher risk of having depression (Naqvi et al., 
2005) and have lower physical functioning than men (Richardson, 2003). Therefore the 
lower levels of health-related quality of life among women reported in the literature 
might be attributed to higher depression and lower physical functioning. 
 
As for depressive symptoms, women with CHD reported higher odds of having 
depressive symptoms than men at baseline and two year follow-up but not at four year 
follow-up. It was when the model was adjusted for covariates other than age that the 
gender difference disappeared. This result is consistent with one previous study that 
showed gender differences in the mental health dimension of HRQOL at one year post-
myocardial infarction did not persist once the model was adjusted for demographic, 
clinical, comorbid and psychosocial covariates (Norris et al., 2007). 
 
One of the possible explanations for not finding any gender difference in depressive 
symptoms at four year follow-up might lie in the measure of CHD used in this thesis 
which included myocardial infarction as well as angina symptoms. It is possible that the 
long term effects of angina lead to fewer impairments than those of myocardial 
infarction. Angina is not a disease but a symptom of coronary heart disease which 
occurs on exertion and is relieved by rest. On the other hand, myocardial infarction is an 
event caused by a blood clot that blocks one of the coronary arteries, whereby the part 
of the heart muscle is damaged and might die. Women in this sample experienced more 
angina symptoms than myocardial infarction (57% of women with CHD experienced 
angina, 28% myocardial infarction and 15% both); it is possible that the gender 
difference in depressive symptoms attenuated after four years as a result of adaptation to 
the coronary event. Mallik et al. (2006) suggested that gender differences in depressive 
symptoms among people with CHD no longer persist at older ages. They found 
significant gender differences in depression up to the age of 60 among men and women 
who had experienced myocardial infarction, but did not find any gender difference in 
depression among older women (aged 60 and over) compared to older men.  
 
It was also hypothesised that shapes of trajectories over time of quality of life and 
depressive symptoms would be different in men and women with CHD. This study 
supported this hypothesis. It was found that, while the quality of life of men with CHD 
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decreased significantly over time, the quality of life of women with CHD was stable at 
two years after baseline, followed by a decline between baseline and four year follow-
up.   
 
Trajectories in depressive symptoms also differed by gender. The odds of having 
depressive symptoms did not change significantly over time for men. Among women 
with CHD the odds of having depressive symptoms at two year follow-up were the 
same as at baseline but at four year follow-up women were significantly less likely to 
report depressive symptoms than baseline.  
 
The results of stable levels of quality of life at two year follow-up and of improvement 
in depressive symptoms among women with CHD at four year follow-up compared to 
baseline suggest that the adaptation to the CHD event might differ by gender. A 
possible explanation is that women might be able to recover quickly to the event in 
terms of quality of life and mental health, while men might not be coping well with the 
long-term consequences of CHD. It has been shown that women have, in general, more 
coping strategies for stressful life events than men (Hobfoll et al., 1994). After 
experiencing a myocardial infarction women are more likely to adopt both problem-
focused and emotional-focused coping strategies to try to change their situation such as 
seeking help, learning new skills and other cognitive and behavioural efforts (Bogg et 
al., 2000). Women are also more likely than men to share the experiences of the cardiac 
event and to simply accept what has happened. Household activities are reported as 
helping the recovery among women (Kristofferzon et al., 2003). Men with CHD are 
usually more likely than women to deny anger, depression and anxiety (Ketterer et al., 
2004). The coping strategy often adopted by men is focusing on work and keeping 
physically active (Kristofferzon et al., 2003). The use of such strategies by men might 
also explain the findings showing a long term decline in quality of life. In fact a high 
proportion of men with CHD in the ELSA sample is retired and physically inactive. 
Therefore it might be that not being able to work or to do physical activity affects the 
capacity of men to cope with the illness. 
 
A final remark should be made on why the quality of life of women with CHD 
decreased between baseline and four year follow-up, while the risk of having depressive 
symptoms reduced. It is possible that subgroups of women with certain characteristics 
(and changes over time therein) contributed to these results. Another possible 
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explanation might be that women experienced depressive symptoms as a consequence 
of the disease, therefore at four years of follow-up they might have adjusted to the CHD 
event and consequently their mental health improved. The decrease in quality of life 
occurred at four year follow-up could have been a consequence of ageing. This can be 
supported by the finding of this thesis which showed a decrease in quality of life over 
time among the healthy population (Well group) used as a reference group. Previous 
studies exploring longitudinal changes in quality of life in a general population of older 
individuals have shown that there is a trend of worsening quality of life over time at 
older ages (Zaninotto et al., 2009; Webb et al. 2010). 
 
Gender differences in trajectories of quality of life and depressive symptoms: 
comparing the CHD and the Well groups 
 
In the Well group men and women reported similar trajectories of quality of life and 
depressive symptoms. The quality of life of people from the Well group decreased 
significantly between baseline and years two and four of follow-up, while the odds of 
having depressive symptoms did not change significantly over time. People from this 
group had levels of quality of life that were on average higher than the general ELSA 
population, and the prevalence of depressive symptoms was lower. It is possible that the 
decline in quality of life levels is a consequence of ageing or development or 
progression of other disease. About 3% of people in this group experienced a CHD 
event after the baseline interview and 7% experienced other diseases (such as diabetes, 
stroke, pulmonary disease, Alzheimer, Parkinson’s and cancer). Stable levels of 
depressive symptoms over time might reflect the relatively good health reported in this 
group of people at baseline; this group of people could also be more resilient to any 
event that might have happened to them. 
 
Gender differences in quality of life were found at two year follow-up only, when 
women had higher quality of life than men. Women from the Well group were more 
likely than men to have depressive symptoms at each time point. It is difficult to 
understand why gender differences in quality of life and depressive symptoms found in 
the CHD group were different from those found in the healthy group at four year 
follow-up, even after controlling for the same covariates. It is possible that some of the 
covariates and their change over time had a different impact on the outcomes considered 
according to their disease status. 
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Gender differences in quality of life and depressive symptoms found among people with 
CHD were different from those found in the reference population of healthy individuals 
(Well group) at four year follow-up. It cannot be concluded that the results are specific 
to people with CHD because individuals with a disease other than CHD were not 
studied. However, for the purpose of this study it was important to see that gender 
differences in quality of life and depressive symptoms found among people with CHD 
were not the same as those in the healthy group, even after adjusting for the same 
covariates.  
 
Covariate adjustment 
 
Covariate adjustment was shown to be important in the analysis of quality of life for 
both the CHD and Well groups and for the CHD group only in the analysis of 
depressive symptoms.  
 
In the models for quality of life, adjustment for depressive symptoms changed the 
conclusions about trajectories of quality of life among people with CHD. If the model 
was not adjusted for depressive symptoms it would have been concluded that there was 
a significant gender difference in the rate of change of quality of life at years two and 
four of follow-up. This is mainly attributable to the fact that for men the risk of 
depressive symptoms did not change over time, therefore not adjusting for depressive 
symptoms would have resulted in a steeper rate of change in quality of life. 
 
Among men with CHD, adjustment for pain (reference category is “not being troubled 
with pain”) resulted in a significant decrease in quality of life between baseline and two 
year follow-up. It is difficult to understand the underlying processes of adjustment. One 
possible reason might be that men with CHD who were often troubled with pain already 
had low quality of life therefore they experienced a small change in their quality of life 
between baseline and two year follow-up (baseline mean quality of life 37.3 S.D. 9.7; 
two year follow-up mean quality of life 35.7 S.D. 9.3).  
 
Also, in the Well group adjustment for social support (simultaneously with the other 
covariates) attenuated the difference in baseline levels of quality of life between men 
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and women, the baseline quality of life would have otherwise been higher among 
women.  
 
Thus depressive symptoms, pain and possibly social support are mediators of the 
relationships between disease status and quality of life. 
 
For the CHD group, it was found that after adjusting for covariates women were no 
longer more likely than men to have depressive symptoms at four year follow-up. That 
was true after adjustment for socio-demographic factors, health behaviour factors, 
health factors and social factors. Suggesting that adjustment for covariates in addition to 
age is important, otherwise the results could have led to different conclusions. 
 
Comparisons with other studies 
 
It is difficult to compare the results from this study with those from the literature as 
most of the latter studies had a shorter length of follow-up than ELSA and also the 
samples came mainly from selected community hospitals, with the exception of two 
studies (Bjerkeset et al., 2005; Ford et al., 2008). Nevertheless, the finding of no gender 
differences in quality of life at baseline is in agreement with two other studies reporting 
no gender differences post-myocardial infarction at baseline (Mendes de Leon et al., 
2001; Kristofferzon et al., 2005b). This study is the first to show that women’s quality 
of life was higher than men’s quality of life at years two and four of follow-up. This 
study is also the first to show that women’s quality of life did not deteriorate following 
the baseline report of a CHD event, while men’s quality of life deteriorated over time. 
 
The results showing that, following a CHD event, women are more likely than men to 
have depressive symptoms is well-known (Forrester et al., 1992; Freasure-Smith et al., 
1999; Mallik et al., 2006), however, this study was the first to show that these gender 
differences were found at baseline and at two year follow-up but not at four year follow-
up. It was explained earlier that the gender difference disappeared after adjustment for 
covariates. Only one previous study reported that gender differences in the mental 
health dimension of HRQOL found at one year post-myocardial infarction did not 
persist once the model was adjusted for demographic, clinical, comorbid and 
psychosocial covariates (Norris et al., 2007).  
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This is also the first study to show that gender differences in depressive symptoms and 
quality of life are not the same in the CHD group and the Well group, at four year 
follow-up. This is an important finding, because previous studies have not shown 
whether gender differences in depressive symptoms were also found in a population free 
from any disease. A possible explanation could be that no previous studies comparing 
the results of the CHD group with a reference population had a length of follow-up 
longer than a year. The result of an improvement in depressive symptoms in women is 
somewhat in line with the study of Bjerkeset et al., (2005) which showed that women 
had a significant decrease in the risk of depression two year post-myocardial infarction.  
 
Strengths and limitations 
 
One of the strengths of this analysis is the use of a large sample of older people living in 
private households in England. The study has been designed to collect information on 
topics necessary to understand the economic, social, psychological and health elements 
of the ageing process. Some of the advantages of using this data set include: information 
on angina symptoms as well as myocardial infarction; the ability to measure well-being 
with two distinct measures such as depressive symptoms (experienced well-being) and 
quality of life (evaluative well-being); and the ability to compare the results for the 
CHD population with those for a healthy population. 
 
The treatment of missing data constitutes a further strength of this analysis. Missing 
data often occur in epidemiological studies where non-response is a major problem. In 
addition to non-response longitudinal studies also face attrition due to death or drop-out 
from the study. The development of sophisticated missing data techniques allow 
researchers to improve the validity of epidemiological research results and to reduce 
estimation bias caused by missing data (Sterne et al., 2009; Jelicic et al., 2009). The 
technique used to impute missing data in this analysis is particularly suitable for 
repeated measures. The inclusion of several auxiliary variables helped reinforce the 
MAR assumption. Results for depressive symptoms based on augmented samples were 
similar to those obtained from the sample with missing data (observed). More 
differences were found in the results of quality of life. This finding most probably 
reflects the fact that the missing data mechanism was not missing completely at random. 
Missingness in quality of life depended on observed characteristics such as increasing 
age, CHD, low education, poor wealth, not cohabiting with a partner, permanently 
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unable to work, not currently in paid employment and looking after home or family and 
being physically inactive. Those reporting these characteristics are more likely to drop-
out and to report a lower quality of life than those who were more advantaged (i.e. those 
in the healthy group, with high education, cohabiting with a partner and so forth).  
Another strength is the use of multilevel models, which enabled modelling individual 
trajectories of quality of life and depressive symptoms over time taking into account the 
hierarchical structure of the data and has the advantage of providing efficient estimates 
of the parameters of interest. 
 
One possible limitation of this analysis is the use of a self-reported measure of CHD. 
Unfortunately ELSA does not collect objective measures of CHD nor does it link the 
respondents’ information with medical or hospital records. The impact that 
misclassification bias might have on the results presented here is addressed in the next 
chapter. It should also be mentioned that the trajectories of quality of life and depressive 
symptoms were studied for people with CHD and those in the Well group according to 
their disease status at baseline. About 12% of people with CHD experienced a repeat 
event at subsequent waves which might have affected their quality of life and depressive 
symptoms. Further, no distinction was made between the first and recurrent CHD event. 
It was implicitly assumed that a recent recurrence of a CHD event was as important as 
the first onset.  
 
Conclusions 
 
To summarise, it was found that, compared to people from the Well group, men and 
women with CHD had, on average, lower levels of quality of life. Men with CHD were 
also at higher risk of having depressive symptoms than men from the Well group. The 
findings from this thesis did not support the hypothesis that women with CHD were 
more likely to have depressive symptoms than women from the Well group. 
 
The results of this analysis supported the hypothesis of differently shaped trajectories 
over time of quality of life and depressive symptoms in men and women following the 
onset of CHD. However, this analysis did not support the hypothesis of women with 
CHD reporting lower quality of life than men at any time. Significant gender differences 
in depressive symptoms were found at baseline and at two year follow-up only. The 
issue of the self-reported measure of CHD is addressed in the next chapter which 
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investigates the impact that misclassification bias might have on the results presented 
here.  
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Chapter 5: A Sensitivity analysis investigating bias due to 
misclassification of self-reported CHD 
 
In the previous chapter gender differences in quality of life and depressive symptoms 
among people with CHD were explored longitudinally. One of the acknowledged 
limitations of the analysis was the use of the self-reported measure of CHD. The impact 
that self-report bias might have on the results presented in Chapter 4 is addressed in this 
chapter.  
 
5.1 Introduction 
 
Most epidemiological studies and health surveys assess the presence of chronic disease 
from self-report, as opposed to clinical assessments mainly because the collection of 
self-reported conditions involves lower costs (Kriesgsman et al., 1996). Several studies 
have assessed the value of a self-reported measure of myocardial infarction (Bush et al., 
1989; Okura et al., 2004; Merkin et al., 2007; Yamagishi et al., 2009; Lampe et al., 
2009), angina (Bush et al., 1989) and CHD (angina and/or myocardial infarction) 
(Kehoe et al., 1994; Haapanen et al., 1997; Lampe et al., 2009; Baumeister et al., 2010) 
by comparing self-reports with medical records. Table 5.1 gives a summary of findings 
from studies that have validated self-reported measures of CHD (angina, myocardial 
infarction or both). These studies have focussed on sensitivity and/or specificity of self-
reported angina and/or myocardial infarction and/or on the agreement (percent and 
kappa) between self-reports and medical records or disease registries. Sensitivity is the 
proportion of true positives (defined as the presence of the condition according to 
clinical assessment of medical records) that are correctly identified by the self-report 
measure; specificity is defined as the proportion of true negatives (absence of the 
condition) that are correctly identified by the self-report measure (Altman and Bland 
1994). Total agreement percent is defined as correctly reported positive and negative 
self-assessments over total reports or records. Cohen’s kappa is a measure of inter-rater 
agreement between self-reports and clinical assessment calculated as the amount by 
which the observed agreement (p) exceeds that expected by chance alone (pe), divided 
by the maximum which this difference could be (1- pe). As suggested by Landis and 
Koch (1977) a kappa value of <0.40 is considered poor-to-fair agreement, a kappa value 
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of 0.41 to 0.60 is considered moderate agreement, a kappa value of 0.61 to 0.80 is 
considered substantial agreement, and a kappa value of 0.81 to 1.00 is considered 
excellent agreement. 
Substantial agreement between self-reported myocardial infarction and/or angina and 
medical records was found in several studies with kappa over 0.70 and/or percent 
agreement greater than or equal to 80 (Bush et al., 1989; Okura et al., 2004;  Lampe et 
al., 2009; Barr et al., 2009). Some of the studies reported moderate sensitivity (60%) 
(Merkin et al., 2007) and high sensitivity (over 89%) of self-reported myocardial 
infarction (Okura et al., 2004; Yamagishi et al., 2009) and angina (Barr et al., 2009). 
The studies reporting specificity of self-reported myocardial infarction found that it was 
considerably higher (over 93%) than the sensitivity (Okura et al., 2004; Merkin et al., 
2007; Yamagishi et al., 2009). Results from studies comparing self-reported medical 
history of CHD with medical records (or physician’s records) found a kappa greater 
than or equal to 0.80 (Haapanen et al., 1997; Lampe et al., 2009; Baumeister et al., 
2010). The specificity of self-reported CHD was greater than or equal to 96%, and the 
sensitivity was greater than or equal to 88% (Haapanen et al., 1997; Baumeister et al., 
2010) with the exception of two studies that found sensitivity values equal to 60% and 
64% (Kehoe et al., 1994; Merkin et al., 2007).  
Overall, from results reported in the literature there is evidence that the assessment of 
CHD by self-reports is a valid alternative when clinical assessment is not feasible. 
Given that self-reported measures of chronic diseases are widely used in epidemiology, 
the next question is to what extent a misclassification in a self-reported exposure 
introduces bias in model estimates in spite of relatively high agreement, high sensitivity 
and specificity. Self-reported CHD is used in the ELSA study. This information is not 
validated by a clinical screening or verified against medical records. Therefore in ELSA 
is not possible to ascertain the potential accuracy of self-reported CHD as compared to 
medical records. Since the definition of CHD used in this thesis has a two-year recall, it 
is possible that only a low rate of positive diagnosis was incorrect. However, it would 
be interesting to investigate the extent to which the self-reported measure of CHD used 
in this thesis may lead to biased estimates and/or different conclusions in the results 
presented in the previous chapter. 
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Table 5.1 Review of studies validating self-reported measures of angina and/or myocardial infarction 
First author Number 
and age of 
subjects  
Setting Condition 
being 
validated 
Validation Agreement 
% and kappa 
Sensitivity 
 
Specificity 
 
Bush T.L. 
1989 
107 aged 
65+ 
Florida 
Screening-based 
Angina 
and MI 
Medical records 85% angina k=0.57 
94% MI k=0.70 
- - 
Kehoe R. 1994 1,389 
mean age 
65 
(S.D.8.2) 
Boston 
Cataract 
case-control study 
CHD Medical records - 64% 96% 
Haapanen N. 
1997 
596 aged 
45 to 73 
Finland CHD Medical records k=0.80 88% 
 
96% 
Okura Y. 2004 1,950 aged 
45+ 
Minnesota 
Population-based 
MI Medical records 97.8%  
k=0.80 
89.5% 
 
98.2% 
 
Merkin S.S 
2007 
1,041 aged 
18+ 
USA 
Patient-based  
MI Medical records 
and physician 
reports 
k=0.55 Medical 
records 
k=0.33 Physician 
reports 
60% 
 
93% 
 
Yamagishi K. 
2009 
90,102 
aged 50+ 
Japan 
Screening-based 
MI Medical records - 82% 
 
- 
Lampe F.C. 
2009 
5,701 men 
aged 52 to 
75 
Britain 
population-based 
CHD Medical records 80% 
k=0.82 
- - 
Baumister H. 
2010 
7,124 aged 
18 to 79 
Germany 
population-based 
CHD Physician 
reports 
k=0.81 91.9% 
 
98.0% 
 
Abbreviations: MI: myocardial infarction; CHD: coronary heart disease; PPV: positive predictive value; NPV: negative predictive 
value 
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When validation of a self-reported measure is not available, several methods have been 
proposed to adjust findings and to investigate the potential bias of a misclassified 
exposure (Lash and Fink, 2003; Fox et al., 2005; Chu et al., 2006; Orsini et al., 2008; 
Lyles and Lin, 2010). The focus of these studies varies from standard tabular data (case-
control study setting), with a binary risk factor subject to misclassification, to estimated 
log odds ratios in logistic regression adjusted for misclassification based on assumed 
sensitivity and specificity parameters (Fox et al., 2005; Lyles and Lin, 2010). These 
methods allowed for both deterministic and probabilistic sensitivity analysis. In a 
deterministic sensitivity analysis the idea is to adjust risk ratios or odds ratios by 
assuming several pairs of sensitivity and specificity. Probabilistic sensitivity analysis 
allows uncertainty about the bias parameters, i.e. sensitivity and specificity (Fox et al., 
2005; Chu et al., 2006; Orsini et al., 2008; Lyles and Lin, 2010), and requires the 
definition of a distribution for the sensitivity and specificity. Therefore, the accuracy of 
a correction for misclassification depends on how accurate the definition is of such a 
distribution (Fox et al., 2005).  
However, the proposed methodologies for performing a sensitivity analysis are not 
suitable in the setting of this thesis. First, I have a continuous outcome (quality of life) 
as well as a binary one (depressive symptoms); to date and to my knowledge, the 
methods proposed in the literature were developed for binary indicator misclassified 
variables (either exposure or outcome); second, my binary exposure (CHD) is interacted 
with gender. The methods to perform sensitivity analysis proposed in the literature 
mentioned above can accommodate a confounder but not an interaction term (Lash and 
Fink, 2003; Fox et al., 2005; Chu et al., 2006; Orsini et al., 2008; Lyles and Lin, 2010).  
One possible way of conducting a sensitivity analysis is to investigate the impact of 
misclassification of self-reported CHD in ELSA using an external validation study. For 
the purpose of this chapter, the Whitehall II study is used, which validates the self-
reported measure of CHD with clinical assessment. From the validation of the self-
reported CHD measure performed in the Whitehall II study two scenarios, under which 
misclassification might have occurred, are hypothesised and applied to the ELSA data. 
Results obtained under these two scenarios are compared to the results presented in the 
previous chapter in order to quantify the potential impact of CHD misclassification bias 
and assess potential accuracy. The Whitehall II study has many similarities with the 
ELSA study, not only in terms of setting and age range of the sample but also in terms 
of data collection and measures. However, in the Whitehall II study only positive self-
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reported cases of CHD could be verified, since follow-up of clinical records and 
validation using clinically verified events was only carried out for the subset of 
Whitehall II participants in whom there was a suggestion of a CHD event. Therefore 
sensitivity and specificity could not be calculated. 
In order to assess the impact that also false negatives could have on the results, a 
deterministic sensitivity analysis (Greenland, 1996) is performed. In a deterministic 
sensitivity analysis the idea is to back-calculate the data that would have been observed 
without bias, assuming several pairs of sensitivity and specificity. The sensitivity and 
specificity values reported in Table 5.1 come from studies that are not directly 
comparable with the ELSA sub-sample used in this thesis. However, results from these 
studies can suggest educated values of specificity and sensitivity. For example, all 
studies found higher specificity than sensitivity; the lowest sensitivity value among 
those reported in Table 5.1 was 60%. The population with age range similar to ELSA 
was the one used by Yamagishi et al. (2009) and they found a sensitivity of self-reported MI 
equal to 82%. For the deterministic sensitivity analysis two values of sensitivity (60% 
and 80%) and two values of specificity (90% and 95%) are used. All possible 
combinations of these values are calculated to create four scenarios (scenario 1: 
sensitivity 60% and specificity 90%; scenario 2: sensitivity 60% specificity 95%; 
scenario 3: sensitivity 80% and specificity 90%; scenario 4: sensitivity 80% and 
specificity 95%) under which the prevalence of CHD in ELSA is modified.  
Even a very simple sensitivity analysis can shed light on the robustness of the results 
presented in Chapter 4. It is hypothesised that the self-report measure of CHD is a 
reliable alternative when clinical assessment is not available and therefore the results 
will not draw different conclusions. 
 
5.2 Sensitivity analysis based on Whitehall II validation study 
5.2.1 Methods 
The Whitehall II study 
 
Whitehall II is a longitudinal study of 10,308 women and men, all of whom were 
employed in the London offices of the British Civil Service at the time they were 
recruited to the study in 1985. The baseline survey (phase 1) included a clinical 
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examination. Since then, ten phases of data collection have been completed, of which 
every odd-numbered phase has included a medical examination in addition to a 
questionnaire. The Whitehall II study was set up with the explicit purpose of testing 
hypotheses as to the causes of the social gradient in cardiovascular and other diseases 
(Marmot and Brunner, 2005; Marmot et al., 1991). For the purpose of the sensitivity 
analysis and matching the sample with ELSA, phase 7 data are used. This phase 
includes the questionnaire and a clinical screening carried out between 1
st
 of October 
2002 and 30
th
 of September 2004, when participants were aged 50 to 74. The sample 
size at phase 7 was 6,761 (66% of Phase 1 responders). 
Measures 
 
In the phase 7 (2003-2004) questionnaire, participants were asked the following 
questions: “Since 2001 has a doctor told you that you have had angina?” and “Since 
2001 has a doctor told you that you have had a heart attack?”. From these questions I 
derived self-reported doctor diagnosed CHD (which occurred on average two years 
preceding the phase 7 interview). A variable on validated CHD events was already 
available in the data set and it was derived by the Whitehall II team. Briefly, CHD 
diagnosis was based on clinically verified events. Non-fatal myocardial infarction was 
defined following MONICA (MONItoring of trends and determinants in 
CArdiovascular disease Project) criteria based on questionnaires, study 
electrocardiograms, hospital acute electrocardiograms (ECGs), cardiac enzymes and 
physician records (Britton and Shipley, 2010).  Angina was assessed on the basis of 
participants’ reports of symptoms and diagnoses with corroboration in medical records 
or abnormalities on a resting ECG, exercise ECG or coronary angiogram. Classification 
was carried out independently by two trained coders, with adjudication in the event of 
disagreement (Britton and Shipley, 2010).  
Only positive self-reported cases of CHD could be verified, since follow-up of clinical 
records and validation using clinically verified events was only carried out for the 
subset of Whitehall II participants in whom there was a suggestion of a CHD event.  
Additional measures used for this sensitivity analysis were age and educational 
attainment based on years of full time education. 
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Data analysis 
 
First, the age and education adjusted prevalence of self-reported CHD in the two years 
preceding the interview was calculated for Whitehall II and for ELSA (Table 5.2). 
Using a direct standardisation method, with the standards being the age and education 
distribution of ELSA at wave 1, the analysis was restricted to participants aged up to 74 
in order to make the standardisation sample comparable to that of Whitehall II. Since it 
was not possible to create a similar Well group in the Whitehall II data, for comparison 
purposes the prevalence of CHD in ELSA reported in this Table is the proportion of 
those reporting CHD in the two years preceding the interview over the total of the 
population (aged up to 74 n=9,347). Among participants of Whitehall II study, the 
adjusted prevalence of those reporting having had a CHD event in the two years 
preceding the interview was about half that of ELSA (Table 5.2).  
 
 
 
 
 
 
 
 
 
 
Second, the prevalence of both true positives (correctly self-reported CHD) and false 
positives (incorrectly self-reported CHD) was calculated based on the validation of 
CHD in Whitehall II. A logistic regression was performed in order to explore the factors 
associated with the false positives in Whitehall II (Table A5.1 in appendix). In 
Whitehall II, gender was not associated with higher odds of reporting a false CHD 
diagnosis; older age (p<0.001) and lowest educational level (compared to highest 
p<0.05) were both associated with higher odds of reporting a false CHD diagnosis. 
Table 5.2 Unadjusted and adjusted prevalence of self-reported 
CHD in ELSA and Whitehall II (age range 50 to 74) 
 No CHD CHD 
 % (95% CI) % (95% CI) 
Unadjusted    
ELSA
a
 93.1 (92.5, 93.6) 6.9 (6.4, 7.5) 
N 8,697 650 
Whitehall II 97.3 (96.9, 97.6) 2.7 (2.4, 3.1) 
N 6,717 189 
Adjusted
b
   
ELSA
a
 93.0 (92.5, 93.5) 7.0 (6.5, 7.5) 
N 8,680 653 
Whitehall II 96.6 (95.7, 97.3) 3.4 (23.1, 28.2) 
N 4, 938 174 
a   ELSA whole sample at wave 1 (not restricted to CHD and Well 
group). b  Age and education-standardised figures using ELSA wave 1 
as standard population. 
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Participants of Whitehall II are white-collar civil servants, therefore results are usually 
affected by the healthy worker effect at baseline (Ferrie et al., 2009). To partly adjust 
for the age and education influence on self-reported CHD true positive and false 
positive were standardised for age and education.  
To quantify the impact of self-reported CHD misclassification bias on the parameter 
estimates obtained from the random intercept models reported in Chapter 4, the age and 
education adjusted prevalence of false positive in Whitehall II (see Table 5.3 in results) 
was applied to each of the ELSA imputed data sets (5 data sets). These data sets were 
re-analysed under two possible scenarios. The first scenario assumes that the number of 
falsely reporting CHD is a random sample of people of the whole population; therefore 
the incorrect diagnosis occurred randomly and did not depend on CHD status. Using 
this definition gives 17% of people in the CHD group misreporting their status (see 
Appendix 5.1 for a detailed description of how the prevalence is derived). 
The second scenario is more realistic and assumes that the number of those incorrectly 
reporting self-reported CHD is a random sample of people in the self-reported CHD 
population. Using this definition gives 35% of people in the CHD group misreporting 
their status (see Appendix 5.1 for a detailed description of how the prevalence is 
derived). 
To introduce some randomness in the alteration of the CHD prevalence in ELSA, 
random uniform numbers were generated (Appendix 5.1). The prevalence of people 
with CHD was altered in each imputed data set according to scenario 1 and to scenario 2 
as follows: people with a self-reported CHD diagnosis were recoded as not having CHD 
if the random number was less than or equal to 0.17 for scenario 1 and less than or equal 
to 0.35 for scenario 2 (see Appendix 5.2 for a Stata code of how the numbers were 
generated and recoded). The newly derived prevalence of individual reports of CHD 
was then used to estimate random intercept models (based on 5 imputed data sets) 
described in chapter 4. For comparison, the results from imputed data sets reported in 
chapter 4 were re-analysed limiting the upper age to 74. For simplicity, results are 
shown only for the main parameters of interest and omitted for covariates. 
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Evaluation criterion   
 
To quantify to what extent the results obtained from the ELSA original sample are 
similar to those which are obtained under the two scenarios, I used bias for assessments 
of the potential accuracy.  
Bias: )
ˆ(    which is the difference between the estimate obtained from the original 
ELSA data and the estimate obtained under one of the two scenarios.  
 
5.2.2 Results 
Self-reported CHD and validation 
 
Table 5.3 reports the age and education standardised prevalence of true positive and 
false positive cases of self-reported CHD in Whitehall II participants. About 2% of 
people in the sample correctly reported a CHD diagnosis (70% of those who self-
reported CHD). About 30% of those who self-reported a CHD event did not have their 
diagnosis confirmed by a clinical screening or medical record (1% of the total sample).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.4 shows the unadjusted prevalence of CHD among ELSA people aged up to 74, 
comparing the original data with the data obtained under scenario 1 and scenario 2. The 
results are combined from the 5 imputed data sets. The original prevalence of self-
reported CHD was 17.2%. Under scenario 1 this prevalence decreased to 14.3%. Under 
scenario 2 there is a lower prevalence of people with CHD (11.3%) compared to 
Table 5.3 Adjusted
a
 prevalence of validated CHD in 
Whitehall II 
 %  (95% CI) 
No CHD 96.6 (95.7, 97.3) 
N  4,938 
True positive 2.2 (1.7, 2.9) 
N  113 
False positive 1.2 (0.8, 1.8) 
N 61 
 
a Age and education-standardised figures using ELSA as 
standard population. Age range 50 to 74 
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scenario 1 and the original data and consequently a higher prevalence of people in the 
Well group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sensitivity analysis of quality of life models 
 
Table 5.5 shows the results of the linear random intercept model of quality of life of the 
original ELSA data compared to the results obtained under scenario 1 and scenario 2. 
The results in the first column of Table 5.5 differ slightly from those reported in chapter 
4, Table 4.3, due to the sample being restricted to those aged of 74 or younger at 
baseline. The main difference compared with the results based on the whole sample 
(aged 50 and over) is that the interaction term between CHD and gender in Table 5.5 
was no longer statistically significant. Results from scenario 1, compared to the original 
results of ELSA were quite similar for the coefficient for gender and the interaction 
term, while the coefficient for CHD has decreased in magnitude (-1.57 for the original 
data and -1.49 for scenario 1). Overall, the potential accuracy of the original estimates 
under the first scenario was good. Assuming that false positives is a random sample of 
the whole population led in general to smaller parameter estimates. Under scenario 2, 
the coefficient for CHD decreased in magnitude, compared to the coefficient from the 
original ELSA data (-1.37 and -1.57 respectively), but the standard error was larger. The 
coefficient for gender was slightly bigger compared to the coefficient for the original 
Table 5.4 Prevalence of self-reported CHD in ELSA 
(imputed data) 
 Well group CHD group 
 %  %  
ELSA original data 
(95% CI) 
82.8 
(82.1,83.5) 
17.2 
(16.5,17.9) 
Scenario 1
a
 
(95% CI) 
85.7 
(84.6,86.9) 
14.3 
(13.1,15.4) 
Scenario 2
 b
 
(95% CI) 
88.9 
(87.7, 89.9) 
11.1 
(9.8, 12.3) 
Figures based on 5 imputed data sets. Age range 50 to 74.  
a False positives is a random sample of people of the whole 
population. b False positives is a random sample of people of 
the self-reported CHD population 
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ELSA data, but the standard errors were the same. The coefficient for the interaction 
term and its standard error decreased in magnitude (0.47 in the original data and 0.36 in 
scenario 2).  The baseline values of quality of life (constant) obtained under the two 
scenarios were almost identical to the original data. Conclusions about the gender 
specific relationships between CHD and quality of life did not change according to 
results from scenario 1 and scenario 2.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.6 reports the results of the linear random intercept model for quality of life with 
time among people with CHD, comparing the results from the original ELSA data with 
those obtained under scenario 1 and scenario 2. Results in the first column of Table 5.6 
differ from those reported in Chapter 4, Table 4.4, in that the interaction term between 
wave 3 and gender was significant in the analysis based on the sample restricted to the 
age of 74 or less, meaning that there was a significant gender difference in the rate of 
change in quality of life. The potential accuracy of the original estimates under the first 
scenario was good, as shown by the small values of bias. Standard errors were a bit 
larger than those presented in the first column. However, under this scenario it was not 
Table 5.5 Sensitivity analysis of the linear random intercept model for 
quality of life, sample aged up to 74 (imputed data) 
 ELSA original Scenario 1a 
 
Scenario 2
 b
 
 Coef. 
Std. 
Err. Coef. 
Std. 
Err. Coef. 
Std. 
Err. 
       
CHD -1.57 0.31 -1.49 0.37 -1.37 0.40 
   Bias   -0.08  -0.19  
Gender 0.56 0.20 0.60 0.20 0.65 0.20 
   Bias   -0.04  -0.08  
CHD*Gender 0.47 0.47 0.43 0.57 0.36 0.78 
   Bias   0.04  0.11  
Constant 47.36 0.24 47.32 0.24 47.27 0.24 
   Bias   0.04  0.09  
a False positives is a random sample of people of the whole population. b False 
positives is a random sample of people of the self-reported CHD population. 
Results adjusted for gender, age, marital status, employment status, educational 
attainment, wealth, smoking status, alcohol consumption, physical activity, pain, 
ADLs, depressive symptoms, positive support and number of close friends.  
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found that women had significantly higher quality of life than men at four year follow-
up (wave 3). Result that contradicted the finding based on the original ELSA data.   
Under scenario 2, the parameter estimates for gender, wave 3 and the interaction term 
between gender and wave 2 were smaller than those obtained from the original data. 
However, the constant was slightly higher than that obtained from the original data. 
Therefore, if the false positives cases are assumed to be a random sample of the CHD 
population the levels of quality of life at each wave found in the original results would 
be slightly lower for both men and women. Also, under scenario 2 the coefficient for 
wave 2 (two year follow-up) was not statistically significant; suggesting that compared 
to baseline (wave 1) the quality of life of men was not significantly lower. This means 
that misclassification might introduce type I error (which occurs when the null 
hypothesis is wrongly rejected). For women under scenario 2, quality of life also did not 
change significantly at wave 3 (four year follow-up). Lastly, under this scenario the 
quality of life of women with CHD at wave 2 (two year follow-up) was not significantly 
higher than that of men. 
 
Table 5.6 Sensitivity analysis of the linear random intercept model for quality of life 
with time, people with CHD aged up to 74 (imputed data) 
 ELSA original Scenario 1a 
 
Scenario 2
 b
 
 Coef. 
Std. 
Err. Coef. 
Std. 
Err. Coef. 
Std. 
Err. 
       
Gender 0.30 0.59 0.31 0.73 0.15 0.87 
   Bias   0.00  0.16  
Wave 2 -1.05 0.42 -1.04 0.49 -0.97 0.66 
   Bias   -0.01  -0.08  
Wave 3 -3.01 0.44 -3.01 0.53 -2.89 0.60 
   Bias   0.00  -0.12  
Wave 2*Gender 1.16 0.63 1.20 0.72 1.02 1.01 
   Bias   -0.04  0.14  
Wave 3*Gender 1.77 0.63 1.72 0.79 1.85 0.89 
   Bias   0.05  -0.08  
Constant 47.76 0.71 47.74 0.79 47.88 1.27 
   Bias   0.02  -0.12  
a False positives is a random sample of people of the whole population. b False positives is 
a random sample of people of the self-reported CHD population. Results adjusted for 
gender, age, marital status, employment status, educational attainment, wealth, smoking 
status, alcohol consumption, physical activity, pain, ADLs, depressive symptoms, positive 
support and number of close friends. 
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Table 5.7 shows the results of the linear random intercept model for quality of life with 
time among people from the Well group, comparing the results from the original ELSA 
data with those obtained under scenario 1 and scenario 2. The results in the first column 
of Table 5.7 differ slightly from those reported in Chapter 4, Table 4.5, due to the age of 
the sample being restricted to less than 74, but conclusions are the same. For the Well 
group, the results obtained under scenario 1 were very similar to those of the ELSA 
original data, and standard errors were the same. Bias values obtained under scenario 1 
were small. This implies that changing the Well population by adding those people with 
a false positive CHD diagnosis did not change quality of life trajectories in this group, 
under scenario 1. Under scenario 2 values of bias were small and standard errors were 
the same as the ELSA original data. However, results obtained under this scenario 
suggest that the coefficient for gender was underestimated in the original data, but the 
constant was slightly higher.  
 
Table 5.7 Sensitivity analysis of the linear random intercept model for quality of life 
with time,  people from the Well group aged up to 74 (imputed data) 
 ELSA original Scenario 1a 
 
Scenario 2
 b
 
 
Coef. Std. 
Err. 
Coef. Std.  
Err. 
Coef. Std. 
Err. 
Gender 0.24 0.24 0.27 0.24 0.35 0.25 
   Bias   -0.03  -0.10  
Wave 2 -1.15 0.19 -1.14 0.19 -1.13 0.19 
   Bias   -0.01  -0.02  
Wave 3 -2.81 0.19 -2.79 0.19 -2.80 0.19 
   Bias   -0.01  -0.01  
Wave 2*Gender 0.47 0.25 0.48 0.25 0.50 0.25 
   Bias   -0.01  -0.03  
Wave 3*Gender 0.40 0.25 0.45 0.25 0.45 0.25 
   Bias   -0.05  -0.05  
Constant 48.82 0.27 48.79 0.27 48.72 0.28 
   Bias   0.03  0.09  
a False positives is a random sample of people of the whole population. b False positives 
is a random sample of people of the self-reported CHD population. Results adjusted for 
gender, age, marital status, employment status, educational attainment, wealth, smoking 
status, alcohol consumption, physical activity, pain, ADLs, depressive symptoms, positive 
support and number of close friends. 
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Sensitivity analysis of depressive symptoms models 
 
Table 5.8 shows the results of the logistic random intercept model for depressive 
symptoms of the original ELSA data compared to the results obtained under scenario 1 
and scenario 2. Although results restricted to age 74 or less showed in the first column 
of Table 5.8 are similar to those reported in chapter 4, Table 4.6, conclusions were the 
same. Results of the sensitivity analysis showed little change in the log odds under 
either scenario 1 or scenario 2, compared to ELSA original data. Also the values of the 
bias were all small, suggesting good potential accuracy. The coefficients for CHD were 
not statistically significant under scenarios 1 and 2, contradicting that obtained in the 
ELSA original data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results of the logistic random intercept model for depressive symptoms with time 
among people with CHD are reported in Table 5.9, where comparisons of results from 
the original ELSA data with those obtained under scenario 1 and scenario 2 are 
presented. In this restricted age sample it was not found that women with CHD were 
significantly less likely to have depressive symptoms at four year follow-up compared 
to baseline (see Table 4.8). The rest of the results led to the same conclusions. The 
parameter estimates for gender, wave 2 and wave 3 obtained from the ELSA original 
Table 5.8 Sensitivity analysis of the logistic random intercept model for 
depressive symptoms, sample aged up to 74 (imputed data) 
 ELSA original Scenario 1a 
 
Scenario 2
 b
 
 Coef. 
Std. 
Err. Coef. 
Std. 
Err. Coef. 
Std. 
Err. 
       
CHD 0.35 0.16 0.30 0.19 0.31 0.25 
   Bias   0.05  -0.01  
Gender 0.73 0.11 0.72 0.11 0.70 0.11 
   Bias   0.01  0.01  
CHD*Gender -0.14 0.23 -0.12 0.27 -0.10 0.41 
   Bias   -0.02  -0.02  
a False positives is a random sample of people of the whole population. b False 
positives is a random sample of people of the self-reported CHD population. 
Results adjusted for gender, age, marital status, employment status, educational 
attainment, wealth, smoking status, alcohol consumption, physical activity, 
pain, ADLs, positive support and number of close friends. Results presented as 
log odds. 
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data would be overestimated if we assume that 17% of people with CHD falsely 
reported their disease (scenario 1), as suggested by the values of the bias. The parameter 
estimates of the interaction terms were not very different. Instead, if we assume that 
35% of people with CHD misreported their disease status, then the results obtained 
from the ELSA original data for gender and wave 2, and the interaction term between 
gender and wave 2 would be underestimated and that of the interaction term between 
wave 3 and gender would be overestimated. Standard errors obtained under scenario 1 
and scenario 2 were larger than those of the original data.  
In terms of the conclusions, the most important difference was that under scenario 2, the 
log odds for gender were no longer statistically significant, implying that women with 
CHD were not at higher risk of having depressive symptoms than men at baseline. Also 
at wave 2 (two year follow-up) women did not have significantly higher odds of 
reporting depressive symptoms than men, result that was not found in the original data. 
 
Table 5.10 shows the results of the logistic random intercept model for depressive 
symptoms with time among people in the Well group, comparing the results from the 
original ELSA data with those obtained under scenario 1 and scenario 2. The log odds 
and standard errors of the parameter estimates under scenario 1 were very close if not 
Table 5.9 Sensitivity analysis of the logistic random intercept model for depressive 
symptoms with time, people with CHD aged up to 74 (imputed data) 
 ELSA original Scenario 1a 
 
Scenario 2
 b
 
 Coef. 
Std.  
Err. Coef. 
Std.  
Err. Coef. 
Std.  
Err. 
       
Gender 0.71 0.28 0.65 0.33 0.76 0.47 
   Bias   0.06  -0.11  
Wave 2 0.09 0.24 0.04 0.26 0.22 0.35 
   Bias   0.05  -0.18  
Wave 3 0.06 0.25 -0.05 0.28 -0.01 0.44 
   Bias   0.11  -0.04  
Wave 2*Gender -0.02 0.34 0.01 0.39 -0.17 0.50 
   Bias   -0.04  0.18  
Wave 3*Gender -0.44 0.35 -0.29 0.40 -0.39 0.62 
   Bias   -0.15  0.11  
a False positives is a random sample of people of the whole population. b False positives 
is a random sample of people of the self-reported CHD population. Results adjusted for 
gender, age, marital status, employment status, educational attainment, wealth, smoking 
status, alcohol consumption, physical activity, pain, ADLs, positive support and number 
of close friends. Results presented as log odds. 
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the same as those of the original data. Under scenario 2, all the coefficients were smaller 
than those of the original data (except that of the interaction term between wave 3 and 
gender), also the standard errors were very similar. Conclusions remained unchanged 
under both scenarios.  
 
 
 
 
5.2.3 Summary of results 
 
The results of the sensitivity analysis of trajectories of quality of life presented in Tables 
5.6 and 5.7 are summarised graphically in Figure 5.1 for the CHD group and 5.2 for the 
Well group. The graphs provided a better insight on how biased the trajectories of 
quality of life might have been under different assumptions about misclassification. 
Assuming that 17% of people with CHD (scenario 1 where the false positives was 
assumed to be a random sample of the total population) misreported their status (and 
therefore they should have been classified as not having CHD) did not change the 
trajectories of quality of life of men with CHD (top part of Figure 5.1). Trajectories of 
Table 5.10 Sensitivity analysis of the logistic random intercept model for depressive 
symptoms with time, people from the Well group aged up to 74 (imputed data) 
 Elsa original Scenario 1
a
 
 
Scenario 2
 b
 
 Coef. Std. Err. Coef. Std. Err. Coef. Std. Err. 
       
Gender 0.84 0.15 0.84 0.14 0.80 0.14 
   Bias   0.00  0.04  
Wave 2 0.22 0.14 0.22 0.13 0.17 0.13 
   Bias   0.00  0.05  
Wave 3 -0.03 0.14 -0.01 0.14 -0.02 0.14 
   Bias   -0.03  0.02  
Wave 2*Gender -0.29 0.17 -0.29 0.17 -0.24 0.17 
   Bias   0.00  -0.05  
Wave 3*Gender -0.01 0.18 -0.06 0.17 -0.05 0.18 
   Bias   0.05  -0.01  
a False positives is a random sample of people of the whole population. b  False positives is a 
random sample of people of the self-reported CHD population. Results adjusted for gender, 
age, marital status, employment status, educational attainment, wealth, smoking status, alcohol 
consumption, physical activity, pain, ADLs, positive support and number of close friends. 
Results presented as log odds. 
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quality of life under scenario 1 overlapped with those found from the original data. If it 
was assumed that 35% of people in the CHD group falsely self-reported their disease 
status (scenario 2 where the false positives is assumed to be a random sample of the 
CHD population), the trajectories of quality of life of men obtained from the original 
data would be slightly underestimated. In fact, under scenario 2, the shape of trajectories 
of quality of life of men with CHD was the same as in the original data, but levels of 
quality of life were slightly higher at each wave (0.1 at wave 1, 0.2 at wave 2 and 0.3 at 
wave 3). 
 
The shape of trajectories of quality of life of women with CHD did change according to 
the first scenario, and the levels of quality of life were higher at years two (0.8) and four 
of follow-up (0.7), than those obtained in the original data, but conclusions were the 
same as those obtained from the original data: women’s quality of life was stable 
between baseline and two year follow-up (non-significant small decrease) and then 
decreased significantly at four year follow-up. 
 
Under scenario 2, women’s quality of life was stable between baseline and two year 
follow-up (wave 2) and then decreased slightly at four year follow-up (wave 3) but the 
change over time was not significant. Also at years two and four of follow-up the levels 
of quality of life were higher than those obtained from the original data (1.1 and 1.3 
respectively). This means that if instead of assuming that people with CHD correctly 
self-report their disease status, we assume that about 35% of them self-reported their 
disease status incorrectly, women’s trajectories of quality of life would be different. 
Women with CHD would not have decreased quality of life over time.  
 
As for gender differences in quality of life, the finding of higher quality of life in 
women with CHD compared to men at four year follow-up could not be replicated 
under scenario 1 and that of higher quality of life at two year follow-up could not be 
replicated under scenario 2. 
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Figure 5.1 Sensitivity analysis of trajectories over time of quality of life for men 
and women with CHD, aged up to 74 (imputed data) 
 
 
 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends. Age range 50 to 74. 
 
From figure 5.2 we can see that the trajectories of quality of life of people from the Well 
obtained from the original data are quite robust, therefore the results for the Well group 
are not biased by false positives. 
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Figure 5.2 Sensitivity analysis of trajectories over time of quality of life for men 
and women from the Well group, aged up to 74 (imputed data) 
 
 
 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends. Age range 50 to 74. 
 
 
Results of the trajectories of depressive symptoms presented in Tables 5.9 and 5.10 are 
presented graphically as odds ratios in Figure 5.3 for the CHD group and figure 5.4 for 
the Well group. The graphs showed that for men and women with CHD trajectories of 
depressive symptoms obtained from the original data and those obtained under 
scenarios 1 and 2 led to the same conclusions (Figure 5.3). However, under scenario 2 
women with CHD were not more likely than men to have depressive symptoms at any 
point in time. Also under this scenario the confidence intervals of the odds ratios for the 
CHD group are larger than those of the original data.  
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The ELSA original results obtained for the Well group were quite robust, as shown in 
figure 5.4. 
 
Figure 5.3 Sensitivity analysis of trajectories over time of depressive symptoms, for 
men and women with CHD, aged up to 74 (imputed data) 
 
 
 
Scenario 1: False positives is a random sample of people of the whole population. Scenario 2:  
False positives is a random sample of people of the self-reported CHD population. Results 
adjusted for gender, age, marital status, employment status, educational attainment, wealth, 
smoking status, alcohol consumption, physical activity, pain, ADLs, positive support and 
number of close friends. Results presented as odds ratios. 
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Figure 5.4 Sensitivity analysis of trajectories over time of depressive symptoms, for 
men and women from the Well group, aged up to 74 (imputed data)  
 
 
 
Scenario 1: False positives is a random sample of people of the whole population. Scenario 2:  
False positives is a random sample of people of the self-reported CHD population. Results 
adjusted for gender, age, marital status, employment status, educational attainment, wealth, 
smoking status, alcohol consumption, physical activity, pain, ADLs, positive support and 
number of close friends. Results presented as odds ratios. 
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5.3 Deterministic sensitivity analysis 
 
In the previous sensitivity analysis an external validation study was used to estimate 
misclassification probabilities and to assess the impact of bias due to false positives. 
However, from the validation study it was not possible to obtain values of sensitivity 
and specificity. In order to address the impact that misclassification error has, not only 
on the false positive cases of CHD but, also on the false negative cases of CHD a 
deterministic sensitivity analysis is conducted. In a deterministic sensitivity analysis it is 
estimated what the true parameter estimate(s) would be in light of the observed data and 
some level of hypothetical bias. Deterministic sensitivity analysis can be seen as a series 
of educated guesses about the bias parameters (Greenland 1996). The idea is to back-
calculate the data that would have been observed without bias, assuming several pairs of 
rates of sensitivity and specificity.  
5.3.1 Methods 
 
Two values of sensitivity equal to 60% and 80% and two values of specificity equal to 
90% and 95% are used. All the possible combinations of these values are calculated to 
create the followings four scenarios: 
 scenario A: sensitivity 60% and specificity 90%;  
 scenario B: sensitivity 60% specificity 95%;  
 scenario C: sensitivity 80% and specificity 90%;  
 scenario D: sensitivity 80% and specificity 95%. 
The variable representing CHD status was manipulated according to the four scenarios 
described above. To introduce some randomness in the alteration of the variable, 
random uniform numbers were generated (appendix 5.3). Four new variables for CHD 
status were obtained in each imputed data set according to the each scenarios as follows: 
for scenario A cases from the CHD category were moved into the Well group if the 
random uniform number was less or equal than 0.40 and cases from the Well group 
were moved into the CHD category if the random uniform number was less or equal 
than 0.10; as for scenario A cases were moved if the probabilities were ≤0.40 and ≤0.05 
for scenario B; ≤0.20 and ≤0.10 for scenario C; and ≤0.20 and ≤0.05 for scenario D. 
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Each newly derived variable for CHD was then used to estimate random intercept 
models (based on 5 imputed data sets) described in chapter 4. 
 
Evaluation criterion   
 
To quantify to what extent the results obtained from the ELSA original sample and 
those obtained under the two scenarios are similar I used the bias for the assessments of 
potential accuracy defined in section 5.2.1. 
 
5.3.2 Results 
 
Table 5.11 reports the pooled prevalence (based on 5 imputed data sets) of self-reported 
CHD obtained under each scenario. Scenario A assumed that the sensitivity (someone 
correctly classified as having CHD) was 60% and the specificity (someone correctly 
classified as not having CHD) was 90% which gave a prevalence of CHD equal to 
19.2% very similar to the original prevalence (19.9%). This could be explained by the 
similar number of people misclassified in the CHD and Well group (40% of 895= 358 
CHD and 10% of 3601=360 Well group). Holding the sensitivity constant (to 60%) and 
changing the specificity to a higher value (95%) led to a lower prevalence of CHD 
(15.9%) compared to the original data (scenario B). The prevalence was lower under 
scenario B because only 5% of people in the Well group were wrongly classified as 
being healthy while a greater number of people with CHD were misclassified as having 
the disease. Assuming a sensitivity of 80% and a specificity of 90% (scenario 3) led to a 
prevalence of CHD that was almost 4 percentage points higher than that of the original 
data. A sensitivity of 80% assumed that a higher number of people with CHD were 
correctly classified as having the disease compared to a sensitivity of 60%. Therefore 
under this scenario the number of healthy people wrongly classified was higher than the 
number of people wrongly classified as having CHD. The last scenario was probably 
the most realistic one, where the sensitivity and specificity were highest reflecting 
results found from most of the studies in the literature. Sensitivity set at 80% and 
specificity set at 95%, led to a prevalence of CHD equal to 21.3%, very close to the 
ELSA original prevalence. 
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Deterministic sensitivity analysis of quality of life models 
 
Table 5.12 shows the results of the deterministic sensitivity analysis of the linear 
random intercept model for quality of life with the interaction term between CHD and 
gender. The four scenarios were compared with the original results reported in chapter 
4. The coefficient for CHD changed from -2.00 to -1.12 under scenario A, to -1.38 
under scenario B, to -1.35 under scenario C and to -1.65 under scenario D.  This implied 
that the difference between men from the Well group and men with CHD in quality of 
life (adjusted) was larger in the ELSA original data where it was assumed that no 
misclassification of the self-reported CHD occurred. 
 
The coefficient for gender increased in magnitude under scenarios A, B and C compared 
to the original data (0.41). These results mean that the difference in quality of life 
between men with CHD and men from the Well group obtained in the original results 
would be overestimated. 
 
Under scenario A the coefficient for the interaction term was about a third of that of the 
original data: if there had been misclassification the difference in quality of life between 
men and women from the Well group changed from 0.98 in the original results to 0.32 
under scenario A. Under scenario B and C the coefficients for the interaction term were 
Table 5.11 Corrected prevalence of the self-reported CHD under 
various assumptions about the CHD sensitivity (Se) and specificity 
(Sp) (imputed data) 
 
Well group CHD group 
 % (95% CI)  % (95% CI )  
   
ELSA  
 
80.1 (79.4, 80.8) 19.9 (19.2, 20.6) 
ScenarioA 
Se: 60% Sp: 90% 
80.8 (80.1, 81.4) 19.2 (18.6, 19.9) 
Scenario B
 
 
Se: 60% Sp: 95% 
84.1 (83.5, 84.8) 15.9 (15.2, 16.5) 
Scenario C 
Se: 80% Sp: 90% 
76.2 (75.5, 76.9) 23.8 (23.1, 24.5) 
Scenario D
 
 
Se: 80% Sp: 95% 
79.8 (79.1, 80.5) 20.2 (19.5, 20.9) 
Figures based on the sample aged 50 and over. 
 206 
 
also lower than that obtained from the original data. Therefore the difference in quality 
of life between men and women from the Well group would be slightly overestimated in 
the original data.  
 
Assuming highest values of sensitivity and specificity (scenario D) gave similar results 
to those obtained from the original data (with the exception of value of the interaction 
term which was larger under scenario D). This scenario showed that the results obtained 
from the original data could possibly be underestimated. 
 
 
 Table 5.12 Deterministic sensitivity analysis of the linear random intercept model for 
quality of life with time (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
CHD -2.00 0.27 -1.12 0.28 -1.38 0.30 -1.35 0.26 -1.65 0.27 
Bias   -0.88  -0.62  -0.65  -0.35  
Gender 0.41 0.19 0.62 0.18 0.56 0.18 0.50 0.19 0.39 0.19 
Bias   -0.21  -0.15  -0.09  0.02  
CHD*gender 0.98 0.40 0.32 0.41 0.78 0.44 0.76 0.38 1.30 0.40 
Bias   0.65  0.20  0.21  -0.32  
Constant 47.69 0.22 47.60 0.22 47.59 0.22 47.69 0.22 47.71 0.22 
Bias   0.09  0.10  0.00  -0.02  
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and 
specificity 95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 
80% and specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends and family. Figures based on the 
sample aged 50 and over. 
 
 
The results of the deterministic sensitivity analysis of the linear random intercept model 
of quality of life with and interaction term between gender and time for the CHD group 
are presented in Table 5.13. Under scenarios A and B the coefficients for gender 
changed from 0.86 to 0.38 and 0.64 respectively, meaning that the difference in quality 
of life at baseline between men and women with CHD was overestimated in the original 
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results. However, under scenarios C and D the coefficients for gender increased in 
magnitude and became significant. Therefore if sensitivity of 80% was assumed 
together with specificity values of 90% and 95% it would be concluded that women 
with CHD had significantly higher quality of life than men at baseline, a result that was 
not found in the original data. Under scenarios A, B and C the coefficients for wave 2 
increased in magnitude compared to the original data, however conclusions remained 
the same (men having lower quality of life at wave 2 compared to wave 1). Under 
scenario D, the coefficient for wave 2 became smaller and was no longer significant. 
Under all four scenarios the coefficients for wave 3 were similar to the coefficient for 
the original data and conclusions were the same (men had lower quality of life at wave 3 
compared to wave 1). The values of the interaction terms would be overestimated in the 
original data, compared to those obtained under the four scenarios. One exception was 
for the interaction term between wave 2 and gender obtained under scenario B which 
was larger than that of the original data and also statistically significant. This implied 
that assuming the lowest value of sensitivity and highest value of specificity led to a 
significant difference between men and women with CHD in the rate of change of 
quality of life at wave 2, a result that was not found in the original data. 
 
The baseline quality of life of men with CHD (constant) was higher under scenarios A, 
B, and C compared to the original data and slightly lower under scenario D.  For women 
the baseline quality of life was lower in the original data compared to scenarios A, C 
and D, but slightly higher compared to scenario B. 
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Table 5.13  Deterministic sensitivity analysis of the linear random intercept model for 
quality of life with time, people with CHD (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
Gender 0.83 0.50 0.38 0.50 0.64 0.54 1.11 0.44 1.39 0.48 
 Bias   0.46  0.19  -0.28  -0.56  
Wave 2 -0.84 0.36 -1.46 0.37 -1.16 0.41 -1.04 0.33 -0.67 0.36 
 Bias   0.62  0.32  0.20  -0.17  
Wave 3 -2.73 0.37 -2.91 0.37 -2.61 0.42 -2.93 0.34 -2.48 0.36 
 Bias   0.18  -0.13  0.20  -0.25  
Wave 
2*Gender 
0.98 0.53 0.88 0.52 1.32 0.59 0.26 0.47 0.72 0.52 
 Bias   0.10  -0.33  0.72  0.26  
Wave 
3*Gender 
0.98 0.53 0.74 0.52 0.69 0.59 0.31 0.47 0.64 0.52 
 Bias   0.25  0.29  0.67  0.35  
Constant 47.38 0.64 48.75 0.58 47.21 0.67 48.18 0.53 47.42 0.59 
Bias   -1.37  0.17  -0.80  -0.04  
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 
95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and 
specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends and family. Figures based on the sample 
aged 50 and over. 
 
 
The results of the deterministic sensitivity analysis of trajectories of quality of life for 
the Well group are presented in Table 5.14. Results obtained under scenarios A and B 
showed that the difference in baseline quality of life of men and women from the Well 
group would be higher than that found from the original data and also statistically 
significant. Under scenario C the coefficient for gender was very similar to that of the 
original data (0.27 and 0.24 respectively); under scenario D the coefficient was slightly 
lower (0.16). Like in the original data, scenario C and D reported non-significant gender 
difference in baseline quality of life. Coefficients of wave 2 and wave 3 were slightly 
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higher under scenarios A, B, and C and slightly lower under scenario D compared to the 
original data. However, conclusions remain unchanged. Smallest values of bias were 
found under scenarios C and D, suggesting that when the sensitivity is highest, the 
results of the original data tend to be more robust. Interaction terms of the original data 
were slightly overestimated according to scenarios A and B and slightly underestimated 
according to scenarios C and D, however conclusions were the same. Standard errors 
were all very similar to those obtained from the original data.  
 
The baseline quality of life of men from the Well group slightly decreased compared to 
the original data. The baseline quality of life of women from the Well group was almost 
the same under the four scenarios as that obtained from the original data.  
 
Table 5.14 Deterministic sensitivity analysis of the linear random intercept model for quality 
of life with time, people from the Well group (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
Gender 0.24 0.23 0.52 0.23 0.45 0.22 0.27 0.23 0.16 0.23 
 Bias   -0.28  -0.21  -0.03  0.08  
Wave 2 -1.11 0.18 -0.90 0.18 -0.97 0.17 -1.05 0.18 -1.16 0.18 
 Bias   -0.21  -0.13  -0.06  0.05  
Wave 3 -2.88 0.18 -2.76 0.18 -2.82 0.18 -2.78 0.18 -2.93 0.18 
 Bias   -0.12  -0.06  -0.10  0.05  
Wave 2*Gender 0.25 0.24 0.18 0.24 0.15 0.23 0.39 0.24 0.32 0.24 
 Bias   0.07  0.10  -0.15  -0.07  
Wave 3*Gender 0.18 0.24 0.16 0.24 0.22 0.23 0.29 0.24 0.26 0.24 
 Bias   0.02  -0.04  -0.11  -0.08  
Constant 49.03 0.25 48.69 0.25 48.91 0.25 48.89 0.26 49.06 0.25 
Bias   0.34  0.12  0.14  -0.03  
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 95%. 
Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, wealth, 
smoking status, alcohol consumption, physical activity, pain, ADLs, depressive symptoms, 
positive support and number of close friends and family. Figures based on the sample aged 50 and 
over. 
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Deterministic sensitivity analysis of depressive symptoms models 
 
Table 5.15 shows the results of the deterministic sensitivity analysis of depressive 
symptoms. The coefficient for CHD decreased in magnitude and was no longer 
significant in any of the four scenarios compared to the original results. Therefore, 
results of the deterministic sensitivity analysis suggest that men with CHD were not 
significantly more likely to have depressive symptoms than men from the Well group. 
The coefficient for gender slightly decreased in magnitude in all four scenarios 
compared to the original results, but conclusions remained unchanged.  The coefficient 
for the interaction term between CHD and gender decreased in magnitude under 
scenarios A, C and D, and was very similar to that of the original data under scenario B; 
as in the original data the interaction term was not statistically significant under any of 
the four scenarios. Values of bias were large for the coefficients of gender and 
interaction term under all scenarios, suggesting lack of potential accuracy of the original 
data. 
 
 
Table 5.15 Deterministic sensitivity analysis of the logistic random intercept model for 
depressive symptoms (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
CHD 0.35 0.16 0.25 0.14 0.21 0.16 0.11 0.13 0.24 0.14 
Bias   0.10  0.14  0.24  0.11  
Gender 0.78 0.11 0.73 0.09 0.75 0.09 0.75 0.10 0.74 0.09 
Bias   0.05  0.03  0.03  0.04  
CHD*gender -0.27 0.23 -0.10 0.20 -0.28 0.21 -0.18 0.18 -0.11 0.19 
Bias   -0.17  0.01  -0.09  -0.16  
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 
95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and 
specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, positive support and 
number of close friends and family. Figures based on the sample aged 50 and over. 
 
Results of the deterministic sensitivity analysis of the trajectories of depressive 
symptoms for the CHD group are shown in Table 5.16. Under scenarios A and D the 
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coefficient for gender increased in magnitude compared to the original data, but 
standard errors were very similar. This means that at baseline the gender difference in 
depressive symptoms obtained in the original data would be slightly underestimated if 
sensitivity and specificity were at the lowest and highest values. Under scenario B and 
C the coefficient decreased in magnitude (from 0.69 original data to 0.44 scenario B and 
to 0.52 scenario C), but under scenario B was no longer significant. Therefore if it was 
assumed that the self-reported measure of CHD had low sensitivity and high specificity, 
women would no longer be more likely than men to have depressive symptoms at 
baseline. The coefficient for wave 2 increased in magnitude under scenarios A and D 
compared to the original data. The coefficient decreased in magnitude under scenario C 
and under scenario B became negative (meaning that men were less likely to have 
depressive symptoms than at baseline). However, none of the coefficients were 
statistically significant, leading to the same conclusions as the original data (men at 
wave 2 were not significantly more likely than baseline to have depressive symptoms).  
 
Standard errors were close to those obtained from the original data, with the exception 
of the standard error obtained under scenario B, which was larger. Under scenarios A to 
D, the coefficient for wave 3 decreased in magnitude; however none of the coefficients 
was statistically significant, implying that the odds of having depressive symptoms did 
not change significantly in men from baseline to four year follow-up, a result that was 
also found in the original data.  Large bias values were found for the interaction terms 
according to all scenarios, suggesting lack of potential accuracy of the results based on 
the original data. None of the interaction terms obtained under the four scenarios were 
statistically significant, in line with results of the original data. In general, the results 
obtained from the original data would be most biased if lowest sensitivity and highest 
specificity are assumed (scenario B).  
 
In terms of trajectories of depressive symptoms of women with CHD, the deterministic 
sensitivity analysis showed that the finding obtained from the original data of women 
being significantly less likely to have depressive symptoms at four year follow-up 
(wave 3) compared to baseline was not replicated when misclassification was assumed. 
Also, under scenarios A and C the finding that women were not at higher risk of having 
depressive symptoms than men was not replicated. 
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Table 5.16 Deterministic sensitivity analysis of the logistic random intercept model for depressive 
symptoms with time, people with CHD (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
Gender 0.69 0.24 0.78 0.25 0.44 0.27 0.52 0.22 0.76 0.25 
 Bias   -0.09  0.25  0.17  -0.07  
Wave 2 0.18 0.20 0.27 0.21 -0.18 0.24 0.13 0.20 0.24 0.20 
 Bias   -0.09  0.36  0.05  -0.06  
Wave 3 0.06 0.21 -0.03 0.22 -0.06 0.24 -0.22 0.20 0.01 0.21 
 Bias   0.09  0.12  0.28  0.05  
Wave 2*Gender -0.12 0.28 -0.29 0.29 0.23 0.33 -0.01 0.26 -0.18 0.29 
 Bias   0.17  -0.35  -0.11  0.06  
Wave 3*Gender -0.52 0.29 -0.15 0.30 -0.33 0.33 0.02 0.27 -0.41 0.29 
 Bias   -0.37  -0.19  -0.54  -0.11  
 Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 95%. 
Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and specificity 95%. 
 Results adjusted for gender, age, marital status, employment status, educational attainment, wealth, 
smoking status, alcohol consumption, physical activity, pain, ADLs, positive support and number of 
close friends and family. Figures based on the sample aged 50 and over. 
 
 
The results of the deterministic sensitivity analysis for depressive symptoms in the Well 
group are shown in Table 5.17. Under the four scenarios the conclusions about 
depressive symptoms trajectories of men and women from the Well group remained 
unchanged compared to those obtained from the original data. Some of the values of the 
bias suggested good potential accuracy. 
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Table 5.17 Deterministic sensitivity analysis of the logistic random intercept model for 
depressive symptoms with time,  people from the Well group (imputed data) 
 
ELSA 
original Scenario A Scenario B Scenario C Scenario D 
 Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. Coeff. s.e. 
           
Gender 0.84 0.13 0.86 0.13 0.86 0.13 0.89 0.13 0.81 0.13 
Bias   -0.02  -0.02  -0.05  0.03  
Wave 2 0.15 0.12 0.16 0.12 0.24 0.12 0.18 0.12 0.13 0.12 
Bias   -0.01  -0.09  -0.03  0.02  
Wave 3 -0.16 0.13 -0.09 0.12 -0.13 0.12 -0.06 0.13 -0.14 0.13 
Bias   -0.07  -0.03  -0.10  -0.02  
Wave2*Gender -0.26 0.16 -0.26 0.15 -0.33 0.15 -0.33 0.16 -0.25 0.15 
 Bias   0.00  0.07  0.07  -0.01  
Wave3*Gender 0.10 0.16 -0.06 0.16 0.04 0.15 -0.06 0.16 0.06 0.16 
 Bias   0.16  0.06  0.16  0.04  
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 95%. 
Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, wealth, 
smoking status, alcohol consumption, physical activity, pain, ADLs, positive support and number of 
close friends and family. Figures based on the sample aged 50 and over. 
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5.3.3 Summary of results 
 
The results of the sensitivity analysis of trajectories of quality of life presented in Tables 
5.13 and 5.14 are summarised graphically in Figure 5.5 for the CHD group and 5.6 for 
the Well group. Regardless of the sensitivity, lower specificity (90%) of the CHD 
measure would lead to underestimated trajectories of quality of life of men and women 
with CHD. If the measure of CHD was assumed to have the lowest sensitivity (60%) 
and the highest specificity (95%), then the levels of quality of life of men with CHD 
would be overestimated at wave 2 and for women would be overestimated at each time. 
If the self-reported measure of CHD was assumed to have a sensitivity of 80% and a 
specificity of 95%, the trajectories of quality of life of men with CHD obtained from the 
original data would be almost the same. For women, the results of the original data 
would be underestimated but the shapes of trajectories would be the same.  
 
Assuming different values of the specificity and sensitivity led to negligible bias in the 
original results of trajectories of quality of life of men and women in the Well group 
(Figure 5.6). The only exception was when the lowest levels of sensitivity (scenario A 
and B) were assumed, which lead to a significant gender difference in baseline levels of 
quality of life of people from the Well group not found in the original data. If a high 
proportion of people with CHD were misreporting their disease status, women from the 
Well group would have had significantly higher quality of life than men at wave 1.  
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Figure 5.5 Trajectories over time of quality of life for men and women with CHD, 
comparing the four scenarios obtained from the deterministic sensitivity analysis (imputed 
data) 
 
 
 
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 
95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and 
specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends and family. Figures based on the 
sample aged 50 and over. 
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Figure 5.6 Trajectories over time of quality of life for men and women from the Well 
group, comparing the four scenarios obtained from the deterministic sensitivity analysis 
(imputed data) 
 
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 
95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: sensitivity 80% and 
specificity 95%. 
Results adjusted for gender, age, marital status, employment status, educational attainment, 
wealth, smoking status, alcohol consumption, physical activity, pain, ADLs, depressive 
symptoms, positive support and number of close friends and family. Figures based on the 
sample aged 50 and over. 
 
 
 
Results obtained in Tables 5.16 and 5.17 are presented graphically as odds ratios in 
figures 5.7 for the CHD group and figure 5.8 for the Well group. From the graphs it is 
easy to see that the trajectories of depressive symptoms obtained from the original data 
and those obtained under four scenarios led to the same conclusions for men with CHD, 
and men and women from the Well group. For women with CHD, under the four 
scenarios the results would be biased towards the null, as suggested by the non-
significant change over time in the odds of having depressive symptoms. 
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Figure 5.7 Trajectories over time of depressive symptoms for men and women with CHD, comparing the four scenarios obtained from the 
deterministic sensitivity analysis, odds ratios (imputed data) 
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Figure 5.7 Continued 
 
 
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: 
sensitivity 80% and specificity 95%.Results adjusted for gender, age, marital status, employment status, educational attainment, wealth, smoking status, alcohol 
consumption, physical activity, pain, ADLs, positive support and number of close friends and family. Figures based on the sample aged 50 and over. Results 
presented as odds ratios
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Figure 5.8 Trajectories over time of depressive symptoms for men and women from the Well group, comparing the four scenarios obtained from 
the deterministic sensitivity analysis, odds ratios (imputed data) 
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Figure 5.8-Continued 
 
Scenario A: sensitivity 60% and specificity 90%. Scenario B: sensitivity 60% and specificity 95%. Scenario C: sensitivity 80% and specificity 90%. Scenario D: 
sensitivity 80% and specificity 95%. Results adjusted for gender, age, marital status, employment status, educational attainment, wealth, smoking status, alcohol 
consumption, physical activity, pain, ADLs, positive support and number of close friends and family. Figures based on the sample aged 50 and over. Results 
presented as odds ratios. 
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5.4 Discussion 
 
Misclassification bias of self-reported measures can occur in epidemiological studies. 
Although previous studies have shown that the assessment of CHD by self-reports is a 
valid alternative when clinical assessment is not feasible, addressing quantitatively the 
effect of bias has been recommended (Jurek et al, 2006). The objective of this chapter 
was to follow this recommendation and quantify the bias that potential misclassification 
of self-reported CHD has on the results and learn how the observed findings may 
change by varying the assumed values of the misclassification parameters. It was 
hypothesised that the self-report measure of CHD is a reliable alternative when clinical 
assessment is not available and therefore the results would not draw different 
conclusions. 
The main problem with the ELSA data is that it does not validate the self-reported 
measure of CHD using clinical screening or medical records. To date it has not been 
possible to link the survey data with hospital records statistics. In order to be able to 
quantify the misclassification bias of the self-reported CHD measure first a sensitivity 
analysis was conducted using an external validation study, the Whitehall II study. The 
study was chosen because it is similar to ELSA in terms of mode and year of data 
collection, and the age range of the sample. The Whitehall II study validated the self-
reported measure of CHD with a clinical screening only for those with positive self-
reported CHD. From this study the prevalence of false positive self-reports of CHD 
were estimated and these were applied randomly to the ELSA data in order to simulate 
two possible scenarios under which misclassification could have occurred. The first 
scenario assumed that the prevalence of false positives was a random sample of the 
whole population. The second scenario was more realistic and assumed that the 
prevalence of false positives was a random sample of the self-reported CHD population.  
The prevalence of people with CHD was 17.2% in the original data. Assuming that 
falsely reporting CHD occurred randomly in the total population resulted in a lower 
prevalence of CHD (14.3% under first scenario) compared to the original. Assuming 
that the false positive group is a random sample of the CHD population led to a 
decrease of nearly 6 percentage points (11.1%) in the prevalence of CHD (second 
scenario). Results from the sensitivity analysis are summarised in Table 5.18. In 
general, results obtained under this first scenario and those from the original data led to 
the same conclusions about trajectories of quality of life of people with CHD and those 
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from the Well group: quality of life decreased over time in men from the CHD group 
and men and women from the Well group, while for women with CHD quality of life 
was stable between baseline and two year follow-up (wave 2) and then decreased. In 
terms of gender differences in quality of life, scenario 1 led to a type I error: women 
with CHD did not have higher quality of life than men at four year follow-up (wave 3).  
Under scenario 2, type I errors (occurring when the null hypothesis is wrongly rejected) 
were introduced at two year follow-up (wave 2) in both quality of life and depressive 
symptoms: women did not have higher quality of life than men and also were not more 
likely than men to have depressive symptoms. The results from the second scenario 
suggest that levels of quality of life for men with CHD would be slightly 
underestimated at each wave (0.1 at baseline, 0.2 at wave 2 and 0.2 at wave 3) and a 
type I error would be introduced at two year follow-up, since the quality of life did not 
decrease significantly. Under scenario 2 a type I error could be introduced by 
misclassification of CHD for women. In fact women’s quality of life would not change 
significantly at four year follow-up if 35% of people with CHD were misreporting their 
disease status. Results of quality of life of people from the Well group were unbiased, 
suggesting that misclassification does not affect the original results for this group. For 
depressive symptoms, results of men and women with CHD obtained under the first 
scenario were slightly biased. Assuming that 17% of people with CHD were wrongly 
classified as having CHD led to a type I error: men with CHD would not be at higher 
risk of having depressive symptoms than men from the Well group. The original 
estimates of the trajectories of depressive symptoms of people with CHD were slightly 
biased under scenario 2 and standard errors were larger, however conclusions remain 
unchanged. Results of trajectories of depressive symptoms for the Well group were 
robust as shown by the small values of bias obtained under the two scenarios and by the 
unchanged conclusions. 
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Table 5.18 Summary of findings of the sensitivity analysis based on the validation study 
 Scenario 1 Scenario 2 
Men with CHD QoL: unbiased results. 
Depression: Type I error for 
the differences with “Well” 
men. 
Slightly biased results but 
same conclusions. 
QoL: slightly underestimated levels 
at each wave. Type I error wave 2. 
Depression: Type I error for the 
differences with “Well” men. 
Biased estimates and large standard 
errors but same conclusions. 
Women with CHD QoL: underestimated levels 
at each wave, but same 
conclusions. 
Depression: slightly biased 
results but same conclusions. 
QoL: underestimated levels at each 
wave. Type I error wave 4.  
Depression: biased estimates and 
large standard errors.   
Gender differences in 
QoL CHD group 
QoL: Type I error, women 
did not have higher QoL than 
men at wave 3. 
QoL: Type I error, women did not 
have higher QoL than men at wave 
2. 
Depression: Type I error, women 
did not have higher risk of 
depressive symptoms at baseline 
and wave2 
   
Men-Well group QoL: unbiased results. 
Depression: unbiased results. 
QoL: unbiased results. 
Depression: unbiased results. 
Women -Well group QoL: unbiased results. 
Depression: unbiased results 
QoL: unbiased results. 
Depression: unbiased results 
Abbreviations: QoL quality of life  
Scenario 1: False positives is a random sample of people of the whole population. Scenario 2:  
False positives is a random sample of people of the self-reported CHD population. 
 
To summarise, if 17% of people with CHD were wrongly classified as having the 
disease, this would not have any impact in the results obtained from the original data for 
men with CHD, the only exception being that men with CHD would not be more likely 
than men from the Well group to have depressive symptoms. For women with CHD the 
levels of quality of life at wave 2 and wave 3 would be slightly higher than the original 
data where it was assumed that the self-reported measure of CHD was reliable.  
On the contrary, if 35% of people with CHD were wrongly classified as having the 
disease, this would change the conclusions of the original results in that the quality of 
life levels of men and women with CHD at each wave were slightly underestimated. 
Also, men would not have decreased quality of life at wave 2 and women would have 
stable quality of life over time, contrary to what was found in the original results. 
Results for depressive symptoms would be slightly biased and variability around the 
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estimates would be greater than the original results. The main impact of the 
misclassification on the depressive symptoms results would be on the baseline 
difference in depressive symptoms between men and women with CHD and on the 
difference between men with CHD and men from the Well group. 
The results of the Well group were not affected by the false positives. 
The sensitivity analysis conducted using an external validation study is a novel 
approach, especially in longitudinal data analysis. The main advantage of using the 
Whitehall II study was that the measures used in the analysis were collected in the same 
way as in ELSA. Also the year of collection was the same and the age range of the 
samples were almost the same. Nevertheless, the use of the Whitehall II study for the 
validation study had some limitations. Participants of the Whitehall II study were white-
collar civil servants and although at study entry they covered a wide range of grades, the 
“healthy worker effect” at baseline might have influenced the generalisability of any 
findings (Ferrie et al., 2009). A recent study on non-response and mortality in Whitehall 
II participants (Ferrie et al., 2009) showed that non-responders or partial responders had 
increased hazard for mortality compared to responders. Even after adjustment for age 
and education the overall prevalence of CHD in the Whitehall II study at phase 7 was 
about half of that of ELSA. This reflects the fact that the ELSA sample is a population-
based sample which therefore includes blue-collar as well as white-collar workers. The 
extent to which the prevalence of false positive found in Whitehall II could be applied at 
the same level to ELSA is not known. It is also possible that the prevalence of false 
positives is positively related to the true prevalence of CHD and therefore might be 
higher in the ELSA study than the Whitehall II study. To some extent the second 
scenario could be seen as a more realistic scenario. Given the scarce availability of 
clinical screening and linkage to medical records in health surveys, this is the best that 
could have been done in order to explore the bias introduced by self-reported measure 
of CHD. A better way to have done the correction would have been to allow the 
probability of a false positive report of CHD for an individual to depend on age and 
education as predicted by the logistic regression for Whitehall II. However, due to the 
small number of false positives it was not possible to predict the probabilities using this 
approach. 
A major limitation was that the Whitehall II study only validated positive cases of self-
reported CHD, and it was not possible to ascertain the validity of negative cases of 
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CHD and calculate the specificity.  It follows that the sensitivity analysis conducted in 
the first section of this chapter is a somewhat crude analysis. The ideal validation study 
to use for this sensitivity analysis would have been one that was performed on the 
ELSA sample, where the information provided by participants (or a subsample) was 
validated using hospital or physicians records. However, these data were not available 
and I am unaware of published papers or studies other than Whitehall II that reported 
appropriate data.  
To address the impact that misclassification error had, not only on the false positive 
cases of CHD but also on the negative cases of CHD a deterministic sensitivity analysis 
was then conducted. The prevalence of people with CHD was 19.9% in the original 
data. Assuming that the sensitivity of the self-reported measure of CHD was 60% and 
the specificity was 90% (scenario A) led to a similar prevalence of CHD (19.2%). A 
lower prevalence of CHD (15.9%) was obtained under scenario B where the specificity 
was increased to 95% (and sensitivity was kept at 60%). When the sensitivity was 
assumed to be 80% and the specificity 90% (scenario C), the prevalence of CHD 
increased to 23.8% compared to that of the original data, while the prevalence of CHD 
was almost the same (20.2%) as the prevalence of the original data when the specificity 
was increased to 95% (and the sensitivity was kept at 80%, scenario D).  
 
The results of the deterministic sensitivity analysis are summarised in Table 5.19. 
Regardless of the sensitivity, lower specificity (90%) of the CHD measure has been 
shown to lead to underestimated levels of quality of life at each time for men and at 
baseline for women with CHD. High specificity (95%) and low sensitivity (60%) of the 
CHD measure led to overestimated levels of quality of life at wave 2 for men and at 
each time for women with CHD. With both high sensitivity and specificity values, the 
trajectories of quality of life of men with CHD obtained from the original data could be 
slightly underestimated (quality of life levels would be lower at each wave) and 
misclassification would introduce a type I error (quality of life at wave 2 would not be 
significantly lower than baseline). For women, the results of the original data could be 
underestimated but the shapes of trajectories would be the same. Keeping the sensitivity 
constant to a high value, and varying the specificity values led to a type II error (which 
occurs when the null hypothesis is not rejected when it is in fact false) in the gender 
difference in quality of life at baseline among people with CHD: women had 
significantly higher quality of life than men. 
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Table 5.19 Summary of findings of the deterministic sensitivity analysis 
Men with CHD Specificity 
 Low High 
Sensitivity Low QoL: overestimated difference with 
men from Well group. 
Underestimated levels of QoL at 
each wave 
Depression: Type I error for the 
differences with men from Well 
group. 
 
QoL: overestimated difference 
with men from Well group.  
Overestimated levels of QoL at 
wave 2 
Depression: Type I error for the 
differences with men from Well 
group 
 
 
High QoL: overestimated difference with  
men from Well group.  
Underestimated levels of QoL at 
each time 
Depression: Type I error for the 
differences with men from Well 
group 
Biased estimates but same 
conclusions 
QoL: overestimated difference 
with men from Well group. 
Trajectories almost the same. 
Type I error QoL at wave 2. 
Depression: Type I error for the 
differences with men from Well 
group 
Biased estimates but same 
conclusions 
Women with CHD Specificity 
 Low High 
Sensitivity Low QoL: baseline level underestimated 
trajectories less steep.  
Depression: Type I error for 
decreased depression at wave 3 
 
QoL: Overestimated levels of at 
each time, but same shape 
Depression: Type I error for 
decreased depression at wave 3 
 
High QoL: baseline level underestimated 
trajectories less steep.  
Depression: Type I error for 
decreased depression at wave 3 
 
QoL: Underestimated levels of at 
each time, but same shape 
Depression: Type I error for 
decreased depression at wave 3 
 
Men and Women 
from the Well group 
Specificity 
 Low High 
Sensitivity Low QoL and depression estimates 
slightly biased, but same conclusions.  
 
QoL and depression estimates 
slightly biased, but same 
conclusions. Women’s QoL at 
baseline: type II error 
 
 
High QoL and depression estimates 
slightly biased, but same conclusions.  
 
QoL and depression estimates 
slightly biased, but same 
conclusions. Women’s QoL at 
baseline: type II error.  
 
Abbreviations: QoL quality of life.  
Sensitivity low 60%, high 80%. Specificity low 90%, high 95%. 
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Assuming different values of the specificity and sensitivity did not identify any bias in 
the original results of trajectories of quality of life of men and women in the Well 
group. The only exception was when the lowest level of sensitivity (regardless of the 
specificity) was assumed, which suggested that a type II error was introduced by 
misclassification (a significant gender difference in baseline levels of quality of life of 
people from the Well group that was not found in the original data).  
 
The original results of trajectories of depressive symptoms were quite robust, as shown 
by the small bias obtained under the four scenarios; results led to same conclusions for 
men with CHD, and men and women from the Well group. For women with CHD type I 
error could be introduced by misclassification (under the four scenarios) as suggested 
by the non-significant change over time in the odds of having depressive symptoms. 
 
The results of the deterministic sensitivity analysis showed that no specific values of 
sensitivity and specificity but rather a combination of both could introduce some bias in 
the results obtained from the original data (mainly those of the people with CHD) where 
it was assumed that the self-reported measure of CHD was correctly identifying people 
with and without the disease.  
 
A major strength of the deterministic sensitivity analysis was that it gave an idea of how 
the results might change according to different assumptions about the sensitivity and 
specificity of the self-reported CHD measure. Researchers might use this approach 
when a validation study is not available. Educated values of sensitivity and specificity 
can be applied to the data and robustness of results can be assessed under different 
assumptions. A more sophisticated way of conducting this deterministic sensitivity 
analysis would have allowed the sensitivity and specificity to depend on age, gender 
and perhaps education. Some studies showed that agreement and/or sensitivity and 
specificity varied according to gender (Okura et al., 2004; Yamagishi et al., 2009), age 
(Kehoe et al., 1994; Okura et al., 2004; Yamagishi et al., 2009) and education (Okura et 
al., 2004). However, it was decided not to take this approach for two reasons: first, it 
was not possible to find from the literature a study that was similar to ELSA from which 
to base the sensitivity and specificity assumptions by age, gender and education; 
second, even in the simplest case of applying different levels of sensitivity and 
specificity to a sample divided in two age groups (younger vs older) would have 
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resulted in 8 different scenarios. In order to make the deterministic sensitivity analysis 
simpler and the interpretation of results straightforward it was assumed that 
misclassification occurred randomly in the whole population. 
 
Researchers should address quantitatively the potential bias that a self-reported measure 
of disease could introduce in their results and conclusions, despite high levels of 
sensitivity and specificity. It was shown that even a simple sensitivity analysis could 
shed some light about the robustness of results based on a self-reported measure of 
CHD. 
 
In conclusion, the sensitivity analyses reported in this chapter helped understand the 
impact that misclassification of the self-reported CHD measure could have on the 
conclusions presented in Chapter 4. Contrary to what was hypothesised, the reliability 
of the results presented in Chapter 4 could be affected by the misclassification of self-
reported measure of CHD. If misclassification of any kind (false positives and a 
combination of both false positive and false negatives) occurred, then the result that 
men with CHD were at higher risk of having depressive symptoms compared to men 
from the Well group could not be replicated and therefore the robustness of the findings 
is compromised. High prevalence of false positives (35%) could compromise the 
robustness of the finding of decreased quality of life and lower risk of depressive 
symptoms at four year follow-up in women with CHD. Men with CHD would have 
stable quality of life at two year follow-up if high specificity (regardless of the 
sensitivity) and high prevalence of false positives (35%) occurred. Among people with 
CHD false positives (in both sensitivity analyses) led to non-significant gender 
differences in quality of life at four year follow-up and also to a non-significant gender 
difference in depressive symptoms at two year follow-up. 
 
In the next chapter the findings from the thesis will be discussed as a whole. 
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Appendix 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A5.1 Logistic regression of factors related 
to number of false positives in Whitehall II 
 
Odds 
Ratio 
Std. 
Err. P-value 
    
Age 1.11 0.03 0.000 
Female 0.67 0.25 0.274 
Medium 
education 1.32 0.51 0.465 
Low education 2.50 1.14 0.046 
Age range 50 to 74 
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Appendix 5.1 Calculation of the prevalence of CHD according to 
scenario 1 and scenario 2 
 
 
The number of people in ELSA population aged 50 to 74 is 9,347.  
The first scenario assumes that the prevalence of false positives is a random sample of 
the total population. Therefore 1.2%, the adjusted prevalence of false positives obtained 
from the Whitehall II study, is applied to the total ELSA population as follows:  
1.2% of 9,347=112. 
In order to find the proportion of people with CHD that are misreporting and should be 
recoded into the healthy group, 112 is divided by 650 (which is the number of people 
with CHD) giving 0.17 (17%).  
The second scenario assumes that the prevalence of false positives is a random sample 
of the CHD population. Therefore the proportion of people with CHD that are 
misreporting according to this definition is found as follows: 
61/174=0.35 (35%) 
where 61 is the adjusted number of false positives in Whitehall II and 174 is the 
adjusted number of people with CHD. 35% of people with CHD in the ELSA are then 
recoded into the healthy group.   
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Appendix 5.2 Stata syntax for generating the two scenarios of the 
sensitivity analysis based on the validation study 
 
 
****The following was applied to each of the 5 imputed data sets separately ***** 
 
set seed 123456789 
gen x=runiform() 
 
gen scen1=0 if x>0.176 
replace scen1=1 if x<=0.176 
tab scen1 
 
tab scen1 chd1 
 
gen y=runiform() 
 
gen scen2=0 if y>0.35 
replace scen2=1 if y<=0.35 
tab scen2 
 
tab scen2 chd1 
 
 
 
gen sc1chd1=chd1 
replace sc1chd1=0 if chd1==1 & scen1==1 
tab sc1chd1 
 
gen sc1chd2=sc1chd1 
gen sc1chd3=sc1chd1 
 
gen sc2chd1=chd1 
replace sc2chd1=0 if chd1==1 & scen2==1 
tab sc2chd1 
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Appendix 5.3 Stata syntax for generating the four scenarios of the 
deterministic sensitivity analysis  
 
****The following was applied to each of the 5 imputed data sets separately ***** 
 
set seed 123456789 
 
gen x=runiform() if chd1==0 
 
sum x  
 
gen y=runiform() if chd1==1 
 
sum y  
 
gen sc1chd1=chd1 
replace sc1chd1=1 if x<=0.1 
replace sc1chd1=0 if y<=0.4 
tab sc1chd1 
 
 
 
gen j=runiform() if chd1==0 
 
sum j  
 
gen k=runiform() if chd1==1 
 
sum k  
 
 
gen sc2chd1=chd1 
replace sc2chd1=1 if j<=0.05 
replace sc2chd1=0 if k<=0.4 
tab sc2chd1 
 
 
 
gen w=runiform() if chd1==0 
 
sum w  
 
gen z=runiform() if chd1==1 
 
sum z  
 
gen sc3chd1=chd1 
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replace sc3chd1=1 if w<=0.1 
replace sc3chd1=0 if z<=0.2 
tab sc3chd1 
 
 
gen u=runiform() if chd1==0 
 
sum u  
 
gen v=runiform() if chd1==1 
 
sum v  
 
gen sc4chd1=chd1 
replace sc4chd1=1 if u<=0.05 
replace sc4chd1=0 if v<=0.2 
tab sc4chd1 
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Chapter 6: Discussion 
 
This thesis focused on gender differences in quality of life and depressive symptoms 
among older people with coronary heart disease (CHD) and addressed common 
methodological problems of epidemiological studies, such as sources of error and 
uncertainty which may arise from missing data and self-reported CHD. 
 
Gender differences in quality of life and depressive symptoms while living with angina 
or a history of myocardial infarction had not previously been researched systematically. 
Findings from previous studies were mixed, and were mainly based on samples from 
hospitals, with a short period of follow-up. One of the contributions to the literature 
made by this thesis is the use of a large national sample of non-institutionalized older 
people living in England, followed over four years.   
 
Substantive results are discussed first, followed by methodological findings. 
 
6.1 Summary of substantive findings 
 
A cardiac event such as myocardial infarction or angina symptoms is a critical 
experience for an individual, with considerable impact upon mental health and quality 
of life. There has been a growing recognition of the importance of exploring the impact 
of coronary heart disease on patients’ well-being, with an emphasis on possible gender 
differences. To date, findings from research on gender differences in quality of life 
and/or depression among people with coronary heart disease have mainly been based on 
small samples with short follow-up periods. Additionally, the majority of research has 
had a selection bias with regards to the focus on myocardial infarction and not angina. 
Therefore this study presents a unique opportunity to explore gender differences in 
quality of life and depressive symptoms among people with coronary heart disease 
(CHD), using a large longitudinal sample of older people living in England.    
 
Based on findings from the literature, this study hypothesised that among people with 
CHD there would be significant gender differences in quality of life and depressive 
symptoms, with women being at higher risk than men of reporting depressive symptoms 
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and having lower quality of life. This study did not support this hypothesis for quality of 
life. Results showed no gender differences in quality of life at baseline (wave 1, 2002-
03), while at two year follow-up (wave 2, 2004-05) and four year follow-up (wave 3, 
2005-07) women had significantly higher quality of life than men. This was also true 
after adjusting for other covariates. The thesis did support the hypothesis of gender 
differences in depressive symptoms at baseline and at two year follow-up: it was found 
that women with CHD were at higher risk of having depressive symptoms than men 
with CHD, independent of other factors. Nevertheless, at four year follow-up there was 
no gender difference in depressive symptoms among men and women with CHD.  
 
Findings from this work supported the hypothesis of differently shaped trajectories over 
time for quality of life and depressive symptoms among men and women with CHD. 
For men with CHD, quality of life decreased significantly over time. Quality of life of 
women with CHD was stable at two years after baseline, followed by a decline at four 
year follow-up.  Trajectories in depressive symptoms were also different according to 
gender. The odds of having depressive symptoms did not change significantly over time 
for men. Among women with CHD, the odds of having depressive symptoms at two 
year follow-up were the same as at baseline, while at four year follow-up women were 
significantly less likely to report depressive symptoms than at baseline.  
 
Current debates about well-being suggest that it is a multifaceted concept from which 
three aspects can generally be distinguished: evaluative well-being, experienced well-being 
and eudemonic well-being (Dolan, Layard, & Metcalfe 2011; Kahneman & Krueger, 2010). 
The measure of quality of life used in this study reflects evaluative well-being, since it 
involves global assessments of how people evaluate their lives. Depressive symptoms 
reflect experienced well-being as they reflect the experience of emotions, such as sadness 
and happiness. Results from this thesis highlight the difference between these two 
aspects of people’s well-being and contribute to the current debate on the importance of 
measuring them separately to develop a broader appreciation of people’s lives. By 
exploring both quality of life and depressive symptoms after the onset of CHD it was 
possible to untangle aspects of people’s well-being never formally identified before.  
 
This study found that the risk of depression was constant over time among men and an 
improvement in depressive symptoms was found in women, while quality of life 
decreased in both men and women in the long term. It is possible that depression 
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reflected the immediate psychological reaction to the cardiac event, while the long term 
decline in quality of life was the consequence of the burdens that the disease placed on 
the health and socioeconomic status of individuals. A CHD event often involves 
changes to an individual’s lifestyles, therefore recovery from poor quality of life might 
require a long time, especially in those who as a result of the disease have experienced 
loss of control and autonomy. In this sample of older people, the long term decline in 
quality of life could also be a consequence of ageing, and not only the result of 
experiencing the disease. This can be supported by the results of this thesis of decline 
over time in quality of life among healthy individuals and it is consistent with previous 
studies reporting a trend of worsening quality of life over time especially at older ages 
(Zaninotto et al., 2009; Webb et al. 2010). On the other hand, the improvement in 
depression seen in women might reflect a process of adaptation to the disease. It has 
been shown that women have in general more coping strategies for stressful life events 
than men (Hobfoll et al., 1994). In particular, after experiencing myocardial infarction 
women are more likely than men to adopt problem-focused and emotion-focused coping 
strategies (Bogg et al., 2000). It is possible that in order to cope with CHD, women in 
this sample have adopted both problem-focused and emotion-focused strategies which 
helped to improve their mental health. It is also possible that women with depression 
were more likely to ask for help and be offered interventions by the general practitioner. 
It has been suggested that women are more likely than men to acknowledge depression 
and to seek for help from their primary care provider (Young et al., 1990). Either of 
these explanations show that the results of this thesis are consistent with previous 
findings; and also suggest that we might need to learn more about how women cope 
with CHD in order to help men adopt similar coping strategies for a long-term recovery 
in their quality of life. 
 
Previous studies focussing on gender differences in quality of life and depression 
among people with CHD did not systematically compare them with a control group of 
healthy persons. This study addressed this limitation by comparing the results of the 
CHD group with those from a healthy control group. It was hypothesised that people 
aged fifty and over who had had a CHD event (first or recurrent) would be at higher risk 
of experiencing depressive symptoms and poor quality of life than those from a healthy 
group. It was found that, compared with “healthy” people, men and women with CHD 
had, on average, lower levels of quality of life. Men with CHD were also at higher risk 
of having depressive symptoms than men from the healthy group. The findings from 
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this thesis did not support the hypothesis that, compared to women from the healthy 
group, women with CHD were more likely to have depressive symptoms. Previous 
studies have shown that women are in general more prone to depression than men 
irrespective of the disease status (Forrester et al., 1992; Freasure-Smith et al., 1999; 
Mallik et al., 2006), which might explain the finding of this study that women with 
CHD were equally likely to have depressive symptoms as “healthy” women. 
 
Among people from the healthy group, gender differences in depressive symptoms were 
found at each survey year; gender differences in quality of life were found at two year 
follow-up only, when women had higher quality of life than men. It is difficult to 
understand why gender differences in quality of life and depressive symptoms found in 
the CHD group were different from those found in the healthy group at four year 
follow-up, even after controlling for the same covariates. It is possible that some of the 
covariates and their change over time had a different impact on the outcomes considered 
according to disease status. 
 
Men and women from the healthy group reported similar trajectories of quality of life 
and depressive symptoms: quality of life decreased over time, while the odds of having 
depressive symptoms did not change significantly over time for both men and women. 
People from this healthy group had levels of quality of life that were on average higher 
than the general ELSA population; therefore, the decline in quality of life levels may 
have been a consequence of ageing or of development or progression of other disease. 
Stable levels of depressive symptoms over time could reflect the relatively good health 
of these individuals. It is also possible that individuals that are healthy are in general 
more resilient to stressors of life and therefore their mental health is maintained as they 
age. 
 
As seen for people in the CHD group, in this healthy population the results based on 
quality of life and those based on depressive symptoms go in different directions, 
strengthening the case for treating these two outcomes as distinct aspects of people’s 
well-being. 
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6.2 Summary of methodological findings 
6.2.1 Missing data 
 
Analyses of longitudinal data offer powerful and insightful approaches to understanding 
changes over time in a certain outcome, and what might be driving that change. 
However, researchers using longitudinal data are faced with some methodological 
problems. The most common problem of epidemiological studies is non-response. In 
addition to item non-response, longitudinal studies also face attrition due to death or 
drop-out from the study.  
 
The longitudinal data used in this thesis had over 50% of information missing that had 
accumulated over three waves due to item non-response and attrition. The data set 
therefore had incomplete time-dependent outcomes (one continuous and one binary) and 
incomplete time-dependent and time-independent covariates (of different types). One of 
the objectives of this thesis was to compare different techniques for dealing with 
missing data in longitudinal studies using full information maximum likelihood, 
multivariate normal imputation and two-fold fully conditional specification, in order to 
find the best model that yields unbiased results when applied to the data. 
 
A simulation study was set up to compare the performance of the three techniques for 
dealing with missing data, in order to investigate which technique was most suitable 
with this data structure. A maximum likelihood based method, full information 
maximum likelihood, was compared with two multiple imputation techniques: 
multivariate normal imputation and the two-fold fully conditional specification. 
Comparisons among the performance of each missing data technique in recovering 
parameter estimates of the continuous outcome (quality of life) and binary outcome 
(depressive symptoms) appeared to draw different conclusions on which of the three 
methodsmissing for dealing with missing data was most suitable for the data structure 
used in this thesis. Results showed that for the continuous outcome, the three missing 
data techniques performed equally well in recovering the targeted parameters. However, 
the two multiple imputation techniques performed better than the maximum likelihood 
based method in recovering the targeted parameter of the interaction term. This finding 
most probably reflected one of the advantages of using a multiple imputation method, 
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over full information maximum likelihood, where the interaction term can be 
accommodated during the imputation stage. 
 
For the binary outcome the two-fold fully conditional specification technique 
outperformed the full information maximum likelihood and multivariate normal 
imputation techniques. The two-fold fully conditional specification method performed 
exceptionally well in recovering targeted parameters with good accuracy and precision. 
The multivariate normal imputation technique lacked precision in recovering some of 
the targeted parameters, especially in the models where there was an interaction term 
with time. However, this method performed better than full information maximum 
likelihood which did not recover the targeted parameters in the model for the healthy 
population with good accuracy and precision. These results suggested that both methods 
that assume a joint multivariate normal distribution do not perform well with a binary 
outcome. 
 
Based on the results of the simulation study the two-fold fully conditional specification 
technique was then used to impute missing data for the substantive analyses, and proved 
to be particularly suitable for repeated measures. Results for depressive symptoms 
based on augmented samples were similar to those obtained from observed data (with 
missing data).  
 
More differences were found in the results for quality of life. For example, results 
obtained from observed data did not show differences in quality of life among people 
with CHD compared with people from the healthy population. Also, among men with 
CHD quality of life did not decrease significantly at two year follow-up in the observed 
data. This difference between analyses based on the augmented samples and those based 
on the sample with missing data in the quality of life results most probably reflects the 
fact that the missing data mechanism was not missing completely at random. 
Missingness in the quality of life measure depended on observed characteristics such as 
increasing age, CHD, low education, poor wealth, not cohabiting with a partner, 
permanently unable to work, not currently in paid employment and looking after home 
or family, and being physically inactive. Those reporting these characteristics are more 
likely to drop-out and to report a lower quality of life than those who were more 
advantaged (i.e. those in the healthy group, with high education, cohabiting with a 
partner and so forth). 
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These results supported the hypothesis that ignoring missing data would give biased 
results, especially when the missing data mechanism is not missing completely at 
random. 
 
6.2.2 Self-reported measure of CHD 
 
This thesis used a self-reported measure of CHD which was not validated against 
medical records or clinical assessment. Although previous studies have shown that the 
assessment of myocardial infarction by self-reports is a valid alternative when clinical 
assessment is not feasible, it has been recommended to address quantitatively the effect 
of bias (Jurek et al, 2006). One of the objectives of this study was to follow this 
recommendation and quantify the bias that potential misclassification of self-reported 
CHD has on the substantive results and learn how these may change by varying the 
assumed values of the misclassification parameters. It was hypothesised that the self-
report measure of CHD is a reliable alternative when clinical assessment is not available 
and therefore the results would not draw different conclusions. 
 
A quantitative sensitivity analysis was done using an external study, the Whitehall II 
study, which collected a self-reported measure of CHD and validated it with a clinical 
screening. From this study the prevalence of false positives was estimated and then 
applied to the ELSA data in order to assess the impact of the bias on the estimates 
obtained from analysis on gender differences in quality of life and depressive 
symptoms. Two possible scenarios under which misclassification could have occurred 
were considered. The first scenario assumed that the prevalence of false positives is a 
random sample of the whole population. The second scenario was more realistic and 
assumed that the prevalence of false positives is a random sample of the self-reported 
CHD population.  
 
In general, results obtained under the first scenario and those from the original data led 
to the same conclusions about trajectories of quality of life of people with CHD: quality 
of life decreased over time in men from the CHD group, while for women with CHD 
quality of life was stable between baseline and two year follow-up and then decreased. 
In terms of gender differences in quality of life, this scenario led to a type I error: 
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women with CHD did not have higher quality of life than men at four year follow-up. A 
type I error could also be introduced under this scenario for the results on depressive 
symptoms: men with CHD would not be at higher risk of having depressive symptoms 
than men from the healthy population. 
 
The results from the second scenario suggested that levels of quality of life for men with 
CHD would be slightly underestimated at each survey year and a type I error would be 
introduced at two year follow-up, since the quality of life of men with CHD did not 
decrease significantly. Under this scenario a type I error could also be introduced by 
misclassification of CHD for women. In fact women’s quality of life would not change 
significantly at four year follow-up. The original estimates of the trajectories of 
depressive symptoms of people with CHD were slightly biased under the second 
scenario and standard errors were larger. Under this scenario women with CHD were 
not at higher risk of having depressive symptoms compared to men at any survey year, a 
result that contradicted the original findings.    
 
The sensitivity analysis showed that the results of the original data were quite robust for 
men and women from the healthy group. It could be concluded that the results obtained 
for this group were not affected by false positive cases of CHD. 
 
It was only when the analysis was completed that I realised that not being able to assess 
the impact of misclassification due to false negatives (as well as false positives) was a 
main limitation. In the Whitehall II data only positive self-reported cases of CHD could 
be verified. Follow-up of clinical records and validation using clinically verified events 
was only carried out for the subset of Whitehall II participants in whom there was a 
suggestion of a CHD event. Therefore sensitivity and specificity could not be 
calculated. For that reason in I decided to conduct also a deterministic sensitivity 
analysis.   
 
From the deterministic sensitivity analysis, it can be concluded that regardless of the 
sensitivity, lower specificity of the CHD measure has been shown to lead to 
underestimated levels of quality of life at each time-point for men and at baseline for 
women with CHD. High specificity and low sensitivity of the CHD measure led to 
overestimated levels of quality of life at two year follow-up for men and at each time for 
women with CHD. With both high sensitivity and specificity values, the trajectories of 
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quality of life of men with CHD obtained from the original data could be slightly under 
estimated (quality of life levels would be lower at each time) and misclassification 
would introduce a type I error (quality of life at wave 2 would not be significantly lower 
than baseline). For women, the results of the original data could be underestimated but 
the shapes of trajectories remain unchanged.  
 
The original results of trajectories of depressive symptoms were quite robust, as shown 
by the small bias obtained under the four scenarios; results led to same conclusions for 
men with CHD. For women with CHD, a type I error could be introduced by 
misclassification (under the four scenarios) as suggested by the non-significant change 
over time in the odds of having depressive symptoms. 
 
Assuming different values of the specificity and sensitivity did not identify any bias in 
the original results of trajectories of quality of life and depressive symptoms of men and 
women in the healthy population. 
 
Contrary to what was hypothesised, the reliability of the results of this thesis could be 
affected by the misclassification of the self-reported measure of CHD. Unfortunately, 
the sensitivity analyses conducted did not give a clear cut answer on which values of 
false positives or false negatives could bias the results. Therefore specific 
recommendations about the use of the self-reported measure of CHD cannot be made 
based on the sensitivity analyses reported here. Rather the results of the sensitivity 
analyses presented in this thesis highlighted the fact that using a self-reported measure 
of disease is something that requires more attention and it is therefore important to 
address quantitatively the effect of any possible bias introduced by its use. 
 
6.3 Implications 
 
The findings from this thesis can be used to inform caregivers that after CHD, 
deterioration in quality of life among women may not occur in the immediate time 
following the CHD event. On the other hand, men seem to be less able to cope with the 
disease in the long term, in terms of their quality of life. Quality of life in men should be 
monitored in the years following the event in order to reduce the risk of long term 
deterioration.  
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Results from this thesis suggest that the mental health of men who have experienced a 
CHD event does not necessarily deteriorate over time, and the mental health of women 
could possibly improve in the long term. Caregivers could advise patients and their 
immediate relatives on effective strategies for coping with the cardiac event to help 
maintain good mental health. Especially for men they could advise adopting problem-
focused coping strategies which may be more useful for long-term coping with lifestyle 
changes caused by the disease. 
 
This research also has implications for the academic community. Researchers that wish 
to explore well-being are encouraged to measure separately evaluative and experience 
components of well-being. Researchers wishing to measure quality of life and its 
relationships with health, among older people, should consider the use of a measure that 
is independent of health and other factors that might influence it, such as CASP. This 
measure has been specifically developed for old age and it is based on the idea that 
quality of life should stand alone from the factors or influences that shape it. It is 
probably this characteristic of the measure that, in this thesis, allowed discovering 
trajectories of quality of life among people with CHD never reported before.  
 
The results from the simulation study for comparing techniques to deal with missing 
data can inform researchers that multiple imputation methods perform better than 
maximum likelihood based methods in the presence of a binary outcome and interaction 
terms. The two-fold fully conditional specification method is particularly recommended 
with repeated measures and in the presence of variables of different nature. Although 
this method is less feasible than the other two techniques in the presence of many 
waves, it proved to be invaluable when used to impute missing data for the substantive 
analyses. Researchers wishing to address the problem of missing data in longitudinal 
studies can be reassured that using this method will improve the validity of their results 
and reduce estimation bias caused by missing data. Recent advances in the use of this 
technique for missing data include the implementation of an algorithm in Stata, which 
will help researchers without technical expertise to apply this method easily. The Stata 
code will be available in the near future (Irene Petersen, personal communication). 
 
In terms of the self-reported measure of CHD, the results from the sensitivity analysis 
showed that results could lead to different conclusions when different values of 
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sensitivity and specificity are assumed. Therefore researchers using a self-reported 
measure of disease should address quantitatively the potential bias that such measures 
could introduce to their results and conclusions. It was shown that even a simple 
sensitivity analysis could shed some light about the robustness of results based on a 
self-reported measure of CHD.  
 
Results from the sensitivity analysis do not suggest that the use of self-reported 
measures of disease inevitably introduce misclassification bias and should not 
discourage researchers from using survey data for medical and epidemiological 
research. Rather results suggested that perceived disease status could be of importance 
in itself.   
6.4 Strengths and limitations 
 
One of the strengths of this thesis included the use of a large sample of older people 
living in private households in England. The study has been designed to collect 
information on topics necessary to understand the economic, social, psychological and 
health elements of the ageing process. Some of the advantages of using this data set 
include: the study collects information on angina as well as myocardial infarction; a 
measure of depressive symptoms as well as a measure of quality of life specifically 
designed for older people (CASP); and the possibility to compare the results for the 
CHD population with those for a healthy population. 
 
A further strength of this study was the possibility to adjust analyses for a wide range of 
covariates relevant to the outcomes and exposure.  
 
A major strength of the simulation study was that, to date and to my knowledge, for the 
first time techniques for dealing with missing data in the presence of both continuous 
and binary outcomes were simultaneously compared. Furthermore, missing data (in the 
outcomes as well as covariates) due not only to item non-response but also to drop-out 
was addressed. This was also the first study to apply the recently proposed two-fold 
fully conditional specification to longitudinal data from a national survey and compared 
it with full information maximum likelihood and multivariate normal imputation. 
 
 245 
 
The sensitivity analysis based on the external validation study to test misclassification 
due to false positive cases of CHD had the strength of being a novel approach, 
especially in the context of longitudinal data analysis. A strength of deterministic 
sensitivity analysis was that it helped understand how the results might change 
according to different assumptions about the sensitivity and specificity of the self-
reported CHD measure. 
 
However, some limitations of this thesis should also be acknowledged. First, in the 
missing data analysis missing at random was assumed. This assumption is often difficult 
to verify. To reinforce the missing at random assumption and to reduce the bias caused 
by missing data, auxiliary variables predictive of missingness were included in the 
imputation stage.  
 
Another limitation of the missing data analysis was that in dealing with attrition, no 
distinction was made between drop-out due to death and other reasons for loss to 
follow-up. By treating death and attrition as the same form of drop-out, it was assumed 
that trajectories continue beyond death and therefore that the panel was immortal. In the 
context of this research it seemed appropriate to consider the possible outcome a 
participant could have had if he or she had not died. 
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A further limitation of this study is that no information about depression and quality of 
life was available before the baseline interview. It is not known whether poor quality of 
life and increased risk of depressive symptoms began before the coronary heart event. 
This is an important issue since recent reviews of the literature (Frasure-Smith 2005, 
2006) showed that there is evidence of both an etiologic role for depression in CHD 
(that is, depression preceding development of CHD) and a prognostic role for 
depression in CHD (that is, depression predicting prognosis in established CHD). It 
could be possible that those who were depressed before the baseline interview were 
more likely to suffer a CHD event, and it is also possible that those who were depressed 
were less likely to take part in the study. If people with CHD had low pre-CHD quality 
of life levels and were depressed then attributing low levels of quality of life and high 
risk of depressive symptoms to a recent CHD event would be erroneous. 
Lastly, due to lack of power it has not been possible to consider angina and myocardial 
infarction as two separate exposures. Angina is the predominant presentation of CHD 
among women while myocardial infarction is predominant among males. Therefore 
considering these two exposures together might have resulted in underestimated gender 
differences in quality of life and depressive symptoms.   
6.5 Future research 
 
During the work on this doctoral thesis some new questions on the methods used to 
adjust for missing data were raised. Attrition and mortality are intrinsically related to 
many ageing-related changes in longitudinal studies. Therefore the analysis and 
interpretation of results should consider the bias introduced by these two different forms 
of missingness. This is an area of research that is still under development, although 
several methods have been proposed.  
 
In future research I would like to expand on the problem of missing data to distinguish 
between attrition and mortality, and possibly incorporate missingness due to item non-
response. Another question that was raised during the simulation study for missing data 
was about the plausibility of the missing at random assumption. It would be interesting 
in future research to investigate the robustness of key inferences to possible departures 
from the missing at random assumption, by doing a sensitivity analysis assuming a 
missing not at random mechanism.  
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Adjustment for socio-demographic factors, health behaviour factors, health factors and 
social factors were also shown to be important in the analysis presented in this thesis. 
The next step for this work is to investigate the effect of independent variables using 
mixture modelling. Under this approach, individuals are classified into subpopulations 
based on heterogeneity in the data. Individuals who are similar along a dimension of 
interest (e.g., health behaviour) are grouped into the same class, and those who are 
different are grouped into different classes. 
 
The sensitivity analysis of self-reported CHD could be extended when the link between 
the ELSA data and the Hospital Episode Statistics has been achieved. A small 
validation study could be performed on the ELSA sample using hospital records.  
 
6.6 Conclusions 
 
The main conclusions that can be drawn from this study are: 
 
Men with CHD were at higher risk of having poor quality of life and depressive 
symptoms than men from the healthy population. Women with CHD had lower levels of 
quality of life than women from the healthy population, but they were not more likely to 
have depressive symptoms. 
 
Different shapes of trajectories of quality of life and depressive symptoms among men 
and women aged fifty and over who had experienced CHD were found. At baseline, 
following the experience of CHD, men and women had same levels of quality of life. 
However, while for men quality of life decreased significantly over time, the quality of 
life of women with CHD was stable at two years after baseline, followed by a decline at 
four year follow-up. In terms of depressive symptoms, men did not report any change in 
their mental health over time. Women at two year follow-up were as likely as at 
baseline to have depressive symptoms, but at four year follow-up were significantly less 
likely to report depressive symptoms compared with baseline. 
 
Women were more likely to have depressive symptoms than men at baseline at two year 
follow-up only. No significant gender differences in quality of life were found at 
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baseline, while at two year follow-up and at four year follow-up women had higher 
quality of life than men. 
 
Women with CHD did not report similar trajectories of quality of life and depressive 
symptoms as men with CHD and men and women from the healthy group. Gender 
differences in quality of life and depressive symptoms found in the CHD group at year 
four of follow-up were not found in the healthy population, even after adjusting for the 
same covariates. 
 
Ignoring missing data would have given biased results, especially for quality of life 
where a large amount of data was missing. 
 
Reliability of the results could be affected by misclassification bias in the self-reported 
measure of CHD. 
 
At this culmination of my PhD thesis, the following quote seems to capture the view I 
now hold about the research process:  
 
“The more we learn about the world, and the deeper our learning, the more conscious, 
specific, and articulate will be our knowledge of what we do not know; our knowledge 
of our ignorance. For this indeed, is the main source of our ignorance - the fact that our 
knowledge can be only finite, while our ignorance must necessarily be infinite.” 
(Popper, 2002:38) 
 
This work is just the beginning of my knowledge on this topic - it can never be the end. 
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